BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy12228
(258 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 146 bits (368), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 75/132 (56%), Positives = 94/132 (71%), Gaps = 3/132 (2%)
Query: 78 AFGKVICAEANGILKQ--GIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
AFG+V+ AEA G+ K +T VAVKMLK ++ ++ DL+SEMEMMKMIG+H NIINL
Sbjct: 40 AFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL 99
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
LG CTQDGPLYVIVE+A GNLR++L+ RP G E ++ L+ KDL+S AYQ
Sbjct: 100 LGACTQDGPLYVIVEYASKGNLREYLQARRP-PGLEFSFNPSHNPEEQLSSKDLVSCAYQ 158
Query: 196 VANGMHYLQSRK 207
VA GM YL S+K
Sbjct: 159 VARGMEYLASKK 170
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 146 bits (368), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 75/132 (56%), Positives = 94/132 (71%), Gaps = 3/132 (2%)
Query: 78 AFGKVICAEANGILKQ--GIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
AFG+V+ AEA G+ K +T VAVKMLK ++ ++ DL+SEMEMMKMIG+H NIINL
Sbjct: 33 AFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL 92
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
LG CTQDGPLYVIVE+A GNLR++L+ RP G E ++ L+ KDL+S AYQ
Sbjct: 93 LGACTQDGPLYVIVEYASKGNLREYLQARRP-PGLEYSYNPSHNPEEQLSSKDLVSCAYQ 151
Query: 196 VANGMHYLQSRK 207
VA GM YL S+K
Sbjct: 152 VARGMEYLASKK 163
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 145 bits (367), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 75/132 (56%), Positives = 94/132 (71%), Gaps = 3/132 (2%)
Query: 78 AFGKVICAEANGILKQ--GIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
AFG+V+ AEA G+ K +T VAVKMLK ++ ++ DL+SEMEMMKMIG+H NIINL
Sbjct: 29 AFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL 88
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
LG CTQDGPLYVIVE+A GNLR++L+ RP G E ++ L+ KDL+S AYQ
Sbjct: 89 LGACTQDGPLYVIVEYASKGNLREYLQARRP-PGLEYSYNPSHNPEEQLSSKDLVSCAYQ 147
Query: 196 VANGMHYLQSRK 207
VA GM YL S+K
Sbjct: 148 VARGMEYLASKK 159
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 145 bits (367), Expect = 2e-35, Method: Compositional matrix adjust.
Identities = 75/132 (56%), Positives = 94/132 (71%), Gaps = 3/132 (2%)
Query: 78 AFGKVICAEANGILKQ--GIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
AFG+V+ AEA G+ K +T VAVKMLK ++ ++ DL+SEMEMMKMIG+H NIINL
Sbjct: 32 AFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL 91
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
LG CTQDGPLYVIVE+A GNLR++L+ RP G E ++ L+ KDL+S AYQ
Sbjct: 92 LGACTQDGPLYVIVEYASKGNLREYLQARRP-PGLEYSYNPSHNPEEQLSSKDLVSCAYQ 150
Query: 196 VANGMHYLQSRK 207
VA GM YL S+K
Sbjct: 151 VARGMEYLASKK 162
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 145 bits (367), Expect = 2e-35, Method: Compositional matrix adjust.
Identities = 75/132 (56%), Positives = 94/132 (71%), Gaps = 3/132 (2%)
Query: 78 AFGKVICAEANGILKQ--GIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
AFG+V+ AEA G+ K +T VAVKMLK ++ ++ DL+SEMEMMKMIG+H NIINL
Sbjct: 40 AFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL 99
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
LG CTQDGPLYVIVE+A GNLR++L+ RP G E ++ L+ KDL+S AYQ
Sbjct: 100 LGACTQDGPLYVIVEYASKGNLREYLQARRP-PGLEYSYNPSHNPEEQLSSKDLVSCAYQ 158
Query: 196 VANGMHYLQSRK 207
VA GM YL S+K
Sbjct: 159 VARGMEYLASKK 170
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 145 bits (366), Expect = 2e-35, Method: Compositional matrix adjust.
Identities = 75/132 (56%), Positives = 94/132 (71%), Gaps = 3/132 (2%)
Query: 78 AFGKVICAEANGILKQ--GIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
AFG+V+ AEA G+ K +T VAVKMLK ++ ++ DL+SEMEMMKMIG+H NIINL
Sbjct: 81 AFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL 140
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
LG CTQDGPLYVIVE+A GNLR++L+ RP G E ++ L+ KDL+S AYQ
Sbjct: 141 LGACTQDGPLYVIVEYASKGNLREYLQARRP-PGLEYSYNPSHNPEEQLSSKDLVSCAYQ 199
Query: 196 VANGMHYLQSRK 207
VA GM YL S+K
Sbjct: 200 VARGMEYLASKK 211
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 145 bits (366), Expect = 2e-35, Method: Compositional matrix adjust.
Identities = 75/132 (56%), Positives = 94/132 (71%), Gaps = 3/132 (2%)
Query: 78 AFGKVICAEANGILKQ--GIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
AFG+V+ AEA G+ K +T VAVKMLK ++ ++ DL+SEMEMMKMIG+H NIINL
Sbjct: 25 AFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL 84
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
LG CTQDGPLYVIVE+A GNLR++L+ RP G E ++ L+ KDL+S AYQ
Sbjct: 85 LGACTQDGPLYVIVEYASKGNLREYLQARRP-PGLEYCYNPSHNPEEQLSSKDLVSCAYQ 143
Query: 196 VANGMHYLQSRK 207
VA GM YL S+K
Sbjct: 144 VARGMEYLASKK 155
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 145 bits (365), Expect = 3e-35, Method: Compositional matrix adjust.
Identities = 75/132 (56%), Positives = 94/132 (71%), Gaps = 3/132 (2%)
Query: 78 AFGKVICAEANGILKQ--GIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
AFG+V+ AEA G+ K +T VAVKMLK ++ ++ DL+SEMEMMKMIG+H NIINL
Sbjct: 40 AFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL 99
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
LG CTQDGPLYVIVE+A GNLR++L+ RP G E ++ L+ KDL+S AYQ
Sbjct: 100 LGACTQDGPLYVIVEYASKGNLREYLQARRP-PGLEYCYNPSHNPEEQLSSKDLVSCAYQ 158
Query: 196 VANGMHYLQSRK 207
VA GM YL S+K
Sbjct: 159 VARGMEYLASKK 170
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 143 bits (361), Expect = 8e-35, Method: Compositional matrix adjust.
Identities = 74/132 (56%), Positives = 93/132 (70%), Gaps = 3/132 (2%)
Query: 78 AFGKVICAEANGILKQ--GIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
AFG+V+ AEA G+ K +T VAVKMLK ++ ++ DL+SEMEMMKMIG+H NIINL
Sbjct: 40 AFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL 99
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
LG CTQDGPLYVIVE+A GNLR++L+ P G E ++ L+ KDL+S AYQ
Sbjct: 100 LGACTQDGPLYVIVEYASKGNLREYLQAREP-PGLEYSYNPSHNPEEQLSSKDLVSCAYQ 158
Query: 196 VANGMHYLQSRK 207
VA GM YL S+K
Sbjct: 159 VARGMEYLASKK 170
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 142 bits (357), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 76/132 (57%), Positives = 91/132 (68%), Gaps = 3/132 (2%)
Query: 78 AFGKVICAEANGILKQGI--ITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
AFG+V+ AEA GI K TVAVKMLK+ ++ ++ DLVSEMEMMKMIG+H NIINL
Sbjct: 47 AFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL 106
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
LG CTQDGPLYVIVE+A GNLR++LR RP G E +T KDL+S YQ
Sbjct: 107 LGACTQDGPLYVIVEYASKGNLREYLRARRP-PGMEXSYDINRVPEEQMTFKDLVSCTYQ 165
Query: 196 VANGMHYLQSRK 207
+A GM YL S+K
Sbjct: 166 LARGMEYLASQK 177
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 141 bits (356), Expect = 3e-34, Method: Compositional matrix adjust.
Identities = 76/132 (57%), Positives = 91/132 (68%), Gaps = 3/132 (2%)
Query: 78 AFGKVICAEANGILKQGI--ITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
AFG+V+ AEA GI K TVAVKMLK+ ++ ++ DLVSEMEMMKMIG+H NIINL
Sbjct: 47 AFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL 106
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
LG CTQDGPLYVIVE+A GNLR++LR RP G E +T KDL+S YQ
Sbjct: 107 LGACTQDGPLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFKDLVSCTYQ 165
Query: 196 VANGMHYLQSRK 207
+A GM YL S+K
Sbjct: 166 LARGMEYLASQK 177
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 141 bits (356), Expect = 3e-34, Method: Compositional matrix adjust.
Identities = 76/132 (57%), Positives = 91/132 (68%), Gaps = 3/132 (2%)
Query: 78 AFGKVICAEANGILKQGI--ITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
AFG+V+ AEA GI K TVAVKMLK+ ++ ++ DLVSEMEMMKMIG+H NIINL
Sbjct: 47 AFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL 106
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
LG CTQDGPLYVIVE+A GNLR++LR RP G E +T KDL+S YQ
Sbjct: 107 LGACTQDGPLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFKDLVSCTYQ 165
Query: 196 VANGMHYLQSRK 207
+A GM YL S+K
Sbjct: 166 LARGMEYLASQK 177
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 141 bits (355), Expect = 4e-34, Method: Compositional matrix adjust.
Identities = 76/132 (57%), Positives = 91/132 (68%), Gaps = 3/132 (2%)
Query: 78 AFGKVICAEANGILKQGI--ITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
AFG+V+ AEA GI K TVAVKMLK+ ++ ++ DLVSEMEMMKMIG+H NIINL
Sbjct: 47 AFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINL 106
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
LG CTQDGPLYVIVE+A GNLR++LR RP G E +T KDL+S YQ
Sbjct: 107 LGACTQDGPLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFKDLVSCTYQ 165
Query: 196 VANGMHYLQSRK 207
+A GM YL S+K
Sbjct: 166 LARGMEYLASQK 177
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 141 bits (355), Expect = 4e-34, Method: Compositional matrix adjust.
Identities = 76/132 (57%), Positives = 91/132 (68%), Gaps = 3/132 (2%)
Query: 78 AFGKVICAEANGILKQGI--ITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
AFG+V+ AEA GI K TVAVKMLK+ ++ ++ DLVSEMEMMKMIG+H NIINL
Sbjct: 47 AFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL 106
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
LG CTQDGPLYVIVE+A GNLR++LR RP G E +T KDL+S YQ
Sbjct: 107 LGACTQDGPLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFKDLVSCTYQ 165
Query: 196 VANGMHYLQSRK 207
+A GM YL S+K
Sbjct: 166 LARGMEYLASQK 177
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 140 bits (353), Expect = 7e-34, Method: Compositional matrix adjust.
Identities = 75/131 (57%), Positives = 90/131 (68%), Gaps = 3/131 (2%)
Query: 79 FGKVICAEANGILKQGI--ITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLL 136
FG+V+ AEA GI K TVAVKMLK+ ++ ++ DLVSEMEMMKMIG+H NIINLL
Sbjct: 94 FGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 153
Query: 137 GVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQV 196
G CTQDGPLYVIVE+A GNLR++LR RP G E +T KDL+S YQ+
Sbjct: 154 GACTQDGPLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFKDLVSCTYQL 212
Query: 197 ANGMHYLQSRK 207
A GM YL S+K
Sbjct: 213 ARGMEYLASQK 223
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 139 bits (351), Expect = 1e-33, Method: Compositional matrix adjust.
Identities = 75/131 (57%), Positives = 90/131 (68%), Gaps = 3/131 (2%)
Query: 79 FGKVICAEANGILKQGI--ITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLL 136
FG+V+ AEA GI K TVAVKMLK+ ++ ++ DLVSEMEMMKMIG+H NIINLL
Sbjct: 40 FGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 99
Query: 137 GVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQV 196
G CTQDGPLYVIVE+A GNLR++LR RP G E +T KDL+S YQ+
Sbjct: 100 GACTQDGPLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFKDLVSCTYQL 158
Query: 197 ANGMHYLQSRK 207
A GM YL S+K
Sbjct: 159 ARGMEYLASQK 169
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 139 bits (351), Expect = 1e-33, Method: Compositional matrix adjust.
Identities = 75/132 (56%), Positives = 90/132 (68%), Gaps = 3/132 (2%)
Query: 78 AFGKVICAEANGILKQGI--ITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
FG+V+ AEA GI K TVAVKMLK+ ++ ++ DLVSEMEMMKMIG+H NIINL
Sbjct: 34 CFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL 93
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
LG CTQDGPLYVIVE+A GNLR++LR RP G E +T KDL+S YQ
Sbjct: 94 LGACTQDGPLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFKDLVSCTYQ 152
Query: 196 VANGMHYLQSRK 207
+A GM YL S+K
Sbjct: 153 LARGMEYLASQK 164
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 139 bits (350), Expect = 1e-33, Method: Compositional matrix adjust.
Identities = 75/131 (57%), Positives = 90/131 (68%), Gaps = 3/131 (2%)
Query: 79 FGKVICAEANGILKQGI--ITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLL 136
FG+V+ AEA GI K TVAVKMLK+ ++ ++ DLVSEMEMMKMIG+H NIINLL
Sbjct: 37 FGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 96
Query: 137 GVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQV 196
G CTQDGPLYVIVE+A GNLR++LR RP G E +T KDL+S YQ+
Sbjct: 97 GACTQDGPLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFKDLVSCTYQL 155
Query: 197 ANGMHYLQSRK 207
A GM YL S+K
Sbjct: 156 ARGMEYLASQK 166
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 139 bits (349), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 75/132 (56%), Positives = 90/132 (68%), Gaps = 3/132 (2%)
Query: 78 AFGKVICAEANGILKQGI--ITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
AFG+V+ AEA GI K TVAVKMLK+ ++ ++ DLVSEMEMMKMIG+H NII L
Sbjct: 47 AFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITL 106
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
LG CTQDGPLYVIVE+A GNLR++LR RP G E +T KDL+S YQ
Sbjct: 107 LGACTQDGPLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFKDLVSCTYQ 165
Query: 196 VANGMHYLQSRK 207
+A GM YL S+K
Sbjct: 166 LARGMEYLASQK 177
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 139 bits (349), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 75/132 (56%), Positives = 91/132 (68%), Gaps = 3/132 (2%)
Query: 78 AFGKVICAEANGILKQGI--ITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
AFG+V+ AEA GI K TVAVKMLK+ ++ ++ DLVSEMEMMKMIG+H NII+L
Sbjct: 47 AFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHL 106
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
LG CTQDGPLYVIVE+A GNLR++LR RP G E +T KDL+S YQ
Sbjct: 107 LGACTQDGPLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFKDLVSCTYQ 165
Query: 196 VANGMHYLQSRK 207
+A GM YL S+K
Sbjct: 166 LARGMEYLASQK 177
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 139 bits (349), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 75/132 (56%), Positives = 90/132 (68%), Gaps = 3/132 (2%)
Query: 78 AFGKVICAEANGILKQGI--ITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
AFG+V+ AEA GI K TVAVKMLK+ ++ ++ DLVSEMEMMKMIG+H NIINL
Sbjct: 47 AFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL 106
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
LG CTQDGPLYVIV +A GNLR++LR RP G E +T KDL+S YQ
Sbjct: 107 LGACTQDGPLYVIVAYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFKDLVSCTYQ 165
Query: 196 VANGMHYLQSRK 207
+A GM YL S+K
Sbjct: 166 LARGMEYLASQK 177
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 138 bits (347), Expect = 3e-33, Method: Compositional matrix adjust.
Identities = 75/132 (56%), Positives = 90/132 (68%), Gaps = 3/132 (2%)
Query: 78 AFGKVICAEANGILKQGI--ITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
AFG+V+ AEA GI K TVAVKMLK+ ++ ++ DLVSEMEMMKMIG+H NIINL
Sbjct: 47 AFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL 106
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
LG CTQDGPLYVIV +A GNLR++LR RP G E +T KDL+S YQ
Sbjct: 107 LGACTQDGPLYVIVGYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFKDLVSCTYQ 165
Query: 196 VANGMHYLQSRK 207
+A GM YL S+K
Sbjct: 166 LARGMEYLASQK 177
>pdb|1RJB|A Chain A, Crystal Structure Of Flt3
Length = 344
Score = 112 bits (279), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 62/133 (46%), Positives = 83/133 (62%), Gaps = 6/133 (4%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFGKV+ A A GI K G+ VAVKMLKE +E L+SE++MM +G H NI+NLLG
Sbjct: 57 AFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLG 116
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSG-----YESPLG-SAYTNGNVLTEKDLIS 191
CT GP+Y+I E+ +G+L ++LR R YE+ + NVLT +DL+
Sbjct: 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLC 176
Query: 192 FAYQVANGMHYLQ 204
FAYQVA GM +L+
Sbjct: 177 FAYQVAKGMEFLE 189
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 107 bits (268), Expect = 5e-24, Method: Compositional matrix adjust.
Identities = 59/130 (45%), Positives = 84/130 (64%), Gaps = 3/130 (2%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKE-GHSDAEMMDLVSEMEMMKMIGQHINIINLL 136
AFGKV+ A A G+ K+ + VAVKMLK H+D E L+SE+++M +GQH NI+NLL
Sbjct: 58 AFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD-EKEALMSELKIMSHLGQHENIVNLL 116
Query: 137 GVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQV 196
G CT GP+ VI E+ +G+L +FLR+ RP G E ++ L+ +DL+ F+ QV
Sbjct: 117 GACTHGGPVLVITEYCCYGDLLNFLRRKRP-PGLEYSYNPSHNPEEQLSSRDLLHFSSQV 175
Query: 197 ANGMHYLQSR 206
A GM +L S+
Sbjct: 176 AQGMAFLASK 185
>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 107 bits (268), Expect = 5e-24, Method: Compositional matrix adjust.
Identities = 63/133 (47%), Positives = 84/133 (63%), Gaps = 6/133 (4%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
+ AFG+VI A+A GI K TVAVKMLKEG + +E L+SE++++ IG H+N++NL
Sbjct: 37 RGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96
Query: 136 LGVCTQD-GPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAY 194
LG CT+ GPL VIVEF GNL +LR R P Y + LT + LI +++
Sbjct: 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF---VPYKDLYK--DFLTLEHLIXYSF 151
Query: 195 QVANGMHYLQSRK 207
QVA GM +L SRK
Sbjct: 152 QVAKGMEFLASRK 164
>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea
Inhibitor
Length = 316
Score = 107 bits (267), Expect = 6e-24, Method: Compositional matrix adjust.
Identities = 64/133 (48%), Positives = 86/133 (64%), Gaps = 5/133 (3%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFG+VI A+A GI K TVAVKMLKEG + +E L+SE++++ IG H+N++NLLG
Sbjct: 40 AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 99
Query: 138 VCTQD-GPLYVIVEFAPHGNLRDFLRKHRPS-SGYESPLGSAYTNGNVLTEKDLISFAYQ 195
CT+ GPL VIVEF GNL +LR R Y++P Y + LT + LI +++Q
Sbjct: 100 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTP-EDLYK--DFLTLEHLICYSFQ 156
Query: 196 VANGMHYLQSRKV 208
VA GM +L SRK
Sbjct: 157 VAKGMEFLASRKC 169
>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 107 bits (267), Expect = 6e-24, Method: Compositional matrix adjust.
Identities = 63/133 (47%), Positives = 84/133 (63%), Gaps = 6/133 (4%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
+ AFG+VI A+A GI K TVAVKMLKEG + +E L+SE++++ IG H+N++NL
Sbjct: 37 RGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96
Query: 136 LGVCTQD-GPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAY 194
LG CT+ GPL VIVEF GNL +LR R P Y + LT + LI +++
Sbjct: 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF---VPYKDLYK--DFLTLEHLICYSF 151
Query: 195 QVANGMHYLQSRK 207
QVA GM +L SRK
Sbjct: 152 QVAKGMEFLASRK 164
>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2
With A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 318
Score = 107 bits (266), Expect = 8e-24, Method: Compositional matrix adjust.
Identities = 63/133 (47%), Positives = 84/133 (63%), Gaps = 4/133 (3%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFG+VI A+A GI K TVAVKMLKEG + +E L+SE++++ IG H+N++NLLG
Sbjct: 41 AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 100
Query: 138 VCTQD-GPLYVIVEFAPHGNLRDFLRKHRPS-SGYESPLGSAYTNGNVLTEKDLISFAYQ 195
CT+ GPL VIVEF GNL +LR R Y+ Y + LT + LI +++Q
Sbjct: 101 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYK--DFLTLEHLICYSFQ 158
Query: 196 VANGMHYLQSRKV 208
VA GM +L SRK
Sbjct: 159 VAKGMEFLASRKC 171
>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120
Length = 316
Score = 107 bits (266), Expect = 8e-24, Method: Compositional matrix adjust.
Identities = 62/133 (46%), Positives = 83/133 (62%), Gaps = 4/133 (3%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
+ AFG+VI A+A GI K TVAVKMLKEG + +E L+SE++++ IG H+N++NL
Sbjct: 39 RGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 98
Query: 136 LGVCTQD-GPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAY 194
LG CT+ GPL VIVEF GNL +LR R P + LT + LI +++
Sbjct: 99 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF---VPYKPEDLYKDFLTLEHLIXYSF 155
Query: 195 QVANGMHYLQSRK 207
QVA GM +L SRK
Sbjct: 156 QVAKGMEFLASRK 168
>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel
4-amino-furo[2,3-d]pyrimidine
Length = 316
Score = 106 bits (265), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 63/133 (47%), Positives = 84/133 (63%), Gaps = 4/133 (3%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFG+VI A+A GI K TVAVKMLKEG + +E L+SE++++ IG H+N++NLLG
Sbjct: 39 AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98
Query: 138 VCTQD-GPLYVIVEFAPHGNLRDFLRKHRPS-SGYESPLGSAYTNGNVLTEKDLISFAYQ 195
CT+ GPL VIVEF GNL +LR R Y+ Y + LT + LI +++Q
Sbjct: 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK--DFLTLEHLICYSFQ 156
Query: 196 VANGMHYLQSRKV 208
VA GM +L SRK
Sbjct: 157 VAKGMEFLASRKC 169
>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|2P2I|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|3EFL|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
pdb|3EFL|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
Length = 314
Score = 106 bits (265), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 63/133 (47%), Positives = 84/133 (63%), Gaps = 4/133 (3%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFG+VI A+A GI K TVAVKMLKEG + +E L+SE++++ IG H+N++NLLG
Sbjct: 30 AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 89
Query: 138 VCTQD-GPLYVIVEFAPHGNLRDFLRKHRPS-SGYESPLGSAYTNGNVLTEKDLISFAYQ 195
CT+ GPL VIVEF GNL +LR R Y+ Y + LT + LI +++Q
Sbjct: 90 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK--DFLTLEHLICYSFQ 147
Query: 196 VANGMHYLQSRKV 208
VA GM +L SRK
Sbjct: 148 VAKGMEFLASRKC 160
>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr)
Kinase Domain
Length = 316
Score = 106 bits (265), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 63/133 (47%), Positives = 84/133 (63%), Gaps = 4/133 (3%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFG+VI A+A GI K TVAVKMLKEG + +E L+SE++++ IG H+N++NLLG
Sbjct: 39 AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98
Query: 138 VCTQD-GPLYVIVEFAPHGNLRDFLRKHRPS-SGYESPLGSAYTNGNVLTEKDLISFAYQ 195
CT+ GPL VIVEF GNL +LR R Y+ Y + LT + LI +++Q
Sbjct: 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK--DFLTLEHLICYSFQ 156
Query: 196 VANGMHYLQSRKV 208
VA GM +L SRK
Sbjct: 157 VAKGMEFLASRKC 169
>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy)
Quinolin-4-Yloxy)benzofuran-3-Carboxamide)
pdb|4AG8|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Axitinib (Ag-013736)
(N-Methyl-2-(3-((E)-2-Pyridin-2-
Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-Benzamide)
Length = 316
Score = 106 bits (265), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 63/133 (47%), Positives = 84/133 (63%), Gaps = 4/133 (3%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFG+VI A+A GI K TVAVKMLKEG + +E L+SE++++ IG H+N++NLLG
Sbjct: 39 AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98
Query: 138 VCTQD-GPLYVIVEFAPHGNLRDFLRKHRPS-SGYESPLGSAYTNGNVLTEKDLISFAYQ 195
CT+ GPL VIVEF GNL +LR R Y+ Y + LT + LI +++Q
Sbjct: 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK--DFLTLEHLICYSFQ 156
Query: 196 VANGMHYLQSRKV 208
VA GM +L SRK
Sbjct: 157 VAKGMEFLASRKC 169
>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Axitinib (Ag-013736)
(N-Methyl-2-(
3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-
Benzamide)
pdb|4AGD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sunitinib (Su11248) (N-2-
Diethylaminoethyl)-5-((Z)-(5-Fluoro-2-Oxo-1h-Indol-3-
Ylidene)methyl)-2,4-Dimethyl-1h-Pyrrole-3-Carboxamide)
pdb|4ASD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sorafenib (Bay 43-9006)
pdb|4ASE|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Tivozanib (Av-951)
Length = 353
Score = 106 bits (264), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 63/133 (47%), Positives = 84/133 (63%), Gaps = 4/133 (3%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFG+VI A+A GI K TVAVKMLKEG + +E L+SE++++ IG H+N++NLLG
Sbjct: 76 AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135
Query: 138 VCTQD-GPLYVIVEFAPHGNLRDFLRKHRPS-SGYESPLGSAYTNGNVLTEKDLISFAYQ 195
CT+ GPL VIVEF GNL +LR R Y+ Y + LT + LI +++Q
Sbjct: 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK--DFLTLEHLICYSFQ 193
Query: 196 VANGMHYLQSRKV 208
VA GM +L SRK
Sbjct: 194 VAKGMEFLASRKC 206
>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyrazolone Inhibitor
Length = 314
Score = 105 bits (261), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 62/133 (46%), Positives = 83/133 (62%), Gaps = 4/133 (3%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFG+VI A+A GI K TVAVKMLKEG + +E L+SE++++ IG H+N++NLLG
Sbjct: 30 AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 89
Query: 138 VCTQD-GPLYVIVEFAPHGNLRDFLRKHRPS-SGYESPLGSAYTNGNVLTEKDLISFAYQ 195
CT+ GPL VI EF GNL +LR R Y+ Y + LT + LI +++Q
Sbjct: 90 ACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK--DFLTLEHLICYSFQ 147
Query: 196 VANGMHYLQSRKV 208
VA GM +L SRK
Sbjct: 148 VAKGMEFLASRKC 160
>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridinyl-Triazine Inhibitor
pdb|2QU5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzimidazole Inhibitor
pdb|2QU6|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|2QU6|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|3B8Q|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8Q|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|2RL5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A 2,3-Dihydro-1,4-Benzoxazine Inhibitor
pdb|3BE2|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzamide Inhibitor
pdb|3CP9|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CP9|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPB|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPB|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPC|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPC|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3DTW|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
pdb|3DTW|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
Length = 314
Score = 105 bits (261), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 62/133 (46%), Positives = 83/133 (62%), Gaps = 4/133 (3%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFG+VI A+A GI K TVAVKMLKEG + +E L+SE++++ IG H+N++NLLG
Sbjct: 30 AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 89
Query: 138 VCTQD-GPLYVIVEFAPHGNLRDFLRKHRPS-SGYESPLGSAYTNGNVLTEKDLISFAYQ 195
CT+ GPL VI EF GNL +LR R Y+ Y + LT + LI +++Q
Sbjct: 90 ACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK--DFLTLEHLICYSFQ 147
Query: 196 VANGMHYLQSRKV 208
VA GM +L SRK
Sbjct: 148 VAKGMEFLASRKC 160
>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridyl-Pyrimidine Benzimidazole Inhibitor
Length = 314
Score = 105 bits (261), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 62/133 (46%), Positives = 83/133 (62%), Gaps = 4/133 (3%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFG+VI A+A GI K TVAVKMLKEG + +E L+SE++++ IG H+N++NLLG
Sbjct: 30 AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 89
Query: 138 VCTQD-GPLYVIVEFAPHGNLRDFLRKHRPS-SGYESPLGSAYTNGNVLTEKDLISFAYQ 195
CT+ GPL VI EF GNL +LR R Y+ Y + LT + LI +++Q
Sbjct: 90 ACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK--DFLTLEHLICYSFQ 147
Query: 196 VANGMHYLQSRKV 208
VA GM +L SRK
Sbjct: 148 VAKGMEFLASRKC 160
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 103 bits (257), Expect = 9e-23, Method: Compositional matrix adjust.
Identities = 62/137 (45%), Positives = 85/137 (62%), Gaps = 8/137 (5%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FGKV+ A A + + TTVAVKMLKE S +E+ DL+SE ++K + H ++I L G
Sbjct: 36 FGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGA 94
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRP-SSGYESPLGSA------YTNGNVLTEKDLIS 191
C+QDGPL +IVE+A +G+LR FLR+ R GY GS + + LT DLIS
Sbjct: 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLIS 154
Query: 192 FAYQVANGMHYLQSRKV 208
FA+Q++ GM YL K+
Sbjct: 155 FAWQISQGMQYLAEMKL 171
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 103 bits (257), Expect = 9e-23, Method: Compositional matrix adjust.
Identities = 62/137 (45%), Positives = 85/137 (62%), Gaps = 8/137 (5%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FGKV+ A A + + TTVAVKMLKE S +E+ DL+SE ++K + H ++I L G
Sbjct: 36 FGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGA 94
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRP-SSGYESPLGSA------YTNGNVLTEKDLIS 191
C+QDGPL +IVE+A +G+LR FLR+ R GY GS + + LT DLIS
Sbjct: 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLIS 154
Query: 192 FAYQVANGMHYLQSRKV 208
FA+Q++ GM YL K+
Sbjct: 155 FAWQISQGMQYLAEMKL 171
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 102 bits (255), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 61/132 (46%), Positives = 83/132 (62%), Gaps = 8/132 (6%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FGKV+ A A + + TTVAVKMLKE S +E+ DL+SE ++K + H ++I L G
Sbjct: 36 FGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGA 94
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRP-SSGYESPLGSA------YTNGNVLTEKDLIS 191
C+QDGPL +IVE+A +G+LR FLR+ R GY GS + + LT DLIS
Sbjct: 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLIS 154
Query: 192 FAYQVANGMHYL 203
FA+Q++ GM YL
Sbjct: 155 FAWQISQGMQYL 166
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 101 bits (251), Expect = 5e-22, Method: Compositional matrix adjust.
Identities = 60/136 (44%), Positives = 85/136 (62%), Gaps = 8/136 (5%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKE-GHSDAEMMDLVSEMEMMKMIGQHINIINLL 136
AFGKV+ A A G+ K+ + VAVKMLK H+D E L+SE+++M +GQH NI+NLL
Sbjct: 43 AFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD-EKEALMSELKIMSHLGQHENIVNLL 101
Query: 137 GVCTQDGPLYVIVEFAPHGNLRDFLRKHR-----PS-SGYESPLGSAYTNGNVLTEKDLI 190
G CT GP+ VI E+ +G+L +FLR+ PS + + P G +G L +DL+
Sbjct: 102 GACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLL 161
Query: 191 SFAYQVANGMHYLQSR 206
F+ QVA GM +L S+
Sbjct: 162 HFSSQVAQGMAFLASK 177
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 100 bits (250), Expect = 7e-22, Method: Compositional matrix adjust.
Identities = 60/130 (46%), Positives = 84/130 (64%), Gaps = 5/130 (3%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKE-GHSDAEMMDLVSEMEMMKMIGQHINIINLL 136
AFGKV+ A A G+ K+ + VAVKMLK H+D E L+SE+++M +GQH NI+NLL
Sbjct: 58 AFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD-EKEALMSELKIMSHLGQHENIVNLL 116
Query: 137 GVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQV 196
G CT GP+ VI E+ +G+L +FLR R S E+ A N + L+ +DL+ F+ QV
Sbjct: 117 GACTHGGPVLVITEYCCYGDLLNFLR--RKSRVLETDPAFAIAN-STLSTRDLLHFSSQV 173
Query: 197 ANGMHYLQSR 206
A GM +L S+
Sbjct: 174 AQGMAFLASK 183
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 99.8 bits (247), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 60/130 (46%), Positives = 82/130 (63%), Gaps = 5/130 (3%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKE-GHSDAEMMDLVSEMEMMKMIGQHINIINLL 136
AFGKV+ A A G+ K+ + VAVKMLK H+D E L+SE+++M +GQH NI+NLL
Sbjct: 58 AFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD-EKEALMSELKIMSHLGQHENIVNLL 116
Query: 137 GVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQV 196
G CT GP+ VI E+ +G+L +FLR R S E+ A N T +DL+ F+ QV
Sbjct: 117 GACTHGGPVLVITEYCCYGDLLNFLR--RKSRVLETDPAFAIANSTAST-RDLLHFSSQV 173
Query: 197 ANGMHYLQSR 206
A GM +L S+
Sbjct: 174 AQGMAFLASK 183
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 98.2 bits (243), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 58/130 (44%), Positives = 82/130 (63%), Gaps = 9/130 (6%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKE-GHSDAEMMDLVSEMEMMKMIGQHINIINLL 136
AFGKV+ A A G+ K+ + VAVKMLK H+D E L+SE+++M +GQH NI+NLL
Sbjct: 50 AFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD-EKEALMSELKIMSHLGQHENIVNLL 108
Query: 137 GVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQV 196
G CT GP+ VI E+ +G+L +FLR+ E+ L +G L +DL+ F+ QV
Sbjct: 109 GACTHGGPVLVITEYCCYGDLLNFLRRKA-----EADLDK--EDGRPLELRDLLHFSSQV 161
Query: 197 ANGMHYLQSR 206
A GM +L S+
Sbjct: 162 AQGMAFLASK 171
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 98.2 bits (243), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 58/130 (44%), Positives = 82/130 (63%), Gaps = 9/130 (6%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKE-GHSDAEMMDLVSEMEMMKMIGQHINIINLL 136
AFGKV+ A A G+ K+ + VAVKMLK H+D E L+SE+++M +GQH NI+NLL
Sbjct: 58 AFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD-EKEALMSELKIMSHLGQHENIVNLL 116
Query: 137 GVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQV 196
G CT GP+ VI E+ +G+L +FLR+ E+ L +G L +DL+ F+ QV
Sbjct: 117 GACTHGGPVLVITEYCCYGDLLNFLRRKA-----EADLDK--EDGRPLELRDLLHFSSQV 169
Query: 197 ANGMHYLQSR 206
A GM +L S+
Sbjct: 170 AQGMAFLASK 179
>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With
N-(4-chlorophenyl)-2-
((pyridin-4-ylmethyl)amino)benzamide
Length = 360
Score = 97.4 bits (241), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 65/182 (35%), Positives = 89/182 (48%), Gaps = 51/182 (28%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFGKV+ A A GI K TVAVKMLKEG + +E L++E++++ IG H+N++NLLG
Sbjct: 39 AFGKVVQASAFGIKKSPTCRTVAVKMLKEGATASEYKALMTELKILTHIGHHLNVVNLLG 98
Query: 138 VCT-QDGPLYVIVEFAPHGNLRDFLRKHR------------------------------- 165
CT Q GPL VIVE+ +GNL ++L+ R
Sbjct: 99 ACTKQGGPLMVIVEYCKYGNLSNYLKSKRDLFFLNKDAALHMEPKKEKMEPGLEQGKKPR 158
Query: 166 ----------PSSGY---------ESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
SSG+ E S +T +DLIS+++QVA GM +L SR
Sbjct: 159 LDSVTSSESFASSGFQEDKSLSDVEEEEDSDGFYKEPITMEDLISYSFQVARGMEFLSSR 218
Query: 207 KV 208
K
Sbjct: 219 KC 220
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 95.1 bits (235), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 52/129 (40%), Positives = 73/129 (56%), Gaps = 4/129 (3%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V+ A I K G+ A+K +KE S + D E+E++ +G H NIINLLG
Sbjct: 35 FGQVLKAR---IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGA 91
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
C G LY+ +E+APHGNL DFLRK R + A + + L+ + L+ FA VA
Sbjct: 92 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLET-DPAFAIANSTASTLSSQQLLHFAADVAR 150
Query: 199 GMHYLQSRK 207
GM YL ++
Sbjct: 151 GMDYLSQKQ 159
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 95.1 bits (235), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 52/129 (40%), Positives = 73/129 (56%), Gaps = 4/129 (3%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V+ A I K G+ A+K +KE S + D E+E++ +G H NIINLLG
Sbjct: 28 FGQVLKAR---IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGA 84
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
C G LY+ +E+APHGNL DFLRK R + A + + L+ + L+ FA VA
Sbjct: 85 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLET-DPAFAIANSTASTLSSQQLLHFAADVAR 143
Query: 199 GMHYLQSRK 207
GM YL ++
Sbjct: 144 GMDYLSQKQ 152
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 95.1 bits (235), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 52/129 (40%), Positives = 73/129 (56%), Gaps = 4/129 (3%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V+ A I K G+ A+K +KE S + D E+E++ +G H NIINLLG
Sbjct: 38 FGQVLKAR---IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGA 94
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
C G LY+ +E+APHGNL DFLRK R + A + + L+ + L+ FA VA
Sbjct: 95 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLET-DPAFAIANSTASTLSSQQLLHFAADVAR 153
Query: 199 GMHYLQSRK 207
GM YL ++
Sbjct: 154 GMDYLSQKQ 162
>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C-kit Tyrosine Kinase
Length = 313
Score = 93.6 bits (231), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 58/131 (44%), Positives = 80/131 (61%), Gaps = 3/131 (2%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFGKV+ A A G++K TVAVKMLK E L+SE++++ +G H+NI+NLLG
Sbjct: 35 AFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLG 94
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPS--SGYESPLGSAYTNGNVLTEKDLISFAYQ 195
CT GP VI E+ +G+L +FLR+ R S SP + L +DL+SF+YQ
Sbjct: 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP-AIMEDDELALDLEDLLSFSYQ 153
Query: 196 VANGMHYLQSR 206
VA GM +L S+
Sbjct: 154 VAKGMAFLASK 164
>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C- Kit Tyrosine Kinase
Length = 331
Score = 93.6 bits (231), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 58/131 (44%), Positives = 80/131 (61%), Gaps = 3/131 (2%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFGKV+ A A G++K TVAVKMLK E L+SE++++ +G H+NI+NLLG
Sbjct: 53 AFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLG 112
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPS--SGYESPLGSAYTNGNVLTEKDLISFAYQ 195
CT GP VI E+ +G+L +FLR+ R S SP + L +DL+SF+YQ
Sbjct: 113 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP-AIMEDDELALDLEDLLSFSYQ 171
Query: 196 VANGMHYLQSR 206
VA GM +L S+
Sbjct: 172 VAKGMAFLASK 182
>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex
pdb|1PKG|B Chain B, Structure Of A C-kit Kinase Product Complex
Length = 329
Score = 93.2 bits (230), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 58/131 (44%), Positives = 80/131 (61%), Gaps = 3/131 (2%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFGKV+ A A G++K TVAVKMLK E L+SE++++ +G H+NI+NLLG
Sbjct: 51 AFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLG 110
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPS--SGYESPLGSAYTNGNVLTEKDLISFAYQ 195
CT GP VI E+ +G+L +FLR+ R S SP + L +DL+SF+YQ
Sbjct: 111 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP-AIMEDDELALDLEDLLSFSYQ 169
Query: 196 VANGMHYLQSR 206
VA GM +L S+
Sbjct: 170 VAKGMAFLASK 180
>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib
Length = 336
Score = 93.2 bits (230), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 58/131 (44%), Positives = 80/131 (61%), Gaps = 3/131 (2%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFGKV+ A A G++K TVAVKMLK E L+SE++++ +G H+NI+NLLG
Sbjct: 58 AFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLG 117
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPS--SGYESPLGSAYTNGNVLTEKDLISFAYQ 195
CT GP VI E+ +G+L +FLR+ R S SP + L +DL+SF+YQ
Sbjct: 118 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP-AIMEDDELALDLEDLLSFSYQ 176
Query: 196 VANGMHYLQSR 206
VA GM +L S+
Sbjct: 177 VAKGMAFLASK 187
>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
pdb|3G0F|B Chain B, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
Length = 336
Score = 93.2 bits (230), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 58/131 (44%), Positives = 80/131 (61%), Gaps = 3/131 (2%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFGKV+ A A G++K TVAVKMLK E L+SE++++ +G H+NI+NLLG
Sbjct: 58 AFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLG 117
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPS--SGYESPLGSAYTNGNVLTEKDLISFAYQ 195
CT GP VI E+ +G+L +FLR+ R S SP + L +DL+SF+YQ
Sbjct: 118 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP-AIMEDDELALDLEDLLSFSYQ 176
Query: 196 VANGMHYLQSR 206
VA GM +L S+
Sbjct: 177 VAKGMAFLASK 187
>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With
Compound A
Length = 356
Score = 92.4 bits (228), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 64/181 (35%), Positives = 85/181 (46%), Gaps = 50/181 (27%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFG+VI A+A GI K TVAVKMLKEG + +E L+SE++++ IG H+N++NLLG
Sbjct: 32 AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 91
Query: 138 VCTQD-GPLYVIVEFAPHGNLRDFLRKHR------PSSGYESPLGSAYTNG--------- 181
CT+ GPL VIVEF GNL +LR R + G G Y
Sbjct: 92 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRL 151
Query: 182 ----------------------------------NVLTEKDLISFAYQVANGMHYLQSRK 207
+ LT + LI +++QVA GM +L SRK
Sbjct: 152 DSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 211
Query: 208 V 208
Sbjct: 212 C 212
>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A
Novel Pyrrolopyrimidine Inhibitor
Length = 359
Score = 92.4 bits (228), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 64/181 (35%), Positives = 85/181 (46%), Gaps = 50/181 (27%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFG+VI A+A GI K TVAVKMLKEG + +E L+SE++++ IG H+N++NLLG
Sbjct: 34 AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 93
Query: 138 VCTQD-GPLYVIVEFAPHGNLRDFLRKHR------PSSGYESPLGSAYTNG--------- 181
CT+ GPL VIVEF GNL +LR R + G G Y
Sbjct: 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRL 153
Query: 182 ----------------------------------NVLTEKDLISFAYQVANGMHYLQSRK 207
+ LT + LI +++QVA GM +L SRK
Sbjct: 154 DSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 213
Query: 208 V 208
Sbjct: 214 C 214
>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
pdb|1Y6B|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
Length = 366
Score = 92.0 bits (227), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 64/181 (35%), Positives = 85/181 (46%), Gaps = 50/181 (27%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFG+VI A+A GI K TVAVKMLKEG + +E L+SE++++ IG H+N++NLLG
Sbjct: 39 AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98
Query: 138 VCTQD-GPLYVIVEFAPHGNLRDFLRKHR------PSSGYESPLGSAYTNG--------- 181
CT+ GPL VIVEF GNL +LR R + G G Y
Sbjct: 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRL 158
Query: 182 ----------------------------------NVLTEKDLISFAYQVANGMHYLQSRK 207
+ LT + LI +++QVA GM +L SRK
Sbjct: 159 DSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 218
Query: 208 V 208
Sbjct: 219 C 219
>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Back Pocket Binder
Length = 368
Score = 92.0 bits (227), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 64/181 (35%), Positives = 85/181 (46%), Gaps = 50/181 (27%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFG+VI A+A GI K TVAVKMLKEG + +E L+SE++++ IG H+N++NLLG
Sbjct: 41 AFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 100
Query: 138 VCTQD-GPLYVIVEFAPHGNLRDFLRKHR------PSSGYESPLGSAYTNG--------- 181
CT+ GPL VIVEF GNL +LR R + G G Y
Sbjct: 101 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRL 160
Query: 182 ----------------------------------NVLTEKDLISFAYQVANGMHYLQSRK 207
+ LT + LI +++QVA GM +L SRK
Sbjct: 161 DSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 220
Query: 208 V 208
Sbjct: 221 C 221
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 77.8 bits (190), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 49/126 (38%), Positives = 68/126 (53%), Gaps = 4/126 (3%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFGKV AE + +L + VAVK LKE S++ D E E++ M+ QH +I+ G
Sbjct: 30 AFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTML-QHQHIVRFFG 87
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
VCT+ PL ++ E+ HG+L FLR H P + + G L L++ A QVA
Sbjct: 88 VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLA--GGEDVAPGPLGLGQLLAVASQVA 145
Query: 198 NGMHYL 203
GM YL
Sbjct: 146 AGMVYL 151
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 77.8 bits (190), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 49/126 (38%), Positives = 68/126 (53%), Gaps = 4/126 (3%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFGKV AE + +L + VAVK LKE S++ D E E++ M+ QH +I+ G
Sbjct: 24 AFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTML-QHQHIVRFFG 81
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
VCT+ PL ++ E+ HG+L FLR H P + + G L L++ A QVA
Sbjct: 82 VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLA--GGEDVAPGPLGLGQLLAVASQVA 139
Query: 198 NGMHYL 203
GM YL
Sbjct: 140 AGMVYL 145
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 77.4 bits (189), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 49/126 (38%), Positives = 68/126 (53%), Gaps = 4/126 (3%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFGKV AE + +L + VAVK LKE S++ D E E++ M+ QH +I+ G
Sbjct: 53 AFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTML-QHQHIVRFFG 110
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
VCT+ PL ++ E+ HG+L FLR H P + + G L L++ A QVA
Sbjct: 111 VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLA--GGEDVAPGPLGLGQLLAVASQVA 168
Query: 198 NGMHYL 203
GM YL
Sbjct: 169 AGMVYL 174
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 72.4 bits (176), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 53/149 (35%), Positives = 72/149 (48%), Gaps = 10/149 (6%)
Query: 68 NSQEYVKI--KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKM 125
N+ EYV+ + AFG+V A A G+L T VAVKMLKE S D E +M
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 126 IGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNV-- 183
+ NI+ LLGVC P+ ++ E+ +G+L +FLR P + T V
Sbjct: 107 F-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 184 -----LTEKDLISFAYQVANGMHYLQSRK 207
L+ + + A QVA GM YL RK
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYLSERK 194
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 71.6 bits (174), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 46/129 (35%), Positives = 67/129 (51%), Gaps = 6/129 (4%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFGKV AE + + VAVK LK+ SD D E E++ + QH +I+ G
Sbjct: 25 AFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNL-QHEHIVKFYG 82
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
VC + PL ++ E+ HG+L FLR H P ++ L + LT+ ++ A Q+A
Sbjct: 83 VCVEGDPLIMVFEYMKHGDLNKFLRAHGP----DAVLMAEGNPPTELTQSQMLHIAQQIA 138
Query: 198 NGMHYLQSR 206
GM YL S+
Sbjct: 139 AGMVYLASQ 147
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 67.4 bits (163), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 43/130 (33%), Positives = 71/130 (54%), Gaps = 8/130 (6%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
+FG V A I+K T VAVK + E S E ++ ++E +MK H +++ LLG
Sbjct: 29 SFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVVRLLG 87
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
V ++ P V++E HG+L+ +LR RP + E+ G T +++I A ++A
Sbjct: 88 VVSKGQPTLVVMELMAHGDLKSYLRSLRPEA--ENNPGRPPP-----TLQEMIQMAAEIA 140
Query: 198 NGMHYLQSRK 207
+GM YL ++K
Sbjct: 141 DGMAYLNAKK 150
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 67.4 bits (163), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 43/130 (33%), Positives = 71/130 (54%), Gaps = 8/130 (6%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
+FG V A I+K T VAVK + E S E ++ ++E +MK H +++ LLG
Sbjct: 29 SFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVVRLLG 87
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
V ++ P V++E HG+L+ +LR RP + E+ G T +++I A ++A
Sbjct: 88 VVSKGQPTLVVMELMAHGDLKSYLRSLRPEA--ENNPGRPPP-----TLQEMIQMAAEIA 140
Query: 198 NGMHYLQSRK 207
+GM YL ++K
Sbjct: 141 DGMAYLNAKK 150
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 67.4 bits (163), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 43/130 (33%), Positives = 71/130 (54%), Gaps = 8/130 (6%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
+FG V A I+K T VAVK + E S E ++ ++E +MK H +++ LLG
Sbjct: 29 SFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVVRLLG 87
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
V ++ P V++E HG+L+ +LR RP + E+ G T +++I A ++A
Sbjct: 88 VVSKGQPTLVVMELMAHGDLKSYLRSLRPEA--ENNPGRPPP-----TLQEMIQMAAEIA 140
Query: 198 NGMHYLQSRK 207
+GM YL ++K
Sbjct: 141 DGMAYLNAKK 150
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 67.4 bits (163), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 43/130 (33%), Positives = 71/130 (54%), Gaps = 8/130 (6%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
+FG V A I+K T VAVK + E S E ++ ++E +MK H +++ LLG
Sbjct: 29 SFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVVRLLG 87
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
V ++ P V++E HG+L+ +LR RP + E+ G T +++I A ++A
Sbjct: 88 VVSKGQPTLVVMELMAHGDLKSYLRSLRPEA--ENNPGRPPP-----TLQEMIQMAAEIA 140
Query: 198 NGMHYLQSRK 207
+GM YL ++K
Sbjct: 141 DGMAYLNAKK 150
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 67.4 bits (163), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 39/109 (35%), Positives = 60/109 (55%), Gaps = 18/109 (16%)
Query: 98 TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
TVAVK LKE + E + + E +MK I +H N++ LLGVCT + P Y++ E+ P+GNL
Sbjct: 59 TVAVKTLKEDTMEVE--EFLKEAAVMKEI-KHPNLVQLLGVCTLEPPFYIVTEYMPYGNL 115
Query: 158 RDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
D+LR+ N +T L+ A Q+++ M YL+ +
Sbjct: 116 LDYLRE---------------CNREEVTAVVLLYMATQISSAMEYLEKK 149
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 67.0 bits (162), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 43/130 (33%), Positives = 71/130 (54%), Gaps = 8/130 (6%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
+FG V A I+K T VAVK + E S E ++ ++E +MK H +++ LLG
Sbjct: 29 SFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVVRLLG 87
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
V ++ P V++E HG+L+ +LR RP + E+ G T +++I A ++A
Sbjct: 88 VVSKGQPTLVVMELMAHGDLKSYLRSLRPEA--ENNPGRPPP-----TLQEMIQMAAEIA 140
Query: 198 NGMHYLQSRK 207
+GM YL ++K
Sbjct: 141 DGMAYLNAKK 150
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 67.0 bits (162), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 43/130 (33%), Positives = 71/130 (54%), Gaps = 8/130 (6%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
+FG V A I+K T VAVK + E S E ++ ++E +MK H +++ LLG
Sbjct: 26 SFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVVRLLG 84
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
V ++ P V++E HG+L+ +LR RP + E+ G T +++I A ++A
Sbjct: 85 VVSKGQPTLVVMELMAHGDLKSYLRSLRPEA--ENNPGRPPP-----TLQEMIQMAAEIA 137
Query: 198 NGMHYLQSRK 207
+GM YL ++K
Sbjct: 138 DGMAYLNAKK 147
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 67.0 bits (162), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 43/130 (33%), Positives = 71/130 (54%), Gaps = 8/130 (6%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
+FG V A I+K T VAVK + E S E ++ ++E +MK H +++ LLG
Sbjct: 30 SFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVVRLLG 88
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
V ++ P V++E HG+L+ +LR RP + E+ G T +++I A ++A
Sbjct: 89 VVSKGQPTLVVMELMAHGDLKSYLRSLRPEA--ENNPGRPPP-----TLQEMIQMAAEIA 141
Query: 198 NGMHYLQSRK 207
+GM YL ++K
Sbjct: 142 DGMAYLNAKK 151
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 66.6 bits (161), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 45/133 (33%), Positives = 67/133 (50%), Gaps = 14/133 (10%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
+FG V A G++K T VA+K + E S E ++ ++E +MK H +++ LLG
Sbjct: 37 SFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLG 95
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDL---ISFAY 194
V +Q P VI+E G+L+ +LR RP A N VL L I A
Sbjct: 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRP----------AMANNPVLAPPSLSKMIQMAG 145
Query: 195 QVANGMHYLQSRK 207
++A+GM YL + K
Sbjct: 146 EIADGMAYLNANK 158
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 66.6 bits (161), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 43/130 (33%), Positives = 71/130 (54%), Gaps = 8/130 (6%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
+FG V A I+K T VAVK + E S E ++ ++E +MK H +++ LLG
Sbjct: 28 SFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVVRLLG 86
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
V ++ P V++E HG+L+ +LR RP + E+ G T +++I A ++A
Sbjct: 87 VVSKGQPTLVVMELMAHGDLKSYLRSLRPEA--ENNPGRPPP-----TLQEMIQMAAEIA 139
Query: 198 NGMHYLQSRK 207
+GM YL ++K
Sbjct: 140 DGMAYLNAKK 149
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 66.6 bits (161), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 45/133 (33%), Positives = 67/133 (50%), Gaps = 14/133 (10%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
+FG V A G++K T VA+K + E S E ++ ++E +MK H +++ LLG
Sbjct: 27 SFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLG 85
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDL---ISFAY 194
V +Q P VI+E G+L+ +LR RP A N VL L I A
Sbjct: 86 VVSQGQPTLVIMELMTRGDLKSYLRSLRP----------AMANNPVLAPPSLSKMIQMAG 135
Query: 195 QVANGMHYLQSRK 207
++A+GM YL + K
Sbjct: 136 EIADGMAYLNANK 148
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 39/109 (35%), Positives = 61/109 (55%), Gaps = 18/109 (16%)
Query: 98 TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
TVAVK LKE + E + + E +MK I +H N++ LLGVCT++ P Y+I+EF +GNL
Sbjct: 38 TVAVKTLKEDTMEVE--EFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIIIEFMTYGNL 94
Query: 158 RDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
D+LR+ N ++ L+ A Q+++ M YL+ +
Sbjct: 95 LDYLRE---------------CNRQEVSAVVLLYMATQISSAMEYLEKK 128
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 39/109 (35%), Positives = 61/109 (55%), Gaps = 18/109 (16%)
Query: 98 TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
TVAVK LKE + E + + E +MK I +H N++ LLGVCT++ P Y+I+EF +GNL
Sbjct: 40 TVAVKTLKEDTMEVE--EFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIIIEFMTYGNL 96
Query: 158 RDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
D+LR+ N ++ L+ A Q+++ M YL+ +
Sbjct: 97 LDYLRE---------------CNRQEVSAVVLLYMATQISSAMEYLEKK 130
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 39/109 (35%), Positives = 61/109 (55%), Gaps = 18/109 (16%)
Query: 98 TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
TVAVK LKE + E + + E +MK I +H N++ LLGVCT++ P Y+I+EF +GNL
Sbjct: 40 TVAVKTLKEDTMEVE--EFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIIIEFMTYGNL 96
Query: 158 RDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
D+LR+ N ++ L+ A Q+++ M YL+ +
Sbjct: 97 LDYLRE---------------CNRQEVSAVVLLYMATQISSAMEYLEKK 130
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 65.9 bits (159), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 44/128 (34%), Positives = 69/128 (53%), Gaps = 23/128 (17%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V G+ K+ +T VAVK LKE + E + + E +MK I +H N++ LLGV
Sbjct: 24 FGEVY----EGVWKKYSLT-VAVKTLKEDTMEVE--EFLKEAAVMKEI-KHPNLVQLLGV 75
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
CT++ P Y+I EF +GNL D+LR+ N ++ L+ A Q+++
Sbjct: 76 CTREPPFYIITEFMTYGNLLDYLRE---------------CNRQEVSAVVLLYMATQISS 120
Query: 199 GMHYLQSR 206
M YL+ +
Sbjct: 121 AMEYLEKK 128
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 65.9 bits (159), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 41/119 (34%), Positives = 65/119 (54%), Gaps = 19/119 (15%)
Query: 88 NGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYV 147
G+ K+ +T VAVK LKE + E + + E +MK I +H N++ LLGVCT++ P Y+
Sbjct: 36 EGVWKKYSLT-VAVKTLKEDTMEVE--EFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYI 91
Query: 148 IVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
I+EF +GNL D+LR+ N + L+ A Q+++ M YL+ +
Sbjct: 92 IIEFMTYGNLLDYLRE---------------CNRQEVNAVVLLYMATQISSAMEYLEKK 135
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 65.9 bits (159), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 39/109 (35%), Positives = 60/109 (55%), Gaps = 18/109 (16%)
Query: 98 TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
TVAVK LKE + E + + E +MK I +H N++ LLGVCT++ P Y+I+EF +GNL
Sbjct: 41 TVAVKTLKEDTMEVE--EFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIIIEFMTYGNL 97
Query: 158 RDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
D+LR+ N + L+ A Q+++ M YL+ +
Sbjct: 98 LDYLRE---------------CNRQEVNAVVLLYMATQISSAMEYLEKK 131
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 65.5 bits (158), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 39/109 (35%), Positives = 60/109 (55%), Gaps = 18/109 (16%)
Query: 98 TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
TVAVK LKE + E + + E +MK I +H N++ LLGVCT++ P Y+I EF +GNL
Sbjct: 40 TVAVKTLKEDTMEVE--EFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 96
Query: 158 RDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
D+LR+ N ++ L+ A Q+++ M YL+ +
Sbjct: 97 LDYLRE---------------CNRQEVSAVVLLYMATQISSAMEYLEKK 130
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 65.5 bits (158), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 39/109 (35%), Positives = 60/109 (55%), Gaps = 18/109 (16%)
Query: 98 TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
TVAVK LKE + E + + E +MK I +H N++ LLGVCT++ P Y+I EF +GNL
Sbjct: 40 TVAVKTLKEDTMEVE--EFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 96
Query: 158 RDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
D+LR+ N ++ L+ A Q+++ M YL+ +
Sbjct: 97 LDYLRE---------------CNRQEVSAVVLLYMATQISSAMEYLEKK 130
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 65.5 bits (158), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 39/109 (35%), Positives = 60/109 (55%), Gaps = 18/109 (16%)
Query: 98 TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
TVAVK LKE + E + + E +MK I +H N++ LLGVCT++ P Y+I EF +GNL
Sbjct: 38 TVAVKTLKEDTMEVE--EFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 94
Query: 158 RDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
D+LR+ N ++ L+ A Q+++ M YL+ +
Sbjct: 95 LDYLRE---------------CNRQEVSAVVLLYMATQISSAMEYLEKK 128
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 65.5 bits (158), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 39/109 (35%), Positives = 60/109 (55%), Gaps = 18/109 (16%)
Query: 98 TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
TVAVK LKE + E + + E +MK I +H N++ LLGVCT++ P Y+I EF +GNL
Sbjct: 45 TVAVKTLKEDTMEVE--EFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 101
Query: 158 RDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
D+LR+ N ++ L+ A Q+++ M YL+ +
Sbjct: 102 LDYLRE---------------CNRQEVSAVVLLYMATQISSAMEYLEKK 135
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 65.1 bits (157), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 39/109 (35%), Positives = 60/109 (55%), Gaps = 18/109 (16%)
Query: 98 TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
TVAVK LKE E+ + + E +MK I +H N++ LLGVCT++ P Y+I EF +GNL
Sbjct: 247 TVAVKTLKE--DTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 303
Query: 158 RDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
D+LR+ N ++ L+ A Q+++ M YL+ +
Sbjct: 304 LDYLRE---------------CNRQEVSAVVLLYMATQISSAMEYLEKK 337
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 65.1 bits (157), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 41/119 (34%), Positives = 64/119 (53%), Gaps = 19/119 (15%)
Query: 88 NGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYV 147
G+ K+ +T VAVK LKE + E + + E +MK I +H N++ LLGVCT++ P Y+
Sbjct: 31 EGVWKKYSLT-VAVKTLKEDTMEVE--EFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYI 86
Query: 148 IVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
I EF +GNL D+LR+ N + L+ A Q+++ M YL+ +
Sbjct: 87 ITEFMTYGNLLDYLRE---------------CNRQEVNAVVLLYMATQISSAMEYLEKK 130
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 65.1 bits (157), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 41/119 (34%), Positives = 64/119 (53%), Gaps = 19/119 (15%)
Query: 88 NGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYV 147
G+ K+ +T VAVK LKE + E + + E +MK I +H N++ LLGVCT++ P Y+
Sbjct: 36 EGVWKKYSLT-VAVKTLKEDTMEVE--EFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYI 91
Query: 148 IVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
I EF +GNL D+LR+ N + L+ A Q+++ M YL+ +
Sbjct: 92 ITEFMTYGNLLDYLRE---------------CNRQEVNAVVLLYMATQISSAMEYLEKK 135
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 65.1 bits (157), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 41/119 (34%), Positives = 64/119 (53%), Gaps = 19/119 (15%)
Query: 88 NGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYV 147
G+ K+ +T VAVK LKE + E + + E +MK I +H N++ LLGVCT++ P Y+
Sbjct: 31 EGVWKKYSLT-VAVKTLKEDTMEVE--EFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYI 86
Query: 148 IVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
I EF +GNL D+LR+ N + L+ A Q+++ M YL+ +
Sbjct: 87 ITEFMTYGNLLDYLRE---------------CNRQEVNAVVLLYMATQISSAMEYLEKK 130
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 64.7 bits (156), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 39/109 (35%), Positives = 59/109 (54%), Gaps = 18/109 (16%)
Query: 98 TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
TVAVK LKE + E + + E +MK I +H N++ LLGVCT++ P Y+I EF +GNL
Sbjct: 41 TVAVKTLKEDTMEVE--EFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 97
Query: 158 RDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
D+LR+ N + L+ A Q+++ M YL+ +
Sbjct: 98 LDYLRE---------------CNRQEVNAVVLLYMATQISSAMEYLEKK 131
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 64.7 bits (156), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 39/109 (35%), Positives = 59/109 (54%), Gaps = 18/109 (16%)
Query: 98 TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
TVAVK LKE + E + + E +MK I +H N++ LLGVCT++ P Y+I EF +GNL
Sbjct: 45 TVAVKTLKEDTMEVE--EFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 101
Query: 158 RDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
D+LR+ N + L+ A Q+++ M YL+ +
Sbjct: 102 LDYLRE---------------CNRQEVNAVVLLYMATQISSAMEYLEKK 135
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 64.7 bits (156), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 39/109 (35%), Positives = 59/109 (54%), Gaps = 18/109 (16%)
Query: 98 TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
TVAVK LKE + E + + E +MK I +H N++ LLGVCT++ P Y+I EF +GNL
Sbjct: 44 TVAVKTLKEDTMEVE--EFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 100
Query: 158 RDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
D+LR+ N + L+ A Q+++ M YL+ +
Sbjct: 101 LDYLRE---------------CNRQEVNAVVLLYMATQISSAMEYLEKK 134
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 64.7 bits (156), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 39/109 (35%), Positives = 59/109 (54%), Gaps = 18/109 (16%)
Query: 98 TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
TVAVK LKE + E + + E +MK I +H N++ LLGVCT++ P Y+I EF +GNL
Sbjct: 42 TVAVKTLKEDTMEVE--EFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 98
Query: 158 RDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
D+LR+ N + L+ A Q+++ M YL+ +
Sbjct: 99 LDYLRE---------------CNRQEVNAVVLLYMATQISSAMEYLEKK 132
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 64.7 bits (156), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 44/133 (33%), Positives = 66/133 (49%), Gaps = 14/133 (10%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
+FG V A G++K T VA+K + E S E ++ ++E +MK H +++ LLG
Sbjct: 37 SFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLG 95
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDL---ISFAY 194
V +Q P VI+E G+L+ +LR RP N VL L I A
Sbjct: 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPE----------MENNPVLAPPSLSKMIQMAG 145
Query: 195 QVANGMHYLQSRK 207
++A+GM YL + K
Sbjct: 146 EIADGMAYLNANK 158
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 64.7 bits (156), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 44/133 (33%), Positives = 66/133 (49%), Gaps = 14/133 (10%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
+FG V A G++K T VA+K + E S E ++ ++E +MK H +++ LLG
Sbjct: 28 SFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLG 86
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDL---ISFAY 194
V +Q P VI+E G+L+ +LR RP N VL L I A
Sbjct: 87 VVSQGQPTLVIMELMTRGDLKSYLRSLRPE----------MENNPVLAPPSLSKMIQMAG 136
Query: 195 QVANGMHYLQSRK 207
++A+GM YL + K
Sbjct: 137 EIADGMAYLNANK 149
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 64.7 bits (156), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 44/133 (33%), Positives = 66/133 (49%), Gaps = 14/133 (10%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
+FG V A G++K T VA+K + E S E ++ ++E +MK H +++ LLG
Sbjct: 30 SFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLG 88
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDL---ISFAY 194
V +Q P VI+E G+L+ +LR RP N VL L I A
Sbjct: 89 VVSQGQPTLVIMELMTRGDLKSYLRSLRPE----------MENNPVLAPPSLSKMIQMAG 138
Query: 195 QVANGMHYLQSRK 207
++A+GM YL + K
Sbjct: 139 EIADGMAYLNANK 151
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 64.7 bits (156), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 39/109 (35%), Positives = 59/109 (54%), Gaps = 18/109 (16%)
Query: 98 TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
TVAVK LKE + E + + E +MK I +H N++ LLGVCT++ P Y+I EF +GNL
Sbjct: 42 TVAVKTLKEDTMEVE--EFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 98
Query: 158 RDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
D+LR+ N + L+ A Q+++ M YL+ +
Sbjct: 99 LDYLRE---------------CNRQEVNAVVLLYMATQISSAMEYLEKK 132
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 64.7 bits (156), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 44/133 (33%), Positives = 66/133 (49%), Gaps = 14/133 (10%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
+FG V A G++K T VA+K + E S E ++ ++E +MK H +++ LLG
Sbjct: 22 SFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLG 80
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDL---ISFAY 194
V +Q P VI+E G+L+ +LR RP N VL L I A
Sbjct: 81 VVSQGQPTLVIMELMTRGDLKSYLRSLRPE----------MENNPVLAPPSLSKMIQMAG 130
Query: 195 QVANGMHYLQSRK 207
++A+GM YL + K
Sbjct: 131 EIADGMAYLNANK 143
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 64.7 bits (156), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 44/133 (33%), Positives = 66/133 (49%), Gaps = 14/133 (10%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
+FG V A G++K T VA+K + E S E ++ ++E +MK H +++ LLG
Sbjct: 31 SFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLG 89
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDL---ISFAY 194
V +Q P VI+E G+L+ +LR RP N VL L I A
Sbjct: 90 VVSQGQPTLVIMELMTRGDLKSYLRSLRPE----------MENNPVLAPPSLSKMIQMAG 139
Query: 195 QVANGMHYLQSRK 207
++A+GM YL + K
Sbjct: 140 EIADGMAYLNANK 152
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 64.7 bits (156), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 44/133 (33%), Positives = 66/133 (49%), Gaps = 14/133 (10%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
+FG V A G++K T VA+K + E S E ++ ++E +MK H +++ LLG
Sbjct: 30 SFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLG 88
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDL---ISFAY 194
V +Q P VI+E G+L+ +LR RP N VL L I A
Sbjct: 89 VVSQGQPTLVIMELMTRGDLKSYLRSLRPE----------MENNPVLAPPSLSKMIQMAG 138
Query: 195 QVANGMHYLQSRK 207
++A+GM YL + K
Sbjct: 139 EIADGMAYLNANK 151
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 64.7 bits (156), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 39/109 (35%), Positives = 59/109 (54%), Gaps = 18/109 (16%)
Query: 98 TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
TVAVK LKE + E + + E +MK I +H N++ LLGVCT++ P Y+I EF +GNL
Sbjct: 53 TVAVKTLKEDTMEVE--EFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 109
Query: 158 RDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
D+LR+ N + L+ A Q+++ M YL+ +
Sbjct: 110 LDYLRE---------------CNRQEVNAVVLLYMATQISSAMEYLEKK 143
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 64.7 bits (156), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 39/109 (35%), Positives = 59/109 (54%), Gaps = 18/109 (16%)
Query: 98 TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
TVAVK LKE + E + + E +MK I +H N++ LLGVCT++ P Y+I EF +GNL
Sbjct: 45 TVAVKTLKEDTMEVE--EFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 101
Query: 158 RDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
D+LR+ N + L+ A Q+++ M YL+ +
Sbjct: 102 LDYLRE---------------CNRQEVNAVVLLYMATQISSAMEYLEKK 135
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 64.7 bits (156), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 39/109 (35%), Positives = 59/109 (54%), Gaps = 18/109 (16%)
Query: 98 TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
TVAVK LKE + E + + E +MK I +H N++ LLGVCT++ P Y+I EF +GNL
Sbjct: 42 TVAVKTLKEDTMEVE--EFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 98
Query: 158 RDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
D+LR+ N + L+ A Q+++ M YL+ +
Sbjct: 99 LDYLRE---------------CNRQEVNAVVLLYMATQISSAMEYLEKK 132
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 64.7 bits (156), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 44/133 (33%), Positives = 66/133 (49%), Gaps = 14/133 (10%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
+FG V A G++K T VA+K + E S E ++ ++E +MK H +++ LLG
Sbjct: 59 SFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLG 117
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDL---ISFAY 194
V +Q P VI+E G+L+ +LR RP N VL L I A
Sbjct: 118 VVSQGQPTLVIMELMTRGDLKSYLRSLRPE----------MENNPVLAPPSLSKMIQMAG 167
Query: 195 QVANGMHYLQSRK 207
++A+GM YL + K
Sbjct: 168 EIADGMAYLNANK 180
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 64.7 bits (156), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 44/133 (33%), Positives = 66/133 (49%), Gaps = 14/133 (10%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
+FG V A G++K T VA+K + E S E ++ ++E +MK H +++ LLG
Sbjct: 31 SFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLG 89
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDL---ISFAY 194
V +Q P VI+E G+L+ +LR RP N VL L I A
Sbjct: 90 VVSQGQPTLVIMELMTRGDLKSYLRSLRPE----------MENNPVLAPPSLSKMIQMAG 139
Query: 195 QVANGMHYLQSRK 207
++A+GM YL + K
Sbjct: 140 EIADGMAYLNANK 152
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 64.3 bits (155), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 44/133 (33%), Positives = 66/133 (49%), Gaps = 14/133 (10%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
+FG V A G++K T VA+K + E S E ++ ++E +MK H +++ LLG
Sbjct: 24 SFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLG 82
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDL---ISFAY 194
V +Q P VI+E G+L+ +LR RP N VL L I A
Sbjct: 83 VVSQGQPTLVIMELMTRGDLKSYLRSLRPE----------MENNPVLAPPSLSKMIQMAG 132
Query: 195 QVANGMHYLQSRK 207
++A+GM YL + K
Sbjct: 133 EIADGMAYLNANK 145
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 64.3 bits (155), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 44/133 (33%), Positives = 66/133 (49%), Gaps = 14/133 (10%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
+FG V A G++K T VA+K + E S E ++ ++E +MK H +++ LLG
Sbjct: 24 SFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVVRLLG 82
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDL---ISFAY 194
V +Q P VI+E G+L+ +LR RP N VL L I A
Sbjct: 83 VVSQGQPTLVIMELMTRGDLKSYLRSLRPE----------MENNPVLAPPSLSKMIQMAG 132
Query: 195 QVANGMHYLQSRK 207
++A+GM YL + K
Sbjct: 133 EIADGMAYLNANK 145
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 64.3 bits (155), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 39/109 (35%), Positives = 59/109 (54%), Gaps = 18/109 (16%)
Query: 98 TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
TVAVK LKE E+ + + E +MK I +H N++ LLGVCT++ P Y+I EF +GNL
Sbjct: 286 TVAVKTLKE--DTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 342
Query: 158 RDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
D+LR+ N + L+ A Q+++ M YL+ +
Sbjct: 343 LDYLRE---------------CNRQEVNAVVLLYMATQISSAMEYLEKK 376
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 64.3 bits (155), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 39/109 (35%), Positives = 59/109 (54%), Gaps = 18/109 (16%)
Query: 98 TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
TVAVK LKE E+ + + E +MK I +H N++ LLGVCT++ P Y+I EF +GNL
Sbjct: 244 TVAVKTLKE--DTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 300
Query: 158 RDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
D+LR+ N + L+ A Q+++ M YL+ +
Sbjct: 301 LDYLRE---------------CNRQEVNAVVLLYMATQISSAMEYLEKK 334
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 62.4 bits (150), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 42/130 (32%), Positives = 60/130 (46%), Gaps = 2/130 (1%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FGKV G VA+K LK+ ++ + + M++ QH N++ LLGV
Sbjct: 22 FGKVYKGHLFGPAPGEQTQAVAIKTLKD-KAEGPLREEFRHEAMLRARLQHPNVVCLLGV 80
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
T+D PL +I + HG+L +FL P S S T + L D + Q+A
Sbjct: 81 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGS-TDDDRTVKSALEPPDFVHLVAQIAA 139
Query: 199 GMHYLQSRKV 208
GM YL S V
Sbjct: 140 GMEYLSSHHV 149
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 62.4 bits (150), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 42/130 (32%), Positives = 60/130 (46%), Gaps = 2/130 (1%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FGKV G VA+K LK+ ++ + + M++ QH N++ LLGV
Sbjct: 39 FGKVYKGHLFGPAPGEQTQAVAIKTLKD-KAEGPLREEFRHEAMLRARLQHPNVVCLLGV 97
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
T+D PL +I + HG+L +FL P S S T + L D + Q+A
Sbjct: 98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGS-TDDDRTVKSALEPPDFVHLVAQIAA 156
Query: 199 GMHYLQSRKV 208
GM YL S V
Sbjct: 157 GMEYLSSHHV 166
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 60.8 bits (146), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 44/129 (34%), Positives = 62/129 (48%), Gaps = 3/129 (2%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFGKV AE + VAVK LK+ + A D E E++ + QH +I+ G
Sbjct: 27 AFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNL-QHEHIVKFYG 84
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
VC PL ++ E+ HG+L FLR H P + G L ++ A Q+A
Sbjct: 85 VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVD-GQPRQAKGELGLSQMLHIASQIA 143
Query: 198 NGMHYLQSR 206
+GM YL S+
Sbjct: 144 SGMVYLASQ 152
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 58.9 bits (141), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 44/135 (32%), Positives = 68/135 (50%), Gaps = 28/135 (20%)
Query: 79 FGKV-IC---AEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIIN 134
FGKV +C E + +Q VAVK LK + DL E+E+++ + H NI+
Sbjct: 34 FGKVELCRYDPEGDNTGEQ-----VAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVK 87
Query: 135 LLGVCTQDG--PLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISF 192
G+CT+DG + +I+EF P G+L+++L K N N + K + +
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPK----------------NKNKINLKQQLKY 131
Query: 193 AYQVANGMHYLQSRK 207
A Q+ GM YL SR+
Sbjct: 132 AVQICKGMDYLGSRQ 146
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 58.9 bits (141), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 44/135 (32%), Positives = 68/135 (50%), Gaps = 28/135 (20%)
Query: 79 FGKV-IC---AEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIIN 134
FGKV +C E + +Q VAVK LK + DL E+E+++ + H NI+
Sbjct: 22 FGKVELCRYDPEGDNTGEQ-----VAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVK 75
Query: 135 LLGVCTQDG--PLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISF 192
G+CT+DG + +I+EF P G+L+++L K N N + K + +
Sbjct: 76 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPK----------------NKNKINLKQQLKY 119
Query: 193 AYQVANGMHYLQSRK 207
A Q+ GM YL SR+
Sbjct: 120 AVQICKGMDYLGSRQ 134
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 58.2 bits (139), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 38/110 (34%), Positives = 55/110 (50%), Gaps = 18/110 (16%)
Query: 97 TTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGN 156
T VAVK LK G + + E +MK + QH ++ L V T++ P+Y+I EF G+
Sbjct: 37 TKVAVKTLKPGTMSVQA--FLEEANLMKTL-QHDKLVRLYAVVTKEEPIYIITEFMAKGS 93
Query: 157 LRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
L DFL+ G VL K LI F+ Q+A GM Y++ +
Sbjct: 94 LLDFLKSDE--------------GGKVLLPK-LIDFSAQIAEGMAYIERK 128
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 57.8 bits (138), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 38/128 (29%), Positives = 61/128 (47%), Gaps = 11/128 (8%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFG+V + +G+ VAVK L E +S+ + +D + E ++ H NI+ +G
Sbjct: 57 AFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKF-NHQNIVRCIG 115
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
V Q P ++++E G+L+ FLR+ RP S L DL+ A +A
Sbjct: 116 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML----------DLLHVARDIA 165
Query: 198 NGMHYLQS 205
G YL+
Sbjct: 166 CGCQYLEE 173
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 57.4 bits (137), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 37/110 (33%), Positives = 55/110 (50%), Gaps = 18/110 (16%)
Query: 97 TTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGN 156
T VAVK LK G + + E +MK + QH ++ L V T++ P+Y+I E+ G+
Sbjct: 38 TKVAVKTLKPGTMSVQA--FLEEANLMKTL-QHDKLVRLYAVVTREEPIYIITEYMAKGS 94
Query: 157 LRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
L DFL+ G VL K LI F+ Q+A GM Y++ +
Sbjct: 95 LLDFLKSDE--------------GGKVLLPK-LIDFSAQIAEGMAYIERK 129
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 38/128 (29%), Positives = 61/128 (47%), Gaps = 11/128 (8%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFG+V + +G+ VAVK L E S+ + +D + E ++ + H NI+ +G
Sbjct: 43 AFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL-NHQNIVRCIG 101
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
V Q P ++++E G+L+ FLR+ RP S L DL+ A +A
Sbjct: 102 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML----------DLLHVARDIA 151
Query: 198 NGMHYLQS 205
G YL+
Sbjct: 152 CGCQYLEE 159
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 56.6 bits (135), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 41/130 (31%), Positives = 63/130 (48%), Gaps = 23/130 (17%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLR 158
VAVKM+KEG S +E MMK+ H ++ GVC+++ P+Y++ E+ +G L
Sbjct: 35 VAVKMIKEG-SMSEDEFFQEAQTMMKL--SHPKLVKFYGVCSKEYPIYIVTEYISNGCLL 91
Query: 159 DFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRK-VGND-AVR-- 214
++LR H G L L+ Y V GM +L+S + + D A R
Sbjct: 92 NYLRSH----------------GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNC 135
Query: 215 FIGFDLCILV 224
+ DLC+ V
Sbjct: 136 LVDRDLCVKV 145
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 56.6 bits (135), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 38/128 (29%), Positives = 61/128 (47%), Gaps = 11/128 (8%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFG+V + +G+ VAVK L E S+ + +D + E ++ + H NI+ +G
Sbjct: 57 AFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL-NHQNIVRCIG 115
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
V Q P ++++E G+L+ FLR+ RP S L DL+ A +A
Sbjct: 116 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML----------DLLHVARDIA 165
Query: 198 NGMHYLQS 205
G YL+
Sbjct: 166 CGCQYLEE 173
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 38/128 (29%), Positives = 60/128 (46%), Gaps = 11/128 (8%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFG+V + +G+ VAVK L E S+ + +D + E ++ H NI+ +G
Sbjct: 49 AFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIG 107
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
V Q P ++++E G+L+ FLR+ RP S L DL+ A +A
Sbjct: 108 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML----------DLLHVARDIA 157
Query: 198 NGMHYLQS 205
G YL+
Sbjct: 158 CGCQYLEE 165
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 39/111 (35%), Positives = 56/111 (50%), Gaps = 22/111 (19%)
Query: 100 AVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQ-DGPLYVIVEFAPHGNLR 158
AVK L E+ ++E +MK H N+++LLG+C + +G V++ + HG+LR
Sbjct: 81 AVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 139
Query: 159 DFLRK--HRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRK 207
+F+R H P T KDLI F QVA GM YL S+K
Sbjct: 140 NFIRNETHNP------------------TVKDLIGFGLQVAKGMKYLASKK 172
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 39/111 (35%), Positives = 56/111 (50%), Gaps = 22/111 (19%)
Query: 100 AVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQ-DGPLYVIVEFAPHGNLR 158
AVK L E+ ++E +MK H N+++LLG+C + +G V++ + HG+LR
Sbjct: 54 AVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 112
Query: 159 DFLRK--HRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRK 207
+F+R H P T KDLI F QVA GM YL S+K
Sbjct: 113 NFIRNETHNP------------------TVKDLIGFGLQVAKGMKYLASKK 145
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 38/128 (29%), Positives = 60/128 (46%), Gaps = 11/128 (8%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFG+V + +G+ VAVK L E S+ + +D + E ++ H NI+ +G
Sbjct: 43 AFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIG 101
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
V Q P ++++E G+L+ FLR+ RP S L DL+ A +A
Sbjct: 102 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML----------DLLHVARDIA 151
Query: 198 NGMHYLQS 205
G YL+
Sbjct: 152 CGCQYLEE 159
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 38/128 (29%), Positives = 60/128 (46%), Gaps = 11/128 (8%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFG+V + +G+ VAVK L E S+ + +D + E ++ H NI+ +G
Sbjct: 43 AFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIG 101
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
V Q P ++++E G+L+ FLR+ RP S L DL+ A +A
Sbjct: 102 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML----------DLLHVARDIA 151
Query: 198 NGMHYLQS 205
G YL+
Sbjct: 152 CGCQYLEE 159
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 38/128 (29%), Positives = 60/128 (46%), Gaps = 11/128 (8%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFG+V + +G+ VAVK L E S+ + +D + E ++ H NI+ +G
Sbjct: 69 AFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIG 127
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
V Q P ++++E G+L+ FLR+ RP S L DL+ A +A
Sbjct: 128 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML----------DLLHVARDIA 177
Query: 198 NGMHYLQS 205
G YL+
Sbjct: 178 CGCQYLEE 185
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 38/128 (29%), Positives = 60/128 (46%), Gaps = 11/128 (8%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFG+V + +G+ VAVK L E S+ + +D + E ++ H NI+ +G
Sbjct: 59 AFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIG 117
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
V Q P ++++E G+L+ FLR+ RP S L DL+ A +A
Sbjct: 118 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML----------DLLHVARDIA 167
Query: 198 NGMHYLQS 205
G YL+
Sbjct: 168 CGCQYLEE 175
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 38/128 (29%), Positives = 60/128 (46%), Gaps = 11/128 (8%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFG+V + +G+ VAVK L E S+ + +D + E ++ H NI+ +G
Sbjct: 34 AFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIG 92
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
V Q P ++++E G+L+ FLR+ RP S L DL+ A +A
Sbjct: 93 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML----------DLLHVARDIA 142
Query: 198 NGMHYLQS 205
G YL+
Sbjct: 143 CGCQYLEE 150
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 39/111 (35%), Positives = 56/111 (50%), Gaps = 22/111 (19%)
Query: 100 AVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQ-DGPLYVIVEFAPHGNLR 158
AVK L E+ ++E +MK H N+++LLG+C + +G V++ + HG+LR
Sbjct: 80 AVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 138
Query: 159 DFLRK--HRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRK 207
+F+R H P T KDLI F QVA GM YL S+K
Sbjct: 139 NFIRNETHNP------------------TVKDLIGFGLQVAKGMKYLASKK 171
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 55.8 bits (133), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 38/128 (29%), Positives = 60/128 (46%), Gaps = 11/128 (8%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFG+V + +G+ VAVK L E S+ + +D + E ++ H NI+ +G
Sbjct: 83 AFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIG 141
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
V Q P ++++E G+L+ FLR+ RP S L DL+ A +A
Sbjct: 142 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML----------DLLHVARDIA 191
Query: 198 NGMHYLQS 205
G YL+
Sbjct: 192 CGCQYLEE 199
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 55.8 bits (133), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 39/111 (35%), Positives = 56/111 (50%), Gaps = 22/111 (19%)
Query: 100 AVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQ-DGPLYVIVEFAPHGNLR 158
AVK L E+ ++E +MK H N+++LLG+C + +G V++ + HG+LR
Sbjct: 61 AVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 119
Query: 159 DFLRK--HRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRK 207
+F+R H P T KDLI F QVA GM YL S+K
Sbjct: 120 NFIRNETHNP------------------TVKDLIGFGLQVAKGMKYLASKK 152
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 55.8 bits (133), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 38/128 (29%), Positives = 60/128 (46%), Gaps = 11/128 (8%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFG+V + +G+ VAVK L E S+ + +D + E ++ H NI+ +G
Sbjct: 42 AFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIG 100
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
V Q P ++++E G+L+ FLR+ RP S L DL+ A +A
Sbjct: 101 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML----------DLLHVARDIA 150
Query: 198 NGMHYLQS 205
G YL+
Sbjct: 151 CGCQYLEE 158
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 55.8 bits (133), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 39/111 (35%), Positives = 56/111 (50%), Gaps = 22/111 (19%)
Query: 100 AVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQ-DGPLYVIVEFAPHGNLR 158
AVK L E+ ++E +MK H N+++LLG+C + +G V++ + HG+LR
Sbjct: 62 AVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 120
Query: 159 DFLRK--HRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRK 207
+F+R H P T KDLI F QVA GM YL S+K
Sbjct: 121 NFIRNETHNP------------------TVKDLIGFGLQVAKGMKYLASKK 153
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 55.8 bits (133), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 39/111 (35%), Positives = 56/111 (50%), Gaps = 22/111 (19%)
Query: 100 AVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQ-DGPLYVIVEFAPHGNLR 158
AVK L E+ ++E +MK H N+++LLG+C + +G V++ + HG+LR
Sbjct: 60 AVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 118
Query: 159 DFLRK--HRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRK 207
+F+R H P T KDLI F QVA GM YL S+K
Sbjct: 119 NFIRNETHNP------------------TVKDLIGFGLQVAKGMKYLASKK 151
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 55.8 bits (133), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 38/128 (29%), Positives = 60/128 (46%), Gaps = 11/128 (8%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFG+V + +G+ VAVK L E S+ + +D + E ++ H NI+ +G
Sbjct: 60 AFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIG 118
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
V Q P ++++E G+L+ FLR+ RP S L DL+ A +A
Sbjct: 119 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML----------DLLHVARDIA 168
Query: 198 NGMHYLQS 205
G YL+
Sbjct: 169 CGCQYLEE 176
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 55.8 bits (133), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 39/111 (35%), Positives = 56/111 (50%), Gaps = 22/111 (19%)
Query: 100 AVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQ-DGPLYVIVEFAPHGNLR 158
AVK L E+ ++E +MK H N+++LLG+C + +G V++ + HG+LR
Sbjct: 59 AVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 117
Query: 159 DFLRK--HRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRK 207
+F+R H P T KDLI F QVA GM YL S+K
Sbjct: 118 NFIRNETHNP------------------TVKDLIGFGLQVAKGMKYLASKK 150
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 55.8 bits (133), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 38/128 (29%), Positives = 60/128 (46%), Gaps = 11/128 (8%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFG+V + +G+ VAVK L E S+ + +D + E ++ H NI+ +G
Sbjct: 57 AFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIG 115
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
V Q P ++++E G+L+ FLR+ RP S L DL+ A +A
Sbjct: 116 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAML----------DLLHVARDIA 165
Query: 198 NGMHYLQS 205
G YL+
Sbjct: 166 CGCQYLEE 173
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 55.8 bits (133), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 38/128 (29%), Positives = 60/128 (46%), Gaps = 11/128 (8%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFG+V + +G+ VAVK L E S+ + +D + E ++ H NI+ +G
Sbjct: 42 AFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIG 100
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
V Q P ++++E G+L+ FLR+ RP S L DL+ A +A
Sbjct: 101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAML----------DLLHVARDIA 150
Query: 198 NGMHYLQS 205
G YL+
Sbjct: 151 CGCQYLEE 158
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 55.8 bits (133), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 39/111 (35%), Positives = 56/111 (50%), Gaps = 22/111 (19%)
Query: 100 AVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQ-DGPLYVIVEFAPHGNLR 158
AVK L E+ ++E +MK H N+++LLG+C + +G V++ + HG+LR
Sbjct: 62 AVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 120
Query: 159 DFLRK--HRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRK 207
+F+R H P T KDLI F QVA GM YL S+K
Sbjct: 121 NFIRNETHNP------------------TVKDLIGFGLQVAKGMKYLASKK 153
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 55.8 bits (133), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 39/111 (35%), Positives = 56/111 (50%), Gaps = 22/111 (19%)
Query: 100 AVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQ-DGPLYVIVEFAPHGNLR 158
AVK L E+ ++E +MK H N+++LLG+C + +G V++ + HG+LR
Sbjct: 61 AVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 119
Query: 159 DFLRK--HRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRK 207
+F+R H P T KDLI F QVA GM YL S+K
Sbjct: 120 NFIRNETHNP------------------TVKDLIGFGLQVAKGMKYLASKK 152
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 55.8 bits (133), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 39/111 (35%), Positives = 56/111 (50%), Gaps = 22/111 (19%)
Query: 100 AVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQ-DGPLYVIVEFAPHGNLR 158
AVK L E+ ++E +MK H N+++LLG+C + +G V++ + HG+LR
Sbjct: 57 AVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 115
Query: 159 DFLRK--HRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRK 207
+F+R H P T KDLI F QVA GM YL S+K
Sbjct: 116 NFIRNETHNP------------------TVKDLIGFGLQVAKGMKYLASKK 148
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 35/113 (30%), Positives = 59/113 (52%), Gaps = 6/113 (5%)
Query: 52 SVHDKVSLINVLTVTINSQEYVKIKCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDA 111
+VH+ ++ ++I+ V FG+V K+ I +VA+K LK G+++
Sbjct: 34 TVHEFAKELDATNISIDK---VVGAGEFGEVCSGRLKLPSKKEI--SVAIKTLKVGYTEK 88
Query: 112 EMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKH 164
+ D + E +M H NII L GV T+ P+ ++ E+ +G+L FLRKH
Sbjct: 89 QRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH 140
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 35/113 (30%), Positives = 59/113 (52%), Gaps = 6/113 (5%)
Query: 52 SVHDKVSLINVLTVTINSQEYVKIKCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDA 111
+VH+ ++ ++I+ V FG+V K+ I +VA+K LK G+++
Sbjct: 34 TVHEFAKELDATNISIDK---VVGAGEFGEVCSGRLKLPSKKEI--SVAIKTLKVGYTEK 88
Query: 112 EMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKH 164
+ D + E +M H NII L GV T+ P+ ++ E+ +G+L FLRKH
Sbjct: 89 QRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH 140
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 35/113 (30%), Positives = 59/113 (52%), Gaps = 6/113 (5%)
Query: 52 SVHDKVSLINVLTVTINSQEYVKIKCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDA 111
+VH+ ++ ++I+ V FG+V K+ I +VA+K LK G+++
Sbjct: 34 TVHEFAKELDATNISIDK---VVGAGEFGEVCSGRLKLPSKKEI--SVAIKTLKVGYTEK 88
Query: 112 EMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKH 164
+ D + E +M H NII L GV T+ P+ ++ E+ +G+L FLRKH
Sbjct: 89 QRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH 140
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 35/113 (30%), Positives = 59/113 (52%), Gaps = 6/113 (5%)
Query: 52 SVHDKVSLINVLTVTINSQEYVKIKCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDA 111
+VH+ ++ ++I+ V FG+V K+ I +VA+K LK G+++
Sbjct: 34 TVHEFAKELDATNISIDK---VVGAGEFGEVCSGRLKLPSKKEI--SVAIKTLKVGYTEK 88
Query: 112 EMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKH 164
+ D + E +M H NII L GV T+ P+ ++ E+ +G+L FLRKH
Sbjct: 89 QRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH 140
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 31/86 (36%), Positives = 48/86 (55%), Gaps = 3/86 (3%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V K+ I +VA+K LK G+++ + D + E +M H NII L GV
Sbjct: 29 FGEVCSGRLKLPSKKEI--SVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGV 85
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKH 164
T+ P+ ++ E+ +G+L FLRKH
Sbjct: 86 VTKSKPVMIVTEYMENGSLDSFLRKH 111
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 35/113 (30%), Positives = 59/113 (52%), Gaps = 6/113 (5%)
Query: 52 SVHDKVSLINVLTVTINSQEYVKIKCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDA 111
+VH+ ++ ++I+ V FG+V K+ I +VA+K LK G+++
Sbjct: 34 TVHEFAKELDATNISIDK---VVGAGEFGEVCSGRLKLPSKKEI--SVAIKTLKVGYTEK 88
Query: 112 EMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKH 164
+ D + E +M H NII L GV T+ P+ ++ E+ +G+L FLRKH
Sbjct: 89 QRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH 140
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 35/113 (30%), Positives = 59/113 (52%), Gaps = 6/113 (5%)
Query: 52 SVHDKVSLINVLTVTINSQEYVKIKCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDA 111
+VH+ ++ ++I+ V FG+V K+ I +VA+K LK G+++
Sbjct: 34 TVHEFAKELDATNISIDK---VVGAGEFGEVCSGRLKLPSKKEI--SVAIKTLKVGYTEK 88
Query: 112 EMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKH 164
+ D + E +M H NII L GV T+ P+ ++ E+ +G+L FLRKH
Sbjct: 89 QRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH 140
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 35/113 (30%), Positives = 59/113 (52%), Gaps = 6/113 (5%)
Query: 52 SVHDKVSLINVLTVTINSQEYVKIKCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDA 111
+VH+ ++ ++I+ V FG+V K+ I +VA+K LK G+++
Sbjct: 32 TVHEFAKELDATNISIDK---VVGAGEFGEVCSGRLKLPSKKEI--SVAIKTLKVGYTEK 86
Query: 112 EMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKH 164
+ D + E +M H NII L GV T+ P+ ++ E+ +G+L FLRKH
Sbjct: 87 QRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH 138
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 35/113 (30%), Positives = 59/113 (52%), Gaps = 6/113 (5%)
Query: 52 SVHDKVSLINVLTVTINSQEYVKIKCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDA 111
+VH+ ++ ++I+ V FG+V K+ I +VA+K LK G+++
Sbjct: 34 TVHEFAKELDATNISIDK---VVGAGEFGEVCSGRLKLPSKKEI--SVAIKTLKVGYTEK 88
Query: 112 EMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKH 164
+ D + E +M H NII L GV T+ P+ ++ E+ +G+L FLRKH
Sbjct: 89 QRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH 140
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 31/86 (36%), Positives = 48/86 (55%), Gaps = 3/86 (3%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V K+ I +VA+K LK G+++ + D + E +M H NII L GV
Sbjct: 46 FGEVCSGRLKLPSKKEI--SVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGV 102
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKH 164
T+ P+ ++ E+ +G+L FLRKH
Sbjct: 103 VTKSKPVMIVTEYMENGSLDSFLRKH 128
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 55.1 bits (131), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 25/128 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VAVK LK+G + ++E +MK + QH ++ L V
Sbjct: 27 FGEVWMGYYNGH------TKVAVKSLKQGSMSPDA--FLAEANLMKQL-QHQRLVRLYAV 77
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
TQ+ P+Y+I E+ +G+L DFL+ PS G LT L+ A Q+A
Sbjct: 78 VTQE-PIYIITEYMENGSLVDFLKT--PS-------------GIKLTINKLLDMAAQIAE 121
Query: 199 GMHYLQSR 206
GM +++ R
Sbjct: 122 GMAFIEER 129
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 55.1 bits (131), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 25/128 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VAVK LK+G + ++E +MK + QH ++ L V
Sbjct: 28 FGEVWMGYYNGH------TKVAVKSLKQGSMSPDA--FLAEANLMKQL-QHQRLVRLYAV 78
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
TQ+ P+Y+I E+ +G+L DFL+ PS G LT L+ A Q+A
Sbjct: 79 VTQE-PIYIITEYMENGSLVDFLKT--PS-------------GIKLTINKLLDMAAQIAE 122
Query: 199 GMHYLQSR 206
GM +++ R
Sbjct: 123 GMAFIEER 130
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 55.1 bits (131), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 25/128 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VAVK LK+G + ++E +MK + QH ++ L V
Sbjct: 26 FGEVWMGYYNGH------TKVAVKSLKQGSMSPDA--FLAEANLMKQL-QHQRLVRLYAV 76
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
TQ+ P+Y+I E+ +G+L DFL+ PS G LT L+ A Q+A
Sbjct: 77 VTQE-PIYIITEYMENGSLVDFLKT--PS-------------GIKLTINKLLDMAAQIAE 120
Query: 199 GMHYLQSR 206
GM +++ R
Sbjct: 121 GMAFIEER 128
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 55.1 bits (131), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 25/128 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VAVK LK+G + ++E +MK + QH ++ L V
Sbjct: 26 FGEVWMGYYNGH------TKVAVKSLKQGSMSPDA--FLAEANLMKQL-QHQRLVRLYAV 76
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
TQ+ P+Y+I E+ +G+L DFL+ PS G LT L+ A Q+A
Sbjct: 77 VTQE-PIYIITEYMENGSLVDFLKT--PS-------------GIKLTINKLLDMAAQIAE 120
Query: 199 GMHYLQSR 206
GM +++ R
Sbjct: 121 GMAFIEER 128
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 55.1 bits (131), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 25/128 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VAVK LK+G + ++E +MK + QH ++ L V
Sbjct: 31 FGEVWMGYYNGH------TKVAVKSLKQGSMSPDA--FLAEANLMKQL-QHQRLVRLYAV 81
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
TQ+ P+Y+I E+ +G+L DFL+ PS G LT L+ A Q+A
Sbjct: 82 VTQE-PIYIITEYMENGSLVDFLKT--PS-------------GIKLTINKLLDMAAQIAE 125
Query: 199 GMHYLQSR 206
GM +++ R
Sbjct: 126 GMAFIEER 133
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 55.1 bits (131), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 25/128 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VAVK LK+G + ++E +MK + QH ++ L V
Sbjct: 32 FGEVWMGYYNGH------TKVAVKSLKQGSMSPDA--FLAEANLMKQL-QHQRLVRLYAV 82
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
TQ+ P+Y+I E+ +G+L DFL+ PS G LT L+ A Q+A
Sbjct: 83 VTQE-PIYIITEYMENGSLVDFLKT--PS-------------GIKLTINKLLDMAAQIAE 126
Query: 199 GMHYLQSR 206
GM +++ R
Sbjct: 127 GMAFIEER 134
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 54.7 bits (130), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 25/128 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VAVK LK+G + ++E +MK + QH ++ L V
Sbjct: 34 FGEVWMGYYNGH------TKVAVKSLKQGSMSPDA--FLAEANLMKQL-QHQRLVRLYAV 84
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
TQ+ P+Y+I E+ +G+L DFL+ PS G LT L+ A Q+A
Sbjct: 85 VTQE-PIYIITEYMENGSLVDFLKT--PS-------------GIKLTINKLLDMAAQIAE 128
Query: 199 GMHYLQSR 206
GM +++ R
Sbjct: 129 GMAFIEER 136
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 54.7 bits (130), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 25/128 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VAVK LK+G + ++E +MK + QH ++ L V
Sbjct: 32 FGEVWMGYYNGH------TKVAVKSLKQGSMSPDA--FLAEANLMKQL-QHQRLVRLYAV 82
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
TQ+ P+Y+I E+ +G+L DFL+ PS G LT L+ A Q+A
Sbjct: 83 VTQE-PIYIITEYMENGSLVDFLKT--PS-------------GIKLTINKLLDMAAQIAE 126
Query: 199 GMHYLQSR 206
GM +++ R
Sbjct: 127 GMAFIEER 134
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 23/135 (17%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAE-MMDLVSEMEMMKMIGQHINIIN 134
K FG V + L+ VAVK L+ HS E + D E+E++K + QH NI+
Sbjct: 21 KGNFGSVEMCRYDP-LQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSL-QHDNIVK 76
Query: 135 LLGVCTQDGP--LYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISF 192
GVC G L +I+E+ P+G+LRD+L+KH+ + L+ +
Sbjct: 77 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----------------IDHIKLLQY 120
Query: 193 AYQVANGMHYLQSRK 207
Q+ GM YL +++
Sbjct: 121 TSQICKGMEYLGTKR 135
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 23/135 (17%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAE-MMDLVSEMEMMKMIGQHINIIN 134
K FG V + L+ VAVK L+ HS E + D E+E++K + QH NI+
Sbjct: 51 KGNFGSVEMCRYDP-LQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSL-QHDNIVK 106
Query: 135 LLGVCTQDGP--LYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISF 192
GVC G L +I+E+ P+G+LRD+L+KH+ + L+ +
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----------------IDHIKLLQY 150
Query: 193 AYQVANGMHYLQSRK 207
Q+ GM YL +++
Sbjct: 151 TSQICKGMEYLGTKR 165
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 34/111 (30%), Positives = 50/111 (45%), Gaps = 21/111 (18%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEME-MMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
VA+K ++EG E D + E E MMK+ H ++ L GVC + P+ ++ EF HG L
Sbjct: 34 VAIKTIREGAMSEE--DFIEEAEVMMKL--SHPKLVQLYGVCLEQAPICLVFEFMEHGCL 89
Query: 158 RDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
D+LR R + + L+ V GM YL+ V
Sbjct: 90 SDYLRTQR----------------GLFAAETLLGMCLDVCEGMAYLEEASV 124
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 25/128 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VAVK LK+G + ++E +MK + QH ++ L V
Sbjct: 35 FGEVWMGYYNGH------TKVAVKSLKQGSMSPDA--FLAEANLMKQL-QHQRLVRLYAV 85
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
TQ+ P+Y+I E+ +G+L DFL+ PS G LT L+ A Q+A
Sbjct: 86 VTQE-PIYIITEYMENGSLVDFLKT--PS-------------GIKLTINKLLDMAAQIAE 129
Query: 199 GMHYLQSR 206
GM +++ R
Sbjct: 130 GMAFIEER 137
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 25/128 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VAVK LK+G + ++E +MK + QH ++ L V
Sbjct: 36 FGEVWMGYYNGH------TKVAVKSLKQGSMSPDA--FLAEANLMKQL-QHQRLVRLYAV 86
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
TQ+ P+Y+I E+ +G+L DFL+ PS G LT L+ A Q+A
Sbjct: 87 VTQE-PIYIITEYMENGSLVDFLKT--PS-------------GIKLTINKLLDMAAQIAE 130
Query: 199 GMHYLQSR 206
GM +++ R
Sbjct: 131 GMAFIEER 138
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 25/128 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VAVK LK+G + ++E +MK + QH ++ L V
Sbjct: 22 FGEVWMGYYNGH------TKVAVKSLKQGSMSPDA--FLAEANLMKQL-QHQRLVRLYAV 72
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
TQ+ P+Y+I E+ +G+L DFL+ PS G LT L+ A Q+A
Sbjct: 73 VTQE-PIYIITEYMENGSLVDFLKT--PS-------------GIKLTINKLLDMAAQIAE 116
Query: 199 GMHYLQSR 206
GM +++ R
Sbjct: 117 GMAFIEER 124
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 25/128 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VAVK LK+G + ++E +MK + QH ++ L V
Sbjct: 26 FGEVWMGYYNGH------TKVAVKSLKQGSMSPDA--FLAEANLMKQL-QHQRLVRLYAV 76
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
TQ+ P+Y+I E+ +G+L DFL+ PS G LT L+ A Q+A
Sbjct: 77 VTQE-PIYIITEYMENGSLVDFLKT--PS-------------GIKLTINKLLDMAAQIAE 120
Query: 199 GMHYLQSR 206
GM +++ R
Sbjct: 121 GMAFIEER 128
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 43/128 (33%), Positives = 64/128 (50%), Gaps = 25/128 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VAVK LK+G + ++E +MK + QH ++ L V
Sbjct: 21 FGEVWMGYYNGH------TKVAVKSLKQGSMSPDA--FLAEANLMKQL-QHQRLVRLYAV 71
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
TQ+ P+Y+I E+ +G+L DFL+ PS G LT L+ A Q+A
Sbjct: 72 VTQE-PIYIITEYMENGSLVDFLKT--PS-------------GIKLTINKLLDMAAQIAE 115
Query: 199 GMHYLQSR 206
GM +++ R
Sbjct: 116 GMAFIEER 123
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 37/112 (33%), Positives = 59/112 (52%), Gaps = 22/112 (19%)
Query: 99 VAVKMLKEGHSDAE-MMDLVSEMEMMKMIGQHINIINLLGVCTQDGP--LYVIVEFAPHG 155
VAVK L+ HS E + D E+E++K + QH NI+ GVC G L +I+E+ P+G
Sbjct: 49 VAVKKLQ--HSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 105
Query: 156 NLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRK 207
+LRD+L+KH+ + L+ + Q+ GM YL +++
Sbjct: 106 SLRDYLQKHKER----------------IDHIKLLQYTSQICKGMEYLGTKR 141
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 23/135 (17%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAE-MMDLVSEMEMMKMIGQHINIIN 134
K FG V + L+ VAVK L+ HS E + D E+E++K + QH NI+
Sbjct: 20 KGNFGSVEMCRYDP-LQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSL-QHDNIVK 75
Query: 135 LLGVCTQDGP--LYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISF 192
GVC G L +I+E+ P+G+LRD+L+KH+ + L+ +
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----------------IDHIKLLQY 119
Query: 193 AYQVANGMHYLQSRK 207
Q+ GM YL +++
Sbjct: 120 TSQICKGMEYLGTKR 134
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 23/135 (17%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAE-MMDLVSEMEMMKMIGQHINIIN 134
K FG V + L+ VAVK L+ HS E + D E+E++K + QH NI+
Sbjct: 20 KGNFGSVEMCRYDP-LQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSL-QHDNIVK 75
Query: 135 LLGVCTQDGP--LYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISF 192
GVC G L +I+E+ P+G+LRD+L+KH+ + L+ +
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----------------IDHIKLLQY 119
Query: 193 AYQVANGMHYLQSRK 207
Q+ GM YL +++
Sbjct: 120 TSQICKGMEYLGTKR 134
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 38/111 (34%), Positives = 56/111 (50%), Gaps = 22/111 (19%)
Query: 100 AVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQ-DGPLYVIVEFAPHGNLR 158
AVK L E+ ++E +MK H N+++LLG+C + +G V++ + HG+LR
Sbjct: 121 AVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179
Query: 159 DFLRK--HRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRK 207
+F+R H P T KDLI F QVA GM +L S+K
Sbjct: 180 NFIRNETHNP------------------TVKDLIGFGLQVAKGMKFLASKK 212
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 23/135 (17%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAE-MMDLVSEMEMMKMIGQHINIIN 134
K FG V + L+ VAVK L+ HS E + D E+E++K + QH NI+
Sbjct: 26 KGNFGSVEMCRYDP-LQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSL-QHDNIVK 81
Query: 135 LLGVCTQDGP--LYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISF 192
GVC G L +I+E+ P+G+LRD+L+KH+ + L+ +
Sbjct: 82 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----------------IDHIKLLQY 125
Query: 193 AYQVANGMHYLQSRK 207
Q+ GM YL +++
Sbjct: 126 TSQICKGMEYLGTKR 140
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 23/135 (17%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAE-MMDLVSEMEMMKMIGQHINIIN 134
K FG V + L+ VAVK L+ HS E + D E+E++K + QH NI+
Sbjct: 18 KGNFGSVEMCRYDP-LQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSL-QHDNIVK 73
Query: 135 LLGVCTQDGP--LYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISF 192
GVC G L +I+E+ P+G+LRD+L+KH+ + L+ +
Sbjct: 74 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----------------IDHIKLLQY 117
Query: 193 AYQVANGMHYLQSRK 207
Q+ GM YL +++
Sbjct: 118 TSQICKGMEYLGTKR 132
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 23/135 (17%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAE-MMDLVSEMEMMKMIGQHINIIN 134
K FG V + L+ VAVK L+ HS E + D E+E++K + QH NI+
Sbjct: 23 KGNFGSVEMCRYDP-LQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSL-QHDNIVK 78
Query: 135 LLGVCTQDGP--LYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISF 192
GVC G L +I+E+ P+G+LRD+L+KH+ + L+ +
Sbjct: 79 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----------------IDHIKLLQY 122
Query: 193 AYQVANGMHYLQSRK 207
Q+ GM YL +++
Sbjct: 123 TSQICKGMEYLGTKR 137
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 23/135 (17%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAE-MMDLVSEMEMMKMIGQHINIIN 134
K FG V + L+ VAVK L+ HS E + D E+E++K + QH NI+
Sbjct: 25 KGNFGSVEMCRYDP-LQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSL-QHDNIVK 80
Query: 135 LLGVCTQDGP--LYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISF 192
GVC G L +I+E+ P+G+LRD+L+KH+ + L+ +
Sbjct: 81 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----------------IDHIKLLQY 124
Query: 193 AYQVANGMHYLQSRK 207
Q+ GM YL +++
Sbjct: 125 TSQICKGMEYLGTKR 139
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 23/135 (17%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAE-MMDLVSEMEMMKMIGQHINIIN 134
K FG V + L+ VAVK L+ HS E + D E+E++K + QH NI+
Sbjct: 19 KGNFGSVEMCRYDP-LQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSL-QHDNIVK 74
Query: 135 LLGVCTQDGP--LYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISF 192
GVC G L +I+E+ P+G+LRD+L+KH+ + L+ +
Sbjct: 75 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----------------IDHIKLLQY 118
Query: 193 AYQVANGMHYLQSRK 207
Q+ GM YL +++
Sbjct: 119 TSQICKGMEYLGTKR 133
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 23/135 (17%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAE-MMDLVSEMEMMKMIGQHINIIN 134
K FG V + L+ VAVK L+ HS E + D E+E++K + QH NI+
Sbjct: 24 KGNFGSVEMCRYDP-LQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSL-QHDNIVK 79
Query: 135 LLGVCTQDGP--LYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISF 192
GVC G L +I+E+ P+G+LRD+L+KH+ + L+ +
Sbjct: 80 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----------------IDHIKLLQY 123
Query: 193 AYQVANGMHYLQSRK 207
Q+ GM YL +++
Sbjct: 124 TSQICKGMEYLGTKR 138
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 23/135 (17%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAE-MMDLVSEMEMMKMIGQHINIIN 134
K FG V + L+ VAVK L+ HS E + D E+E++K + QH NI+
Sbjct: 20 KGNFGSVEMCRYDP-LQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSL-QHDNIVK 75
Query: 135 LLGVCTQDGP--LYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISF 192
GVC G L +I+E+ P+G+LRD+L+KH+ + L+ +
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----------------IDHIKLLQY 119
Query: 193 AYQVANGMHYLQSRK 207
Q+ GM YL +++
Sbjct: 120 TSQICKGMEYLGTKR 134
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 23/135 (17%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAE-MMDLVSEMEMMKMIGQHINIIN 134
K FG V + L+ VAVK L+ HS E + D E+E++K + QH NI+
Sbjct: 38 KGNFGSVEMCRYDP-LQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSL-QHDNIVK 93
Query: 135 LLGVCTQDGP--LYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISF 192
GVC G L +I+E+ P+G+LRD+L+KH+ + L+ +
Sbjct: 94 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----------------IDHIKLLQY 137
Query: 193 AYQVANGMHYLQSRK 207
Q+ GM YL +++
Sbjct: 138 TSQICKGMEYLGTKR 152
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 54.7 bits (130), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 37/112 (33%), Positives = 59/112 (52%), Gaps = 22/112 (19%)
Query: 99 VAVKMLKEGHSDAE-MMDLVSEMEMMKMIGQHINIINLLGVCTQDGP--LYVIVEFAPHG 155
VAVK L+ HS E + D E+E++K + QH NI+ GVC G L +I+E+ P+G
Sbjct: 60 VAVKKLQ--HSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 116
Query: 156 NLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRK 207
+LRD+L+KH+ + L+ + Q+ GM YL +++
Sbjct: 117 SLRDYLQKHKER----------------IDHIKLLQYTSQICKGMEYLGTKR 152
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 54.7 bits (130), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 38/111 (34%), Positives = 56/111 (50%), Gaps = 22/111 (19%)
Query: 100 AVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQ-DGPLYVIVEFAPHGNLR 158
AVK L E+ ++E +MK H N+++LLG+C + +G V++ + HG+LR
Sbjct: 62 AVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 120
Query: 159 DFLRK--HRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRK 207
+F+R H P T KDLI F QVA GM +L S+K
Sbjct: 121 NFIRNETHNP------------------TVKDLIGFGLQVAKGMKFLASKK 153
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 54.7 bits (130), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 38/111 (34%), Positives = 56/111 (50%), Gaps = 22/111 (19%)
Query: 100 AVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQ-DGPLYVIVEFAPHGNLR 158
AVK L E+ ++E +MK H N+++LLG+C + +G V++ + HG+LR
Sbjct: 63 AVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 121
Query: 159 DFLRK--HRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRK 207
+F+R H P T KDLI F QVA GM +L S+K
Sbjct: 122 NFIRNETHNP------------------TVKDLIGFGLQVAKGMKFLASKK 154
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 54.3 bits (129), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 38/111 (34%), Positives = 56/111 (50%), Gaps = 22/111 (19%)
Query: 100 AVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQ-DGPLYVIVEFAPHGNLR 158
AVK L E+ ++E +MK H N+++LLG+C + +G V++ + HG+LR
Sbjct: 63 AVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 121
Query: 159 DFLRK--HRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRK 207
+F+R H P T KDLI F QVA GM +L S+K
Sbjct: 122 NFIRNETHNP------------------TVKDLIGFGLQVAKGMKFLASKK 154
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 54.3 bits (129), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 40/125 (32%), Positives = 58/125 (46%), Gaps = 19/125 (15%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V K+ I VA+K LK G++D + D +SE +M H NII+L GV
Sbjct: 42 FGEVCSGRLKVPGKREI--CVAIKTLKAGYTDKQRRDFLSEASIMGQF-DHPNIIHLEGV 98
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
T+ P+ +I E+ +G+L FLRK N T L+ + +
Sbjct: 99 VTKCKPVMIITEYMENGSLDAFLRK----------------NDGRFTVIQLVGMLRGIGS 142
Query: 199 GMHYL 203
GM YL
Sbjct: 143 GMKYL 147
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 54.3 bits (129), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 38/111 (34%), Positives = 56/111 (50%), Gaps = 22/111 (19%)
Query: 100 AVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQ-DGPLYVIVEFAPHGNLR 158
AVK L E+ ++E +MK H N+++LLG+C + +G V++ + HG+LR
Sbjct: 62 AVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 120
Query: 159 DFLRK--HRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRK 207
+F+R H P T KDLI F QVA GM +L S+K
Sbjct: 121 NFIRNETHNP------------------TVKDLIGFGLQVAKGMKFLASKK 153
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 54.3 bits (129), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 33/108 (30%), Positives = 49/108 (45%), Gaps = 21/108 (19%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEME-MMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
VA+K ++EG E D + E E MMK+ H ++ L GVC + P+ ++ EF HG L
Sbjct: 35 VAIKTIREGAMSEE--DFIEEAEVMMKL--SHPKLVQLYGVCLEQAPICLVTEFMEHGCL 90
Query: 158 RDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQS 205
D+LR R + + L+ V GM YL+
Sbjct: 91 SDYLRTQR----------------GLFAAETLLGMCLDVCEGMAYLEE 122
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 54.3 bits (129), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 38/111 (34%), Positives = 56/111 (50%), Gaps = 22/111 (19%)
Query: 100 AVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQ-DGPLYVIVEFAPHGNLR 158
AVK L E+ ++E +MK H N+++LLG+C + +G V++ + HG+LR
Sbjct: 60 AVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 118
Query: 159 DFLRK--HRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRK 207
+F+R H P T KDLI F QVA GM +L S+K
Sbjct: 119 NFIRNETHNP------------------TVKDLIGFGLQVAKGMKFLASKK 151
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 54.3 bits (129), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 38/111 (34%), Positives = 56/111 (50%), Gaps = 22/111 (19%)
Query: 100 AVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQ-DGPLYVIVEFAPHGNLR 158
AVK L E+ ++E +MK H N+++LLG+C + +G V++ + HG+LR
Sbjct: 67 AVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 125
Query: 159 DFLRK--HRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRK 207
+F+R H P T KDLI F QVA GM +L S+K
Sbjct: 126 NFIRNETHNP------------------TVKDLIGFGLQVAKGMKFLASKK 158
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 54.3 bits (129), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 40/125 (32%), Positives = 58/125 (46%), Gaps = 19/125 (15%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V K+ I VA+K LK G++D + D +SE +M H NII+L GV
Sbjct: 21 FGEVCSGRLKVPGKREI--CVAIKTLKAGYTDKQRRDFLSEASIMGQF-DHPNIIHLEGV 77
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
T+ P+ +I E+ +G+L FLRK N T L+ + +
Sbjct: 78 VTKCKPVMIITEYMENGSLDAFLRK----------------NDGRFTVIQLVGMLRGIGS 121
Query: 199 GMHYL 203
GM YL
Sbjct: 122 GMKYL 126
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 54.3 bits (129), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 40/125 (32%), Positives = 58/125 (46%), Gaps = 19/125 (15%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V K+ I VA+K LK G++D + D +SE +M H NII+L GV
Sbjct: 27 FGEVCSGRLKVPGKREI--CVAIKTLKAGYTDKQRRDFLSEASIMGQF-DHPNIIHLEGV 83
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
T+ P+ +I E+ +G+L FLRK N T L+ + +
Sbjct: 84 VTKCKPVMIITEYMENGSLDAFLRK----------------NDGRFTVIQLVGMLRGIGS 127
Query: 199 GMHYL 203
GM YL
Sbjct: 128 GMKYL 132
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 53.9 bits (128), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 33/108 (30%), Positives = 49/108 (45%), Gaps = 21/108 (19%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEME-MMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
VA+K ++EG E D + E E MMK+ H ++ L GVC + P+ ++ EF HG L
Sbjct: 37 VAIKTIREGAMSEE--DFIEEAEVMMKL--SHPKLVQLYGVCLEQAPICLVFEFMEHGCL 92
Query: 158 RDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQS 205
D+LR R + + L+ V GM YL+
Sbjct: 93 SDYLRTQR----------------GLFAAETLLGMCLDVCEGMAYLEE 124
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 53.9 bits (128), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 33/108 (30%), Positives = 49/108 (45%), Gaps = 21/108 (19%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEME-MMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
VA+K ++EG E D + E E MMK+ H ++ L GVC + P+ ++ EF HG L
Sbjct: 34 VAIKTIREGAMSEE--DFIEEAEVMMKL--SHPKLVQLYGVCLEQAPICLVFEFMEHGCL 89
Query: 158 RDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQS 205
D+LR R + + L+ V GM YL+
Sbjct: 90 SDYLRTQR----------------GLFAAETLLGMCLDVCEGMAYLEE 121
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 53.9 bits (128), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 23/135 (17%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAE-MMDLVSEMEMMKMIGQHINIIN 134
K FG V + L+ VAVK L+ HS E + D E+E++K + QH NI+
Sbjct: 23 KGNFGSVEMCRYDP-LQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSL-QHDNIVK 78
Query: 135 LLGVCTQDGP--LYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISF 192
GVC G L +I+EF P+G+LR++L+KH+ + L+ +
Sbjct: 79 YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKER----------------IDHIKLLQY 122
Query: 193 AYQVANGMHYLQSRK 207
Q+ GM YL +++
Sbjct: 123 TSQICKGMEYLGTKR 137
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 53.9 bits (128), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 35/110 (31%), Positives = 49/110 (44%), Gaps = 17/110 (15%)
Query: 97 TTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGN 156
T VAVK +E + E ++K H NI+ L+GVCTQ P+Y+++E G+
Sbjct: 140 TLVAVKSCRETLPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQGGD 198
Query: 157 LRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
FLR T G L K L+ A GM YL+S+
Sbjct: 199 FLTFLR----------------TEGARLRVKTLLQMVGDAAAGMEYLESK 232
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 53.9 bits (128), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 35/110 (31%), Positives = 49/110 (44%), Gaps = 17/110 (15%)
Query: 97 TTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGN 156
T VAVK +E + E ++K H NI+ L+GVCTQ P+Y+++E G+
Sbjct: 140 TLVAVKSCRETLPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQGGD 198
Query: 157 LRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
FLR T G L K L+ A GM YL+S+
Sbjct: 199 FLTFLR----------------TEGARLRVKTLLQMVGDAAAGMEYLESK 232
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 53.9 bits (128), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 32/107 (29%), Positives = 48/107 (44%), Gaps = 19/107 (17%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLR 158
VA+K ++EG E D + E E+M M H ++ L GVC + P+ ++ EF HG L
Sbjct: 32 VAIKTIREGAMSEE--DFIEEAEVM-MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 88
Query: 159 DFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQS 205
D+LR R + + L+ V GM YL+
Sbjct: 89 DYLRTQR----------------GLFAAETLLGMCLDVCEGMAYLEE 119
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 53.9 bits (128), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 19/110 (17%)
Query: 97 TTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGN 156
T VAVK +K G E ++E +MK + QH ++ L V T++ P+Y+I EF G+
Sbjct: 40 TKVAVKTMKPGSMSVEA--FLAEANVMKTL-QHDKLVKLHAVVTKE-PIYIITEFMAKGS 95
Query: 157 LRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
L DFL+ G + PL LI F+ Q+A GM +++ R
Sbjct: 96 LLDFLKS---DEGSKQPLPK------------LIDFSAQIAEGMAFIEQR 130
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 53.9 bits (128), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 34/105 (32%), Positives = 51/105 (48%), Gaps = 17/105 (16%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLR 158
VA+K LK G+++ + D +SE +M H N+I+L GV T+ P+ +I EF +G+L
Sbjct: 38 VAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTKSTPVMIITEFMENGSLD 96
Query: 159 DFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYL 203
FLR+ N T L+ +A GM YL
Sbjct: 97 SFLRQ----------------NDGQFTVIQLVGMLRGIAAGMKYL 125
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 38/110 (34%), Positives = 58/110 (52%), Gaps = 19/110 (17%)
Query: 97 TTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGN 156
T VAVK LK+G + ++E +MK + QH ++ L V TQ+ P+Y+I E+ +G+
Sbjct: 38 TKVAVKSLKQGSMSPDA--FLAEANLMKQL-QHQRLVRLYAVVTQE-PIYIITEYMENGS 93
Query: 157 LRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
L DFL+ PS G LT L+ A Q+A GM +++ R
Sbjct: 94 LVDFLKT--PS-------------GIKLTINKLLDMAAQIAEGMAFIEER 128
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 39/125 (31%), Positives = 58/125 (46%), Gaps = 19/125 (15%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V K+ I VA+K LK G+++ + D +SE +M H N+I+L GV
Sbjct: 46 FGEVCSGHLKLPGKREIF--VAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHLEGV 102
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
T+ P+ +I EF +G+L FLR+ N T L+ +A
Sbjct: 103 VTKSTPVMIITEFMENGSLDSFLRQ----------------NDGQFTVIQLVGMLRGIAA 146
Query: 199 GMHYL 203
GM YL
Sbjct: 147 GMKYL 151
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 42/128 (32%), Positives = 62/128 (48%), Gaps = 25/128 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V A N T VAVK +K G E ++E +MK + QH ++ L V
Sbjct: 195 FGEVWMATYNKH------TKVAVKTMKPGSMSVEA--FLAEANVMKTL-QHDKLVKLHAV 245
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
T++ P+Y+I EF G+L DFL+ G + PL LI F+ Q+A
Sbjct: 246 VTKE-PIYIITEFMAKGSLLDFLKS---DEGSKQPLPK------------LIDFSAQIAE 289
Query: 199 GMHYLQSR 206
GM +++ R
Sbjct: 290 GMAFIEQR 297
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 31/86 (36%), Positives = 47/86 (54%), Gaps = 3/86 (3%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V K+ I +VA+K LK G+++ + D + E +M H NII L GV
Sbjct: 29 FGEVCSGRLKLPSKKEI--SVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGV 85
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKH 164
T+ P+ ++ E +G+L FLRKH
Sbjct: 86 VTKSKPVMIVTEXMENGSLDSFLRKH 111
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 35/113 (30%), Positives = 58/113 (51%), Gaps = 6/113 (5%)
Query: 52 SVHDKVSLINVLTVTINSQEYVKIKCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDA 111
+VH+ ++ ++I+ V FG+V K+ I +VA+K LK G+++
Sbjct: 34 TVHEFAKELDATNISIDK---VVGAGEFGEVCSGRLKLPSKKEI--SVAIKTLKVGYTEK 88
Query: 112 EMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKH 164
+ D + E +M H NII L GV T+ P+ ++ E +G+L FLRKH
Sbjct: 89 QRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKH 140
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 37/110 (33%), Positives = 56/110 (50%), Gaps = 19/110 (17%)
Query: 97 TTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGN 156
T VAVK +K G E ++E +MK + QH ++ L V T++ P+Y+I EF G+
Sbjct: 213 TKVAVKTMKPGSMSVEA--FLAEANVMKTL-QHDKLVKLHAVVTKE-PIYIITEFMAKGS 268
Query: 157 LRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSR 206
L DFL+ G + PL LI F+ Q+A GM +++ R
Sbjct: 269 LLDFLKS---DEGSKQPL------------PKLIDFSAQIAEGMAFIEQR 303
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 35/113 (30%), Positives = 58/113 (51%), Gaps = 6/113 (5%)
Query: 52 SVHDKVSLINVLTVTINSQEYVKIKCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDA 111
+VH+ ++ ++I+ V FG+V K+ I +VA+K LK G+++
Sbjct: 34 TVHEFAKELDATNISIDK---VVGAGEFGEVCSGRLKLPSKKEI--SVAIKTLKVGYTEK 88
Query: 112 EMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKH 164
+ D + E +M H NII L GV T+ P+ ++ E +G+L FLRKH
Sbjct: 89 QRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKH 140
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 53.5 bits (127), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 33/108 (30%), Positives = 49/108 (45%), Gaps = 21/108 (19%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEME-MMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
VA+K +KEG + D + E E MMK+ H ++ L GVC + P+ ++ EF HG L
Sbjct: 54 VAIKTIKEGSMSED--DFIEEAEVMMKL--SHPKLVQLYGVCLEQAPICLVFEFMEHGCL 109
Query: 158 RDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQS 205
D+LR R + + L+ V GM YL+
Sbjct: 110 SDYLRTQR----------------GLFAAETLLGMCLDVCEGMAYLEE 141
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 43/130 (33%), Positives = 64/130 (49%), Gaps = 23/130 (17%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMM-DLVSEMEMMKMIGQHINIINLL 136
+FG V AE +G + VAVK+L E AE + + + E+ +MK + +H NI+ +
Sbjct: 49 SFGTVHRAEWHG-------SDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFM 100
Query: 137 GVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQV 196
G TQ L ++ E+ G+L L K S E L E+ +S AY V
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHK---SGAREQ-----------LDERRRLSMAYDV 146
Query: 197 ANGMHYLQSR 206
A GM+YL +R
Sbjct: 147 AKGMNYLHNR 156
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 43/130 (33%), Positives = 64/130 (49%), Gaps = 23/130 (17%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMM-DLVSEMEMMKMIGQHINIINLL 136
+FG V AE +G + VAVK+L E AE + + + E+ +MK + +H NI+ +
Sbjct: 49 SFGTVHRAEWHG-------SDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFM 100
Query: 137 GVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQV 196
G TQ L ++ E+ G+L L K S E L E+ +S AY V
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHK---SGAREQ-----------LDERRRLSMAYDV 146
Query: 197 ANGMHYLQSR 206
A GM+YL +R
Sbjct: 147 AKGMNYLHNR 156
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 52.0 bits (123), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 25/67 (37%), Positives = 41/67 (61%), Gaps = 1/67 (1%)
Query: 98 TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
VA+K LK G+++ + D + E +M H N+++L GV T+ P+ +++EF +G L
Sbjct: 73 AVAIKTLKVGYTEKQRRDFLCEASIMGQF-DHPNVVHLEGVVTRGKPVMIVIEFMENGAL 131
Query: 158 RDFLRKH 164
FLRKH
Sbjct: 132 DAFLRKH 138
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 51.6 bits (122), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 41/137 (29%), Positives = 61/137 (44%), Gaps = 24/137 (17%)
Query: 72 YVKIK-----CAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMI 126
YVKI+ FG+V K+ + VA+K LK G+++ + + +SE +M
Sbjct: 15 YVKIEEVIGAGEFGEVCRGRLKAPGKKE--SCVAIKTLKGGYTERQRREFLSEASIMGQF 72
Query: 127 GQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTE 186
+H NII L GV T P+ ++ EF +G L FLR N T
Sbjct: 73 -EHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLR----------------LNDGQFTV 115
Query: 187 KDLISFAYQVANGMHYL 203
L+ +A+GM YL
Sbjct: 116 IQLVGMLRGIASGMRYL 132
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 51.6 bits (122), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 41/135 (30%), Positives = 64/135 (47%), Gaps = 23/135 (17%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAE-MMDLVSEMEMMKMIGQHINIIN 134
K FG V + L+ VAVK L+ HS E + D E+E++K + QH NI+
Sbjct: 23 KGNFGSVEMCRYDP-LQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSL-QHDNIVK 78
Query: 135 LLGVCTQDGP--LYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISF 192
GVC G L +I+E+ P+G+LRD+L+ H + L+ +
Sbjct: 79 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAH----------------AERIDHIKLLQY 122
Query: 193 AYQVANGMHYLQSRK 207
Q+ GM YL +++
Sbjct: 123 TSQICKGMEYLGTKR 137
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 51.2 bits (121), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 41/137 (29%), Positives = 61/137 (44%), Gaps = 24/137 (17%)
Query: 72 YVKIK-----CAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMI 126
YVKI+ FG+V K+ + VA+K LK G+++ + + +SE +M
Sbjct: 17 YVKIEEVIGAGEFGEVCRGRLKAPGKKE--SCVAIKTLKGGYTERQRREFLSEASIMGQF 74
Query: 127 GQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTE 186
+H NII L GV T P+ ++ EF +G L FLR N T
Sbjct: 75 -EHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLR----------------LNDGQFTV 117
Query: 187 KDLISFAYQVANGMHYL 203
L+ +A+GM YL
Sbjct: 118 IQLVGMLRGIASGMRYL 134
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 51.2 bits (121), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 9/91 (9%)
Query: 81 KVICAEANGILKQGIITT--------VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINI 132
KVI A G + +G++ T VA+K LK G+++ + +D + E +M H NI
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH-NI 108
Query: 133 INLLGVCTQDGPLYVIVEFAPHGNLRDFLRK 163
I L GV ++ P+ +I E+ +G L FLR+
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLRE 139
>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
pdb|4EBV|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
Length = 304
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 49/185 (26%), Positives = 79/185 (42%), Gaps = 40/185 (21%)
Query: 71 EYVKIKCAFGKVICAEANGILKQGIITT-------VAVKMLKEGHSDAEMMDLVSEMEMM 123
E + + G+ I G + QGI + VA+K K SD+ + E M
Sbjct: 34 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 93
Query: 124 KMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNV 183
+ H +I+ L+GV T++ P+++I+E G LR FL+ + Y L S
Sbjct: 94 RQF-DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRK----YSLDLAS------- 140
Query: 184 LTEKDLISFAYQVANGMHYLQSRKV-------------GNDAVRFIGFDLCILVFFHDST 230
LI +AYQ++ + YL+S++ ND V+ F L + DST
Sbjct: 141 -----LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS--RYMEDST 193
Query: 231 LLKTT 235
K +
Sbjct: 194 YYKAS 198
>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak)
pdb|4I4F|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With An Allosteric Binding Pyrazolobenzothiazine
Compound
Length = 281
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 49/185 (26%), Positives = 79/185 (42%), Gaps = 40/185 (21%)
Query: 71 EYVKIKCAFGKVICAEANGILKQGIITT-------VAVKMLKEGHSDAEMMDLVSEMEMM 123
E + + G+ I G + QGI + VA+K K SD+ + E M
Sbjct: 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 70
Query: 124 KMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNV 183
+ H +I+ L+GV T++ P+++I+E G LR FL+ + Y L S
Sbjct: 71 RQF-DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRK----YSLDLAS------- 117
Query: 184 LTEKDLISFAYQVANGMHYLQSRKV-------------GNDAVRFIGFDLCILVFFHDST 230
LI +AYQ++ + YL+S++ ND V+ F L + DST
Sbjct: 118 -----LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS--RYMEDST 170
Query: 231 LLKTT 235
K +
Sbjct: 171 YYKAS 175
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 33/122 (27%), Positives = 59/122 (48%), Gaps = 22/122 (18%)
Query: 89 GILKQGIIT---TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPL 145
G++K G VA+KM+KEG + + + E ++M M H ++ L GVCT+ P+
Sbjct: 18 GVVKYGKWRGQYDVAIKMIKEGSMSED--EFIEEAKVM-MNLSHEKLVQLYGVCTKQRPI 74
Query: 146 YVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQS 205
++I E+ +G L ++LR+ R + + L+ V M YL+S
Sbjct: 75 FIITEYMANGCLLNYLREMR----------------HRFQTQQLLEMCKDVCEAMEYLES 118
Query: 206 RK 207
++
Sbjct: 119 KQ 120
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 33/122 (27%), Positives = 59/122 (48%), Gaps = 22/122 (18%)
Query: 89 GILKQGIIT---TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPL 145
G++K G VA+KM+KEG + + + E ++M M H ++ L GVCT+ P+
Sbjct: 22 GVVKYGKWRGQYDVAIKMIKEGSMSED--EFIEEAKVM-MNLSHEKLVQLYGVCTKQRPI 78
Query: 146 YVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQS 205
++I E+ +G L ++LR+ R + + L+ V M YL+S
Sbjct: 79 FIITEYMANGCLLNYLREMR----------------HRFQTQQLLEMCKDVCEAMEYLES 122
Query: 206 RK 207
++
Sbjct: 123 KQ 124
>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2ETM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2IJM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
pdb|2IJM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
Length = 281
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 49/185 (26%), Positives = 79/185 (42%), Gaps = 40/185 (21%)
Query: 71 EYVKIKCAFGKVICAEANGILKQGIITT-------VAVKMLKEGHSDAEMMDLVSEMEMM 123
E + + G+ I G + QGI + VA+K K SD+ + E M
Sbjct: 8 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 67
Query: 124 KMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNV 183
+ H +I+ L+GV T++ P+++I+E G LR FL+ + Y L S
Sbjct: 68 RQF-DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRK----YSLDLAS------- 114
Query: 184 LTEKDLISFAYQVANGMHYLQSRKV-------------GNDAVRFIGFDLCILVFFHDST 230
LI +AYQ++ + YL+S++ ND V+ F L + DST
Sbjct: 115 -----LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS--RYMEDST 167
Query: 231 LLKTT 235
K +
Sbjct: 168 YYKAS 172
>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And
Kinase Domains Of Focal Adhesion Kinase.
pdb|2JKQ|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 49/185 (26%), Positives = 79/185 (42%), Gaps = 40/185 (21%)
Query: 71 EYVKIKCAFGKVICAEANGILKQGIITT-------VAVKMLKEGHSDAEMMDLVSEMEMM 123
E + + G+ I G + QGI + VA+K K SD+ + E M
Sbjct: 6 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 124 KMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNV 183
+ H +I+ L+GV T++ P+++I+E G LR FL+ + Y L S
Sbjct: 66 RQF-DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRK----YSLDLAS------- 112
Query: 184 LTEKDLISFAYQVANGMHYLQSRKV-------------GNDAVRFIGFDLCILVFFHDST 230
LI +AYQ++ + YL+S++ ND V+ F L + DST
Sbjct: 113 -----LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS--RYMEDST 165
Query: 231 LLKTT 235
K +
Sbjct: 166 YYKAS 170
>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 49/185 (26%), Positives = 79/185 (42%), Gaps = 40/185 (21%)
Query: 71 EYVKIKCAFGKVICAEANGILKQGIITT-------VAVKMLKEGHSDAEMMDLVSEMEMM 123
E + + G+ I G + QGI + VA+K K SD+ + E M
Sbjct: 6 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 124 KMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNV 183
+ H +I+ L+GV T++ P+++I+E G LR FL+ + Y L S
Sbjct: 66 RQF-DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRK----YSLDLAS------- 112
Query: 184 LTEKDLISFAYQVANGMHYLQSRKV-------------GNDAVRFIGFDLCILVFFHDST 230
LI +AYQ++ + YL+S++ ND V+ F L + DST
Sbjct: 113 -----LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS--RYMEDST 165
Query: 231 LLKTT 235
K +
Sbjct: 166 YYKAS 170
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 33/122 (27%), Positives = 59/122 (48%), Gaps = 22/122 (18%)
Query: 89 GILKQGIIT---TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPL 145
G++K G VA+KM+KEG + + + E ++M M H ++ L GVCT+ P+
Sbjct: 23 GVVKYGKWRGQYDVAIKMIKEGSMSED--EFIEEAKVM-MNLSHEKLVQLYGVCTKQRPI 79
Query: 146 YVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQS 205
++I E+ +G L ++LR+ R + + L+ V M YL+S
Sbjct: 80 FIITEYMANGCLLNYLREMR----------------HRFQTQQLLEMCKDVCEAMEYLES 123
Query: 206 RK 207
++
Sbjct: 124 KQ 125
>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
pdb|3PXK|B Chain B, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
Length = 282
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 49/185 (26%), Positives = 79/185 (42%), Gaps = 40/185 (21%)
Query: 71 EYVKIKCAFGKVICAEANGILKQGIITT-------VAVKMLKEGHSDAEMMDLVSEMEMM 123
E + + G+ I G + QGI + VA+K K SD+ + E M
Sbjct: 9 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 68
Query: 124 KMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNV 183
+ H +I+ L+GV T++ P+++I+E G LR FL+ + Y L S
Sbjct: 69 RQF-DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRK----YSLDLAS------- 115
Query: 184 LTEKDLISFAYQVANGMHYLQSRKV-------------GNDAVRFIGFDLCILVFFHDST 230
LI +AYQ++ + YL+S++ ND V+ F L + DST
Sbjct: 116 -----LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS--RYMEDST 168
Query: 231 LLKTT 235
K +
Sbjct: 169 YYKAS 173
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 33/122 (27%), Positives = 59/122 (48%), Gaps = 22/122 (18%)
Query: 89 GILKQGIIT---TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPL 145
G++K G VA+KM+KEG + + + E ++M M H ++ L GVCT+ P+
Sbjct: 23 GVVKYGKWRGQYDVAIKMIKEGSMSED--EFIEEAKVM-MNLSHEKLVQLYGVCTKQRPI 79
Query: 146 YVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQS 205
++I E+ +G L ++LR+ R + + L+ V M YL+S
Sbjct: 80 FIITEYMANGCLLNYLREMR----------------HRFQTQQLLEMCKDVCEAMEYLES 123
Query: 206 RK 207
++
Sbjct: 124 KQ 125
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 33/122 (27%), Positives = 59/122 (48%), Gaps = 22/122 (18%)
Query: 89 GILKQGIIT---TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPL 145
G++K G VA+KM+KEG + + + E ++M M H ++ L GVCT+ P+
Sbjct: 38 GVVKYGKWRGQYDVAIKMIKEGSMSED--EFIEEAKVM-MNLSHEKLVQLYGVCTKQRPI 94
Query: 146 YVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQS 205
++I E+ +G L ++LR+ R + + L+ V M YL+S
Sbjct: 95 FIITEYMANGCLLNYLREMR----------------HRFQTQQLLEMCKDVCEAMEYLES 138
Query: 206 RK 207
++
Sbjct: 139 KQ 140
>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A
Methanesulfonamide Diaminopyrimidine Inhibitor
Length = 276
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 49/185 (26%), Positives = 79/185 (42%), Gaps = 40/185 (21%)
Query: 71 EYVKIKCAFGKVICAEANGILKQGIITT-------VAVKMLKEGHSDAEMMDLVSEMEMM 123
E + + G+ I G + QGI + VA+K K SD+ + E M
Sbjct: 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 62
Query: 124 KMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNV 183
+ H +I+ L+GV T++ P+++I+E G LR FL+ + Y L S
Sbjct: 63 RQF-DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRK----YSLDLAS------- 109
Query: 184 LTEKDLISFAYQVANGMHYLQSRKV-------------GNDAVRFIGFDLCILVFFHDST 230
LI +AYQ++ + YL+S++ ND V+ F L + DST
Sbjct: 110 -----LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS--RYMEDST 162
Query: 231 LLKTT 235
K +
Sbjct: 163 YYKAS 167
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 33/122 (27%), Positives = 59/122 (48%), Gaps = 22/122 (18%)
Query: 89 GILKQGIIT---TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPL 145
G++K G VA+KM+KEG + + + E ++M M H ++ L GVCT+ P+
Sbjct: 29 GVVKYGKWRGQYDVAIKMIKEGSMSED--EFIEEAKVM-MNLSHEKLVQLYGVCTKQRPI 85
Query: 146 YVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQS 205
++I E+ +G L ++LR+ R + + L+ V M YL+S
Sbjct: 86 FIITEYMANGCLLNYLREMR----------------HRFQTQQLLEMCKDVCEAMEYLES 129
Query: 206 RK 207
++
Sbjct: 130 KQ 131
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 33/122 (27%), Positives = 59/122 (48%), Gaps = 22/122 (18%)
Query: 89 GILKQGIIT---TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPL 145
G++K G VA+KM+KEG + + + E ++M M H ++ L GVCT+ P+
Sbjct: 38 GVVKYGKWRGQYDVAIKMIKEGSMSED--EFIEEAKVM-MNLSHEKLVQLYGVCTKQRPI 94
Query: 146 YVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQS 205
++I E+ +G L ++LR+ R + + L+ V M YL+S
Sbjct: 95 FIITEYMANGCLLNYLREMR----------------HRFQTQQLLEMCKDVCEAMEYLES 138
Query: 206 RK 207
++
Sbjct: 139 KQ 140
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 36/126 (28%), Positives = 59/126 (46%), Gaps = 25/126 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VA+K LK G E + E ++MK + +H ++ L V
Sbjct: 197 FGEVWMGTWNGT------TRVAIKTLKPGTMSPEA--FLQEAQVMKKL-RHEKLVQLYAV 247
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
+++ P+Y++ E+ G+L DFL+ G L L+ A Q+A+
Sbjct: 248 VSEE-PIYIVTEYMSKGSLLDFLKGE---------------TGKYLRLPQLVDMAAQIAS 291
Query: 199 GMHYLQ 204
GM Y++
Sbjct: 292 GMAYVE 297
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 36/126 (28%), Positives = 59/126 (46%), Gaps = 25/126 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VA+K LK G E + E ++MK + +H ++ L V
Sbjct: 280 FGEVWMGTWNGT------TRVAIKTLKPGTMSPEA--FLQEAQVMKKL-RHEKLVQLYAV 330
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
+++ P+Y++ E+ G+L DFL+ G L L+ A Q+A+
Sbjct: 331 VSEE-PIYIVTEYMSKGSLLDFLKGE---------------TGKYLRLPQLVDMAAQIAS 374
Query: 199 GMHYLQ 204
GM Y++
Sbjct: 375 GMAYVE 380
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 36/126 (28%), Positives = 59/126 (46%), Gaps = 25/126 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VA+K LK G E + E ++MK + +H ++ L V
Sbjct: 197 FGEVWMGTWNGT------TRVAIKTLKPGTMSPEA--FLQEAQVMKKL-RHEKLVQLYAV 247
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
+++ P+Y++ E+ G+L DFL+ G L L+ A Q+A+
Sbjct: 248 VSEE-PIYIVTEYMSKGSLLDFLKGE---------------TGKYLRLPQLVDMAAQIAS 291
Query: 199 GMHYLQ 204
GM Y++
Sbjct: 292 GMAYVE 297
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 36/126 (28%), Positives = 59/126 (46%), Gaps = 25/126 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VA+K LK G E + E ++MK + +H ++ L V
Sbjct: 24 FGEVWMGTWNGT------TRVAIKTLKPGTMSPEA--FLQEAQVMKKL-RHEKLVQLYAV 74
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
+++ P+Y++ E+ G+L DFL+ G L L+ A Q+A+
Sbjct: 75 VSEE-PIYIVTEYMSKGSLLDFLKGE---------------TGKYLRLPQLVDMAAQIAS 118
Query: 199 GMHYLQ 204
GM Y++
Sbjct: 119 GMAYVE 124
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 36/126 (28%), Positives = 60/126 (47%), Gaps = 25/126 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VA+K LK G+ E + E ++MK + +H ++ L V
Sbjct: 198 FGEVWMGTWNGT------TRVAIKTLKPGNMSPEA--FLQEAQVMKKL-RHEKLVQLYAV 248
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
+++ P+Y++ E+ G+L DFL+ G L L+ A Q+A+
Sbjct: 249 VSEE-PIYIVTEYMSKGSLLDFLKGEM---------------GKYLRLPQLVDMAAQIAS 292
Query: 199 GMHYLQ 204
GM Y++
Sbjct: 293 GMAYVE 298
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 51/145 (35%), Positives = 67/145 (46%), Gaps = 29/145 (20%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEG-HSDAEMMD-LVSEMEMMKMIGQHINIINL 135
+FG V E + G +VAVK LK S E MD + E+ M + H N+I L
Sbjct: 24 SFGVVRRGEWDA--PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRL 80
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
GV P+ ++ E AP G+L D LRKH+ G+ L L +A Q
Sbjct: 81 YGVVLTP-PMKMVTELAPLGSLLDRLRKHQ---------------GHFLL-GTLSRYAVQ 123
Query: 196 VANGMHYLQSRKVGNDAVRFIGFDL 220
VA GM YL+S+ RFI DL
Sbjct: 124 VAEGMGYLESK-------RFIHRDL 141
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 51/145 (35%), Positives = 67/145 (46%), Gaps = 29/145 (20%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEG-HSDAEMMD-LVSEMEMMKMIGQHINIINL 135
+FG V E + G +VAVK LK S E MD + E+ M + H N+I L
Sbjct: 30 SFGVVRRGEWDA--PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRL 86
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
GV P+ ++ E AP G+L D LRKH+ G+ L L +A Q
Sbjct: 87 YGVVLTP-PMKMVTELAPLGSLLDRLRKHQ---------------GHFLL-GTLSRYAVQ 129
Query: 196 VANGMHYLQSRKVGNDAVRFIGFDL 220
VA GM YL+S+ RFI DL
Sbjct: 130 VAEGMGYLESK-------RFIHRDL 147
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 51/145 (35%), Positives = 67/145 (46%), Gaps = 29/145 (20%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEG-HSDAEMMD-LVSEMEMMKMIGQHINIINL 135
+FG V E + G +VAVK LK S E MD + E+ M + H N+I L
Sbjct: 20 SFGVVRRGEWDA--PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRL 76
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
GV P+ ++ E AP G+L D LRKH+ G+ L L +A Q
Sbjct: 77 YGVVLTP-PMKMVTELAPLGSLLDRLRKHQ---------------GHFLL-GTLSRYAVQ 119
Query: 196 VANGMHYLQSRKVGNDAVRFIGFDL 220
VA GM YL+S+ RFI DL
Sbjct: 120 VAEGMGYLESK-------RFIHRDL 137
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 51/145 (35%), Positives = 67/145 (46%), Gaps = 29/145 (20%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEG-HSDAEMMD-LVSEMEMMKMIGQHINIINL 135
+FG V E + G +VAVK LK S E MD + E+ M + H N+I L
Sbjct: 20 SFGVVRRGEWDA--PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRL 76
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
GV P+ ++ E AP G+L D LRKH+ G+ L L +A Q
Sbjct: 77 YGVVLTP-PMKMVTELAPLGSLLDRLRKHQ---------------GHFLL-GTLSRYAVQ 119
Query: 196 VANGMHYLQSRKVGNDAVRFIGFDL 220
VA GM YL+S+ RFI DL
Sbjct: 120 VAEGMGYLESK-------RFIHRDL 137
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 51/145 (35%), Positives = 67/145 (46%), Gaps = 29/145 (20%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEG-HSDAEMMD-LVSEMEMMKMIGQHINIINL 135
+FG V E + G +VAVK LK S E MD + E+ M + H N+I L
Sbjct: 24 SFGVVRRGEWDA--PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRL 80
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
GV P+ ++ E AP G+L D LRKH+ G+ L L +A Q
Sbjct: 81 YGVVLTP-PMKMVTELAPLGSLLDRLRKHQ---------------GHFLL-GTLSRYAVQ 123
Query: 196 VANGMHYLQSRKVGNDAVRFIGFDL 220
VA GM YL+S+ RFI DL
Sbjct: 124 VAEGMGYLESK-------RFIHRDL 141
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 51/145 (35%), Positives = 67/145 (46%), Gaps = 29/145 (20%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEG-HSDAEMMD-LVSEMEMMKMIGQHINIINL 135
+FG V E + G +VAVK LK S E MD + E+ M + H N+I L
Sbjct: 30 SFGVVRRGEWDA--PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRL 86
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
GV P+ ++ E AP G+L D LRKH+ G+ L L +A Q
Sbjct: 87 YGVVLTP-PMKMVTELAPLGSLLDRLRKHQ---------------GHFLL-GTLSRYAVQ 129
Query: 196 VANGMHYLQSRKVGNDAVRFIGFDL 220
VA GM YL+S+ RFI DL
Sbjct: 130 VAEGMGYLESK-------RFIHRDL 147
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 35/113 (30%), Positives = 58/113 (51%), Gaps = 6/113 (5%)
Query: 52 SVHDKVSLINVLTVTINSQEYVKIKCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDA 111
+VH+ I +TI E V FG+V K+ + VA+K LK G+++
Sbjct: 11 AVHEFAKEIEASCITI---ERVIGAGEFGEVCSGRLKLPGKREL--PVAIKTLKVGYTEK 65
Query: 112 EMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKH 164
+ D + E +M H NII+L GV T+ P+ ++ E+ +G+L FL+K+
Sbjct: 66 QRRDFLGEASIMGQF-DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKN 117
>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The
Kinase Domain Of Focal Adhesion Kinase With A
Phosphorylated Activation Loop
Length = 276
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 48/185 (25%), Positives = 78/185 (42%), Gaps = 40/185 (21%)
Query: 71 EYVKIKCAFGKVICAEANGILKQGIITT-------VAVKMLKEGHSDAEMMDLVSEMEMM 123
E + + G+ I G + QGI + VA+K K SD+ + E M
Sbjct: 6 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 124 KMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNV 183
+ H +I+ L+GV T++ P+++I+E G LR FL+ + S
Sbjct: 66 RQF-DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFS---------------- 107
Query: 184 LTEKDLISFAYQVANGMHYLQSRKV-------------GNDAVRFIGFDLCILVFFHDST 230
L LI +AYQ++ + YL+S++ ND V+ F L + DST
Sbjct: 108 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS--RYMEDST 165
Query: 231 LLKTT 235
K +
Sbjct: 166 XXKAS 170
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 37/126 (29%), Positives = 59/126 (46%), Gaps = 25/126 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VA+K LK G E + E ++MK I +H ++ L V
Sbjct: 31 FGEVWMGTWNGT------TRVAIKTLKPGTMSPEA--FLQEAQVMKKI-RHEKLVQLYAV 81
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
+++ P+Y++ E+ G+L DFL+ G L L+ A Q+A+
Sbjct: 82 VSEE-PIYIVTEYMSKGSLLDFLKGE---------------MGKYLRLPQLVDMAAQIAS 125
Query: 199 GMHYLQ 204
GM Y++
Sbjct: 126 GMAYVE 131
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 36/126 (28%), Positives = 60/126 (47%), Gaps = 25/126 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VA+K LK G E + E ++MK + +H ++ L V
Sbjct: 31 FGEVWMGTWNGT------TRVAIKTLKPGTMSPEA--FLQEAQVMKKL-RHEKLVQLYAV 81
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
+++ P+Y+++E+ G+L DFL+ G L L+ A Q+A+
Sbjct: 82 VSEE-PIYIVIEYMSKGSLLDFLKGE---------------MGKYLRLPQLVDMAAQIAS 125
Query: 199 GMHYLQ 204
GM Y++
Sbjct: 126 GMAYVE 131
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 51/145 (35%), Positives = 67/145 (46%), Gaps = 29/145 (20%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEG-HSDAEMMD-LVSEMEMMKMIGQHINIINL 135
+FG V E + G +VAVK LK S E MD + E+ M + H N+I L
Sbjct: 20 SFGVVRRGEWDA--PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRL 76
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
GV P+ ++ E AP G+L D LRKH+ G+ L L +A Q
Sbjct: 77 YGVVLTP-PMKMVTELAPLGSLLDRLRKHQ---------------GHFLL-GTLSRYAVQ 119
Query: 196 VANGMHYLQSRKVGNDAVRFIGFDL 220
VA GM YL+S+ RFI DL
Sbjct: 120 VAEGMGYLESK-------RFIHRDL 137
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 36/126 (28%), Positives = 60/126 (47%), Gaps = 25/126 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VA+K LK G E + E ++MK + +H ++ L V
Sbjct: 31 FGEVWMGTWNGT------TRVAIKTLKPGTMSPEA--FLQEAQVMKKL-RHEKLVQLYAV 81
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
+++ P+Y+++E+ G+L DFL+ G L L+ A Q+A+
Sbjct: 82 VSEE-PIYIVIEYMSKGSLLDFLKGEM---------------GKYLRLPQLVDMAAQIAS 125
Query: 199 GMHYLQ 204
GM Y++
Sbjct: 126 GMAYVE 131
>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 48.9 bits (115), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 48/185 (25%), Positives = 78/185 (42%), Gaps = 40/185 (21%)
Query: 71 EYVKIKCAFGKVICAEANGILKQGIITT-------VAVKMLKEGHSDAEMMDLVSEMEMM 123
E + + G+ I G + QGI + VA+K K SD+ + E M
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 124 KMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNV 183
+ H +I+ L+GV T++ P+++I+E G LR FL+ + S
Sbjct: 446 RQF-DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFS---------------- 487
Query: 184 LTEKDLISFAYQVANGMHYLQSRKV-------------GNDAVRFIGFDLCILVFFHDST 230
L LI +AYQ++ + YL+S++ ND V+ F L + DST
Sbjct: 488 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS--RYMEDST 545
Query: 231 LLKTT 235
K +
Sbjct: 546 YYKAS 550
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 48.9 bits (115), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 37/126 (29%), Positives = 59/126 (46%), Gaps = 25/126 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VA+K LK G E + E ++MK + +H ++ L V
Sbjct: 22 FGEVWMGTWNGN------TKVAIKTLKPGTMSPE--SFLEEAQIMKKL-KHDKLVQLYAV 72
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
+++ P+Y++ E+ G+L DFL+ G L +L+ A QVA
Sbjct: 73 VSEE-PIYIVTEYMNKGSLLDFLKD---------------GEGRALKLPNLVDMAAQVAA 116
Query: 199 GMHYLQ 204
GM Y++
Sbjct: 117 GMAYIE 122
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 48.9 bits (115), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 36/126 (28%), Positives = 59/126 (46%), Gaps = 25/126 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VA+K LK G E + E ++MK + +H ++ L V
Sbjct: 197 FGEVWMGTWNGT------TRVAIKTLKPGTMSPEA--FLQEAQVMKKL-RHEKLVQLYAV 247
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
+++ P+Y++ E+ G+L DFL+ G L L+ A Q+A+
Sbjct: 248 VSEE-PIYIVGEYMSKGSLLDFLKGE---------------TGKYLRLPQLVDMAAQIAS 291
Query: 199 GMHYLQ 204
GM Y++
Sbjct: 292 GMAYVE 297
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 48.5 bits (114), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 36/126 (28%), Positives = 59/126 (46%), Gaps = 25/126 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VA+K LK G E + E ++MK + +H ++ L V
Sbjct: 20 FGEVWMGTWNGT------TRVAIKTLKPGTMSPEA--FLQEAQVMKKL-RHEKLVQLYAV 70
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
+++ P+Y++ E+ G+L DFL+ G L L+ A Q+A+
Sbjct: 71 VSEE-PIYIVTEYMSKGSLLDFLKGE---------------MGKYLRLPQLVDMAAQIAS 114
Query: 199 GMHYLQ 204
GM Y++
Sbjct: 115 GMAYVE 120
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 48.5 bits (114), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 36/126 (28%), Positives = 59/126 (46%), Gaps = 25/126 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VA+K LK G E + E ++MK + +H ++ L V
Sbjct: 22 FGEVWMGTWNGT------TRVAIKTLKPGTMSPEA--FLQEAQVMKKL-RHEKLVQLYAV 72
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
+++ P+Y++ E+ G+L DFL+ G L L+ A Q+A+
Sbjct: 73 VSEE-PIYIVTEYMSKGSLLDFLKGE---------------MGKYLRLPQLVDMAAQIAS 116
Query: 199 GMHYLQ 204
GM Y++
Sbjct: 117 GMAYVE 122
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 48.5 bits (114), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 36/126 (28%), Positives = 59/126 (46%), Gaps = 25/126 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VA+K LK G E + E ++MK + +H ++ L V
Sbjct: 31 FGEVWMGTWNGT------TRVAIKTLKPGTMSPEA--FLQEAQVMKKL-RHEKLVQLYAV 81
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
+++ P+Y++ E+ G+L DFL+ G L L+ A Q+A+
Sbjct: 82 VSEE-PIYIVTEYMSKGSLLDFLKGEM---------------GKYLRLPQLVDMAAQIAS 125
Query: 199 GMHYLQ 204
GM Y++
Sbjct: 126 GMAYVE 131
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 48.5 bits (114), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 36/126 (28%), Positives = 59/126 (46%), Gaps = 25/126 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VA+K LK G E + E ++MK + +H ++ L V
Sbjct: 31 FGEVWMGTWNGT------TRVAIKTLKPGTMSPEA--FLQEAQVMKKL-RHEKLVQLYAV 81
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
+++ P+Y++ E+ G+L DFL+ G L L+ A Q+A+
Sbjct: 82 VSEE-PIYIVTEYMSKGSLLDFLKGE---------------MGKYLRLPQLVDMAAQIAS 125
Query: 199 GMHYLQ 204
GM Y++
Sbjct: 126 GMAYVE 131
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 48.1 bits (113), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 36/127 (28%), Positives = 59/127 (46%), Gaps = 25/127 (19%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
FG+V NG T VA+K LK G E + E ++MK + +H ++ L
Sbjct: 30 CFGEVWMGTWNGT------TRVAIKTLKPGTMSPEA--FLQEAQVMKKL-RHEKLVQLYA 80
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
V +++ P+Y++ E+ G+L DFL+ G L L+ A Q+A
Sbjct: 81 VVSEE-PIYIVCEYMSKGSLLDFLKGE---------------MGKYLRLPQLVDMAAQIA 124
Query: 198 NGMHYLQ 204
+GM Y++
Sbjct: 125 SGMAYVE 131
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 47.8 bits (112), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 35/126 (27%), Positives = 59/126 (46%), Gaps = 25/126 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VA+K LK G E + E ++MK + +H ++ L V
Sbjct: 28 FGEVWMGTWNGT------TRVAIKTLKPGTMSPEA--FLQEAQVMKKL-RHEKLVQLYAV 78
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
+++ P+Y++ E+ G+L DFL+ G L L+ + Q+A+
Sbjct: 79 VSEE-PIYIVTEYMNKGSLLDFLKGE---------------TGKYLRLPQLVDMSAQIAS 122
Query: 199 GMHYLQ 204
GM Y++
Sbjct: 123 GMAYVE 128
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 47.8 bits (112), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 35/126 (27%), Positives = 59/126 (46%), Gaps = 25/126 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VA+K LK G E + E ++MK + +H ++ L V
Sbjct: 28 FGEVWMGTWNGT------TRVAIKTLKPGTMSPEA--FLQEAQVMKKL-RHEKLVQLYAV 78
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
+++ P+Y++ E+ G+L DFL+ G L L+ + Q+A+
Sbjct: 79 VSEE-PIYIVTEYMNKGSLLDFLKGE---------------TGKYLRLPQLVDMSAQIAS 122
Query: 199 GMHYLQ 204
GM Y++
Sbjct: 123 GMAYVE 128
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 47.8 bits (112), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 25/66 (37%), Positives = 38/66 (57%), Gaps = 1/66 (1%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLR 158
VA+K LK G+++ + D +SE +M H NII L GV T+ ++ E+ +G+L
Sbjct: 80 VAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLEGVVTRGRLAMIVTEYMENGSLD 138
Query: 159 DFLRKH 164
FLR H
Sbjct: 139 TFLRTH 144
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 47.8 bits (112), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 25/66 (37%), Positives = 38/66 (57%), Gaps = 1/66 (1%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLR 158
VA+K LK G+++ + D +SE +M H NII L GV T+ ++ E+ +G+L
Sbjct: 80 VAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLEGVVTRGRLAMIVTEYMENGSLD 138
Query: 159 DFLRKH 164
FLR H
Sbjct: 139 TFLRTH 144
>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
pdb|2JKO|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 47.4 bits (111), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 47/185 (25%), Positives = 77/185 (41%), Gaps = 40/185 (21%)
Query: 71 EYVKIKCAFGKVICAEANGILKQGIITT-------VAVKMLKEGHSDAEMMDLVSEMEMM 123
E + + G+ I G + QGI + VA+K K SD+ + E M
Sbjct: 6 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 124 KMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNV 183
+ H +I+ L+GV T++ P+++I+E G LR FL+ + S
Sbjct: 66 RQF-DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFS---------------- 107
Query: 184 LTEKDLISFAYQVANGMHYLQSRKV-------------GNDAVRFIGFDLCILVFFHDST 230
L LI +AYQ++ + YL+S++ D V+ F L + DST
Sbjct: 108 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLS--RYMEDST 165
Query: 231 LLKTT 235
K +
Sbjct: 166 YYKAS 170
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 47.4 bits (111), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 36/127 (28%), Positives = 59/127 (46%), Gaps = 25/127 (19%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
FG+V NG T VA+K LK G E + E ++MK + +H ++ L
Sbjct: 30 CFGEVWMGTWNGT------TRVAIKTLKPGTMSPEA--FLQEAQVMKKL-RHEKLVQLYA 80
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
V +++ P+Y+++E+ G L DFL+ G L L+ A Q+A
Sbjct: 81 VVSEE-PIYIVMEYMSKGCLLDFLKGE---------------MGKYLRLPQLVDMAAQIA 124
Query: 198 NGMHYLQ 204
+GM Y++
Sbjct: 125 SGMAYVE 131
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 36/127 (28%), Positives = 58/127 (45%), Gaps = 25/127 (19%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
FG+V NG T VA+K LK G E + E ++MK + +H ++ L
Sbjct: 30 CFGEVWMGTWNGT------TRVAIKTLKPGTMSPEA--FLQEAQVMKKL-RHEKLVQLYA 80
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
V +++ P+Y++ E+ G L DFL+ G L L+ A Q+A
Sbjct: 81 VVSEE-PIYIVTEYMSKGCLLDFLKGE---------------MGKYLRLPQLVDMAAQIA 124
Query: 198 NGMHYLQ 204
+GM Y++
Sbjct: 125 SGMAYVE 131
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 37/131 (28%), Positives = 60/131 (45%), Gaps = 27/131 (20%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
K FG V+ + G VAVK +K +DA ++E +M + +H N++ L
Sbjct: 31 KGEFGDVMLGDYRG-------NKVAVKCIK---NDATAQAFLAEASVMTQL-RHSNLVQL 79
Query: 136 LGVCTQD-GPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAY 194
LGV ++ G LY++ E+ G+L D+LR G + G+ L+ F+
Sbjct: 80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSR----------GRSVLGGDC-----LLKFSL 124
Query: 195 QVANGMHYLQS 205
V M YL+
Sbjct: 125 DVCEAMEYLEG 135
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 37/131 (28%), Positives = 60/131 (45%), Gaps = 27/131 (20%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
K FG V+ + G VAVK +K +DA ++E +M + +H N++ L
Sbjct: 22 KGEFGDVMLGDYRG-------NKVAVKCIK---NDATAQAFLAEASVMTQL-RHSNLVQL 70
Query: 136 LGVCTQD-GPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAY 194
LGV ++ G LY++ E+ G+L D+LR G + G+ L+ F+
Sbjct: 71 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSR----------GRSVLGGDC-----LLKFSL 115
Query: 195 QVANGMHYLQS 205
V M YL+
Sbjct: 116 DVCEAMEYLEG 126
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 43/171 (25%), Positives = 82/171 (47%), Gaps = 35/171 (20%)
Query: 46 AFNIATSVHDKVSLINVLTVTINSQEYVKIKCAFGKVICAEANGILKQG--------IIT 97
A I + +L+ +L T E+ KIK V+ + A G + +G +
Sbjct: 2 AMGIRSGEAPNQALLRILKET----EFKKIK-----VLSSGAFGTVYKGLWIPEGEKVKI 52
Query: 98 TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
VA+K L+E S +++ E +M + + ++ LLG+C + +I++ P G L
Sbjct: 53 PVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLIMQLMPFGCL 110
Query: 158 RDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
D++R+H+ + +GS Y L+++ Q+A GM+YL+ R++
Sbjct: 111 LDYVREHKDN------IGSQY----------LLNWCVQIAKGMNYLEDRRL 145
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 37/131 (28%), Positives = 60/131 (45%), Gaps = 27/131 (20%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
K FG V+ + G VAVK +K +DA ++E +M + +H N++ L
Sbjct: 16 KGEFGDVMLGDYRG-------NKVAVKCIK---NDATAQAFLAEASVMTQL-RHSNLVQL 64
Query: 136 LGVCTQD-GPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAY 194
LGV ++ G LY++ E+ G+L D+LR G + G+ L+ F+
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSR----------GRSVLGGDC-----LLKFSL 109
Query: 195 QVANGMHYLQS 205
V M YL+
Sbjct: 110 DVCEAMEYLEG 120
>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains.
pdb|2J0K|B Chain B, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 47/185 (25%), Positives = 77/185 (41%), Gaps = 40/185 (21%)
Query: 71 EYVKIKCAFGKVICAEANGILKQGIITT-------VAVKMLKEGHSDAEMMDLVSEMEMM 123
E + + G+ I G + QGI + VA+K K SD+ + E M
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 124 KMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNV 183
+ H +I+ L+GV T++ P+++I+E G LR FL+ + S
Sbjct: 446 RQF-DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFS---------------- 487
Query: 184 LTEKDLISFAYQVANGMHYLQSRKV-------------GNDAVRFIGFDLCILVFFHDST 230
L LI +AYQ++ + YL+S++ D V+ F L + DST
Sbjct: 488 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLS--RYMEDST 545
Query: 231 LLKTT 235
K +
Sbjct: 546 YYKAS 550
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 43/158 (27%), Positives = 80/158 (50%), Gaps = 33/158 (20%)
Query: 58 SLINVLTVTINSQEYVKIKC----AFGKVICAEANGI-LKQG--IITTVAVKMLKEGHSD 110
+L+ +L T E+ KIK AFG V G+ + +G + VA+K L+E S
Sbjct: 8 ALLRILKET----EFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIKELREATSP 59
Query: 111 AEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGY 170
+++ E +M + + ++ LLG+C + +I++ P G L D++R+H+ +
Sbjct: 60 KANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLIMQLMPFGXLLDYVREHKDN--- 114
Query: 171 ESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
+GS Y L+++ Q+A GM+YL+ R++
Sbjct: 115 ---IGSQY----------LLNWCVQIAKGMNYLEDRRL 139
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 43/171 (25%), Positives = 81/171 (47%), Gaps = 35/171 (20%)
Query: 46 AFNIATSVHDKVSLINVLTVTINSQEYVKIKCAFGKVICAEANGILKQG--------IIT 97
A I + +L+ +L T E+ KIK V+ + A G + +G +
Sbjct: 2 AMGIRSGEAPNQALLRILKET----EFKKIK-----VLSSGAFGTVYKGLWIPEGEKVKI 52
Query: 98 TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
VA+K L+E S +++ E +M + + ++ LLG+C + +I + P G L
Sbjct: 53 PVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLITQLMPFGCL 110
Query: 158 RDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
D++R+H+ + +GS Y L+++ Q+A GM+YL+ R++
Sbjct: 111 LDYVREHKDN------IGSQY----------LLNWCVQIAKGMNYLEDRRL 145
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 33/170 (19%)
Query: 46 AFNIATSVHDKVSLINVLTVTINSQEYVKIKC----AFGKVICAEANGI-LKQG--IITT 98
A I + +L+ +L T E+ KIK AFG V G+ + +G +
Sbjct: 2 AMGIRSGEAPNQALLRILKET----EFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIP 53
Query: 99 VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLR 158
VA+K L+E S +++ E +M + + ++ LLG+C + +I + P G L
Sbjct: 54 VAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLITQLMPFGCLL 111
Query: 159 DFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
D++R+H+ + +GS Y L+++ Q+A GM+YL+ R++
Sbjct: 112 DYVREHKDN------IGSQY----------LLNWCVQIAKGMNYLEDRRL 145
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 33/170 (19%)
Query: 46 AFNIATSVHDKVSLINVLTVTINSQEYVKIKC----AFGKVICAEANGI-LKQG--IITT 98
A I + +L+ +L T E+ KIK AFG V G+ + +G +
Sbjct: 2 AMGIRSGEAPNQALLRILKET----EFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIP 53
Query: 99 VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLR 158
VA+K L+E S +++ E +M + + ++ LLG+C + +I + P G L
Sbjct: 54 VAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLITQLMPFGCLL 111
Query: 159 DFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
D++R+H+ + +GS Y L+++ Q+A GM+YL+ R++
Sbjct: 112 DYVREHKDN------IGSQY----------LLNWCVQIAKGMNYLEDRRL 145
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 43/158 (27%), Positives = 79/158 (50%), Gaps = 33/158 (20%)
Query: 58 SLINVLTVTINSQEYVKIKC----AFGKVICAEANGI-LKQG--IITTVAVKMLKEGHSD 110
+L+ +L T E+ KIK AFG V G+ + +G + VA+K L+E S
Sbjct: 7 ALLRILKET----EFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIKELREATSP 58
Query: 111 AEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGY 170
+++ E +M + + ++ LLG+C + +I + P G L D++R+H+ +
Sbjct: 59 KANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLITQLMPFGXLLDYVREHKDN--- 113
Query: 171 ESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
+GS Y L+++ Q+A GM+YL+ R++
Sbjct: 114 ---IGSQY----------LLNWCVQIAKGMNYLEDRRL 138
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 37/131 (28%), Positives = 60/131 (45%), Gaps = 27/131 (20%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
K FG V+ + G VAVK +K +DA ++E +M + +H N++ L
Sbjct: 203 KGEFGDVMLGDYRG-------NKVAVKCIK---NDATAQAFLAEASVMTQL-RHSNLVQL 251
Query: 136 LGVCTQD-GPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAY 194
LGV ++ G LY++ E+ G+L D+LR G + G+ L+ F+
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSR----------GRSVLGGDC-----LLKFSL 296
Query: 195 QVANGMHYLQS 205
V M YL+
Sbjct: 297 DVCEAMEYLEG 307
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 35/136 (25%), Positives = 68/136 (50%), Gaps = 26/136 (19%)
Query: 81 KVICAEANGILKQG--------IITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINI 132
KV+ + A G + +G + VA+K L+E S +++ E +M + + ++
Sbjct: 21 KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHV 79
Query: 133 INLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISF 192
LLG+C + +I + P G L D++R+H+ + +GS Y L+++
Sbjct: 80 CRLLGICLTST-VQLITQLMPFGCLLDYVREHKDN------IGSQY----------LLNW 122
Query: 193 AYQVANGMHYLQSRKV 208
Q+A GM+YL+ R++
Sbjct: 123 CVQIAKGMNYLEDRRL 138
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 43/158 (27%), Positives = 80/158 (50%), Gaps = 33/158 (20%)
Query: 58 SLINVLTVTINSQEYVKIKC----AFGKVICAEANGI-LKQG--IITTVAVKMLKEGHSD 110
+L+ +L T E+ KIK AFG V G+ + +G + VA+K L+E S
Sbjct: 9 ALLRILKET----EFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIKELREATSP 60
Query: 111 AEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGY 170
+++ E +M + + ++ LLG+C + +I++ P G L D++R+H+ +
Sbjct: 61 KANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDN--- 115
Query: 171 ESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
+GS Y L+++ Q+A GM+YL+ R++
Sbjct: 116 ---IGSQY----------LLNWCVQIAKGMNYLEDRRL 140
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 25/126 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FG+V NG T VA+K LK G E + E ++MK + +H ++ L V
Sbjct: 21 FGEVWMGTWNGT------TRVAIKTLKPGTMSPEA--FLQEAQVMKKL-RHEKLVQLYAV 71
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
+++ P+ ++ E+ G+L DFL+ G L L+ A Q+A+
Sbjct: 72 VSEE-PIXIVTEYMSKGSLLDFLKGE---------------TGKYLRLPQLVDMAAQIAS 115
Query: 199 GMHYLQ 204
GM Y++
Sbjct: 116 GMAYVE 121
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/110 (27%), Positives = 58/110 (52%), Gaps = 18/110 (16%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLR 158
VA+K L+E S +++ E +M + + ++ LLG+C + +I + P G L
Sbjct: 47 VAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLITQLMPFGCLL 104
Query: 159 DFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
D++R+H+ + +GS Y L+++ Q+A GM+YL+ R++
Sbjct: 105 DYVREHKDN------IGSQY----------LLNWCVQIAKGMNYLEDRRL 138
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 43/158 (27%), Positives = 80/158 (50%), Gaps = 33/158 (20%)
Query: 58 SLINVLTVTINSQEYVKIKC----AFGKVICAEANGI-LKQG--IITTVAVKMLKEGHSD 110
+L+ +L T E+ KIK AFG V G+ + +G + VA+K L+E S
Sbjct: 9 ALLRILKET----EFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIKELREATSP 60
Query: 111 AEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGY 170
+++ E +M + + ++ LLG+C + +I++ P G L D++R+H+ +
Sbjct: 61 KANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDN--- 115
Query: 171 ESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
+GS Y L+++ Q+A GM+YL+ R++
Sbjct: 116 ---IGSQY----------LLNWCVQIAKGMNYLEDRRL 140
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 43/158 (27%), Positives = 80/158 (50%), Gaps = 33/158 (20%)
Query: 58 SLINVLTVTINSQEYVKIKC----AFGKVICAEANGI-LKQG--IITTVAVKMLKEGHSD 110
+L+ +L T E+ KIK AFG V G+ + +G + VA+K L+E S
Sbjct: 11 ALLRILKET----EFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIKELREATSP 62
Query: 111 AEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGY 170
+++ E +M + + ++ LLG+C + +I++ P G L D++R+H+ +
Sbjct: 63 KANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDN--- 117
Query: 171 ESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
+GS Y L+++ Q+A GM+YL+ R++
Sbjct: 118 ---IGSQY----------LLNWCVQIAKGMNYLEDRRL 142
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/110 (27%), Positives = 59/110 (53%), Gaps = 18/110 (16%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLR 158
VA+K L+E S +++ E +M + + ++ LLG+C + +I++ P G L
Sbjct: 47 VAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLIMQLMPFGCLL 104
Query: 159 DFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
D++R+H+ + +GS Y L+++ Q+A GM+YL+ R++
Sbjct: 105 DYVREHKDN------IGSQY----------LLNWCVQIAKGMNYLEDRRL 138
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/110 (27%), Positives = 58/110 (52%), Gaps = 18/110 (16%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLR 158
VA+K L+E S +++ E +M + + ++ LLG+C + +I + P G L
Sbjct: 41 VAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLITQLMPFGCLL 98
Query: 159 DFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
D++R+H+ + +GS Y L+++ Q+A GM+YL+ R++
Sbjct: 99 DYVREHKDN------IGSQY----------LLNWCVQIAKGMNYLEDRRL 132
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/110 (27%), Positives = 59/110 (53%), Gaps = 18/110 (16%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLR 158
VA+K L+E S +++ E +M + + ++ LLG+C + +I++ P G L
Sbjct: 48 VAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLIMQLMPFGCLL 105
Query: 159 DFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
D++R+H+ + +GS Y L+++ Q+A GM+YL+ R++
Sbjct: 106 DYVREHKDN------IGSQY----------LLNWCVQIAKGMNYLEDRRL 139
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 43/158 (27%), Positives = 80/158 (50%), Gaps = 33/158 (20%)
Query: 58 SLINVLTVTINSQEYVKIKC----AFGKVICAEANGI-LKQG--IITTVAVKMLKEGHSD 110
+L+ +L T E+ KIK AFG V G+ + +G + VA+K L+E S
Sbjct: 11 ALLRILKET----EFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIKELREATSP 62
Query: 111 AEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGY 170
+++ E +M + + ++ LLG+C + +I++ P G L D++R+H+ +
Sbjct: 63 KANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDN--- 117
Query: 171 ESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
+GS Y L+++ Q+A GM+YL+ R++
Sbjct: 118 ---IGSQY----------LLNWCVQIAKGMNYLEDRRL 142
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/110 (27%), Positives = 59/110 (53%), Gaps = 18/110 (16%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLR 158
VA+K L+E S +++ E +M + + ++ LLG+C + +I++ P G L
Sbjct: 49 VAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLIMQLMPFGCLL 106
Query: 159 DFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
D++R+H+ + +GS Y L+++ Q+A GM+YL+ R++
Sbjct: 107 DYVREHKDN------IGSQY----------LLNWCVQIAKGMNYLEDRRL 140
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 43/159 (27%), Positives = 80/159 (50%), Gaps = 33/159 (20%)
Query: 57 VSLINVLTVTINSQEYVKIKC----AFGKVICAEANGI-LKQG--IITTVAVKMLKEGHS 109
++L+ +L T E+ KIK AFG V G+ + +G + VA+K L+E S
Sbjct: 3 MALLRILKET----EFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIKELREATS 54
Query: 110 DAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSG 169
+++ E +M + + ++ LLG+C + +I + P G L D++R+H+ +
Sbjct: 55 PKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDN-- 110
Query: 170 YESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
+GS Y L+++ Q+A GM+YL+ R++
Sbjct: 111 ----IGSQY----------LLNWCVQIAEGMNYLEDRRL 135
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/110 (27%), Positives = 59/110 (53%), Gaps = 18/110 (16%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLR 158
VA+K L+E S +++ E +M + + ++ LLG+C + +I++ P G L
Sbjct: 50 VAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLIMQLMPFGCLL 107
Query: 159 DFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
D++R+H+ + +GS Y L+++ Q+A GM+YL+ R++
Sbjct: 108 DYVREHKDN------IGSQY----------LLNWCVQIAKGMNYLEDRRL 141
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 43/158 (27%), Positives = 79/158 (50%), Gaps = 33/158 (20%)
Query: 58 SLINVLTVTINSQEYVKIKC----AFGKVICAEANGI-LKQG--IITTVAVKMLKEGHSD 110
+L+ +L T E+ KIK AFG V G+ + +G + VA+K L+E S
Sbjct: 9 ALLRILKET----EFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIKELREATSP 60
Query: 111 AEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGY 170
+++ E +M + + ++ LLG+C + +I + P G L D++R+H+ +
Sbjct: 61 KANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDN--- 115
Query: 171 ESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
+GS Y L+++ Q+A GM+YL+ R++
Sbjct: 116 ---IGSQY----------LLNWCVQIAKGMNYLEDRRL 140
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/110 (27%), Positives = 58/110 (52%), Gaps = 18/110 (16%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLR 158
VA+K L+E S +++ E +M + + ++ LLG+C + +I + P G L
Sbjct: 47 VAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLITQLMPFGCLL 104
Query: 159 DFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
D++R+H+ + +GS Y L+++ Q+A GM+YL+ R++
Sbjct: 105 DYVREHKDN------IGSQY----------LLNWCVQIAKGMNYLEDRRL 138
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/110 (27%), Positives = 58/110 (52%), Gaps = 18/110 (16%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLR 158
VA+K L+E S +++ E +M + + ++ LLG+C + +I + P G L
Sbjct: 49 VAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLITQLMPFGCLL 106
Query: 159 DFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
D++R+H+ + +GS Y L+++ Q+A GM+YL+ R++
Sbjct: 107 DYVREHKDN------IGSQY----------LLNWCVQIAKGMNYLEDRRL 140
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/110 (27%), Positives = 58/110 (52%), Gaps = 18/110 (16%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLR 158
VA+K L+E S +++ E +M + + ++ LLG+C + +I + P G L
Sbjct: 72 VAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLITQLMPFGCLL 129
Query: 159 DFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
D++R+H+ + +GS Y L+++ Q+A GM+YL+ R++
Sbjct: 130 DYVREHKDN------IGSQY----------LLNWCVQIAKGMNYLEDRRL 163
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 39/132 (29%), Positives = 60/132 (45%), Gaps = 26/132 (19%)
Query: 79 FGKV--ICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLL 136
FGKV C + G VAVK LKEG E+E+++ + H +I+
Sbjct: 22 FGKVSLYCYDPT---NDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTL-YHEHIVKYK 77
Query: 137 GVCTQDGP--LYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAY 194
G C G + +++E+ P G+LRD+L +H +G A L+ FA
Sbjct: 78 GCCEDQGEKSVQLVMEYVPLGSLRDYLPRH--------CVGLA----------QLLLFAQ 119
Query: 195 QVANGMHYLQSR 206
Q+ GM YL ++
Sbjct: 120 QICEGMAYLHAQ 131
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/110 (27%), Positives = 58/110 (52%), Gaps = 18/110 (16%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLR 158
VA+K L+E S +++ E +M + + ++ LLG+C + +I + P G L
Sbjct: 47 VAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLITQLMPFGCLL 104
Query: 159 DFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
D++R+H+ + +GS Y L+++ Q+A GM+YL+ R++
Sbjct: 105 DYVREHKDN------IGSQY----------LLNWCVQIAKGMNYLEDRRL 138
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 43/158 (27%), Positives = 79/158 (50%), Gaps = 33/158 (20%)
Query: 58 SLINVLTVTINSQEYVKIKC----AFGKVICAEANGI-LKQG--IITTVAVKMLKEGHSD 110
+L+ +L T E+ KIK AFG V G+ + +G + VA+K L+E S
Sbjct: 17 ALLRILKET----EFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIKELREATSP 68
Query: 111 AEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGY 170
+++ E +M + + ++ LLG+C + +I + P G L D++R+H+ +
Sbjct: 69 KANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDN--- 123
Query: 171 ESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
+GS Y L+++ Q+A GM+YL+ R++
Sbjct: 124 ---IGSQY----------LLNWCVQIAKGMNYLEDRRL 148
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/110 (27%), Positives = 58/110 (52%), Gaps = 18/110 (16%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLR 158
VA+K L+E S +++ E +M + + ++ LLG+C + +I + P G L
Sbjct: 50 VAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLITQLMPFGCLL 107
Query: 159 DFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
D++R+H+ + +GS Y L+++ Q+A GM+YL+ R++
Sbjct: 108 DYVREHKDN------IGSQY----------LLNWCVQIAKGMNYLEDRRL 141
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 30/110 (27%), Positives = 58/110 (52%), Gaps = 18/110 (16%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLR 158
VA+K L+E S +++ E +M + + ++ LLG+C + +I + P G L
Sbjct: 50 VAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLITQLMPFGCLL 107
Query: 159 DFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
D++R+H+ + +GS Y L+++ Q+A GM+YL+ R++
Sbjct: 108 DYVREHKDN------IGSQY----------LLNWCVQIAKGMNYLEDRRL 141
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 43/158 (27%), Positives = 79/158 (50%), Gaps = 33/158 (20%)
Query: 58 SLINVLTVTINSQEYVKIKC----AFGKVICAEANGI-LKQG--IITTVAVKMLKEGHSD 110
+L+ +L T E+ KIK AFG V G+ + +G + VA+K L+E S
Sbjct: 13 ALLRILKET----EFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIKELREATSP 64
Query: 111 AEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGY 170
+++ E +M + + ++ LLG+C + +I + P G L D++R+H+ +
Sbjct: 65 KANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDN--- 119
Query: 171 ESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
+GS Y L+++ Q+A GM+YL+ R++
Sbjct: 120 ---IGSQY----------LLNWCVQIAKGMNYLEDRRL 144
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 39/132 (29%), Positives = 60/132 (45%), Gaps = 26/132 (19%)
Query: 79 FGKV--ICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLL 136
FGKV C + G VAVK LKEG E+E+++ + H +I+
Sbjct: 21 FGKVSLYCYDPT---NDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTL-YHEHIVKYK 76
Query: 137 GVCTQDGP--LYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAY 194
G C G + +++E+ P G+LRD+L +H +G A L+ FA
Sbjct: 77 GCCEDQGEKSVQLVMEYVPLGSLRDYLPRH--------CVGLA----------QLLLFAQ 118
Query: 195 QVANGMHYLQSR 206
Q+ GM YL ++
Sbjct: 119 QICEGMAYLHAQ 130
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 43/158 (27%), Positives = 79/158 (50%), Gaps = 33/158 (20%)
Query: 58 SLINVLTVTINSQEYVKIKC----AFGKVICAEANGI-LKQG--IITTVAVKMLKEGHSD 110
+L+ +L T E+ KIK AFG V G+ + +G + VA+K L+E S
Sbjct: 10 ALLRILKET----EFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIKELREATSP 61
Query: 111 AEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGY 170
+++ E +M + + ++ LLG+C + +I + P G L D++R+H+ +
Sbjct: 62 KANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDN--- 116
Query: 171 ESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
+GS Y L+++ Q+A GM+YL+ R++
Sbjct: 117 ---IGSQY----------LLNWCVQIAKGMNYLEDRRL 141
>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXL|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 327
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 33/112 (29%), Positives = 52/112 (46%), Gaps = 20/112 (17%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDG--PLYVIVEFAPHGN 156
VAVK L+ D + D E++++K + I+ GV G L +++E+ P G
Sbjct: 55 VAVKQLQHSGPD-QQRDFQREIQILKALHSDF-IVKYRGVSYGPGRQSLRLVMEYLPSGC 112
Query: 157 LRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
LRDFL++HR L L+ ++ Q+ GM YL SR+
Sbjct: 113 LRDFLQRHR----------------ARLDASRLLLYSSQICKGMEYLGSRRC 148
>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site
Inhibitor Showing High Selectivity Within The Janus
Kinase Family
Length = 315
Score = 45.4 bits (106), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 33/112 (29%), Positives = 52/112 (46%), Gaps = 20/112 (17%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDG--PLYVIVEFAPHGN 156
VAVK L+ D + D E++++K + I+ GV G L +++E+ P G
Sbjct: 43 VAVKQLQHSGPD-QQRDFQREIQILKALHSDF-IVKYRGVSYGPGRQSLRLVMEYLPSGC 100
Query: 157 LRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
LRDFL++HR L L+ ++ Q+ GM YL SR+
Sbjct: 101 LRDFLQRHR----------------ARLDASRLLLYSSQICKGMEYLGSRRC 136
>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-1,2,2-trimethyl-propyl)-amide
pdb|4HVG|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-2-hydroxy-1,2-dimethyl-propyl)- Amide
pdb|4HVH|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-2-hydroxy-1,2-dimethyl-propyl
pdb|4HVI|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-1-methyl-2-oxo-2-piperidin-1-yl- Ethyl)-amide
Length = 314
Score = 45.4 bits (106), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 33/112 (29%), Positives = 52/112 (46%), Gaps = 20/112 (17%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDG--PLYVIVEFAPHGN 156
VAVK L+ D + D E++++K + I+ GV G L +++E+ P G
Sbjct: 42 VAVKQLQHSGPD-QQRDFQREIQILKALHSDF-IVKYRGVSYGPGRQSLRLVMEYLPSGC 99
Query: 157 LRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
LRDFL++HR L L+ ++ Q+ GM YL SR+
Sbjct: 100 LRDFLQRHR----------------ARLDASRLLLYSSQICKGMEYLGSRRC 135
>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex
With A Staurosporine Analogue
Length = 290
Score = 45.4 bits (106), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 33/112 (29%), Positives = 52/112 (46%), Gaps = 20/112 (17%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDG--PLYVIVEFAPHGN 156
VAVK L+ D + D E++++K + I+ GV G L +++E+ P G
Sbjct: 39 VAVKQLQHSGPD-QQRDFQREIQILKALHSDF-IVKYRGVSYGPGRPELRLVMEYLPSGC 96
Query: 157 LRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
LRDFL++HR L L+ ++ Q+ GM YL SR+
Sbjct: 97 LRDFLQRHR----------------ARLDASRLLLYSSQICKGMEYLGSRRC 132
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 45.1 bits (105), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 44/136 (32%), Positives = 64/136 (47%), Gaps = 24/136 (17%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLK-EGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
FG V+ E N + G VAVK +K + S E+ + +SE MK H N+I LLG
Sbjct: 47 FGSVM--EGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLG 103
Query: 138 VCTQ------DGPLYVIVEFAPHGNLRDFLRKHRPSSGYES-PLGSAYTNGNVLTEKDLI 190
VC + P+ VI+ F +G+L +L R +G + PL + L+
Sbjct: 104 VCIEMSSQGIPKPM-VILPFMKYGDLHTYLLYSRLETGPKHIPLQT------------LL 150
Query: 191 SFAYQVANGMHYLQSR 206
F +A GM YL +R
Sbjct: 151 KFMVDIALGMEYLSNR 166
>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With
Quinoline-Thiadiazole- Thiophene Inhibitor
Length = 302
Score = 44.3 bits (103), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 48/162 (29%), Positives = 68/162 (41%), Gaps = 28/162 (17%)
Query: 79 FGKV--ICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLL 136
FGKV C + G VAVK LK E+++++ + H +II
Sbjct: 27 FGKVSLYCYDPTN---DGTGEMVAVKALKADCGPQHRSGWKQEIDILRTL-YHEHIIKYK 82
Query: 137 GVCTQDGP--LYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAY 194
G C G L +++E+ P G+LRD+L +H +G A L+ FA
Sbjct: 83 GCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--------IGLA----------QLLLFAQ 124
Query: 195 QVANGMHYLQSRKV--GNDAVRFIGFDLCILVFFHDSTLLKT 234
Q+ GM YL S+ N A R + D LV D L K
Sbjct: 125 QICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKA 166
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 43.5 bits (101), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 42/158 (26%), Positives = 78/158 (49%), Gaps = 33/158 (20%)
Query: 58 SLINVLTVTINSQEYVKIKC----AFGKVICAEANGI-LKQG--IITTVAVKMLKEGHSD 110
+L+ +L T E+ KIK AFG V G+ + +G + VA+ L+E S
Sbjct: 41 ALLRILKET----EFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIMELREATSP 92
Query: 111 AEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGY 170
+++ E +M + + ++ LLG+C + +I + P G L D++R+H+ +
Sbjct: 93 KANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDN--- 147
Query: 171 ESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
+GS Y L+++ Q+A GM+YL+ R++
Sbjct: 148 ---IGSQY----------LLNWCVQIAKGMNYLEDRRL 172
>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6
Length = 302
Score = 43.1 bits (100), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 47/162 (29%), Positives = 68/162 (41%), Gaps = 28/162 (17%)
Query: 79 FGKV--ICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLL 136
FGKV C + G VAVK LK E+++++ + H +II
Sbjct: 27 FGKVSLYCYDPTN---DGTGEMVAVKALKADCGPQHRSGWKQEIDILRTL-YHEHIIKYK 82
Query: 137 GVCTQDGP--LYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAY 194
G C G L +++E+ P G+LRD+L +H +G A L+ FA
Sbjct: 83 GCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--------IGLA----------QLLLFAQ 124
Query: 195 QVANGMHYLQSRKV--GNDAVRFIGFDLCILVFFHDSTLLKT 234
Q+ GM YL ++ N A R + D LV D L K
Sbjct: 125 QICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKA 166
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 42.7 bits (99), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 33/136 (24%), Positives = 65/136 (47%), Gaps = 26/136 (19%)
Query: 81 KVICAEANGILKQGIITT--------VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINI 132
KV+ + A G + +GI VA+K+L E ++ + E +M + H ++
Sbjct: 44 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHL 102
Query: 133 INLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISF 192
+ LLGVC + ++ + PHG L +++ +H+ + G + L+++
Sbjct: 103 VRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQL----------------LLNW 145
Query: 193 AYQVANGMHYLQSRKV 208
Q+A GM YL+ R++
Sbjct: 146 CVQIAKGMMYLEERRL 161
>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXP|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 318
Score = 42.7 bits (99), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 38/132 (28%), Positives = 58/132 (43%), Gaps = 26/132 (19%)
Query: 79 FGKV--ICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLL 136
FGKV C + G VAVK LK E+++++ + H +II
Sbjct: 44 FGKVSLYCYDPT---NDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHIIKYK 99
Query: 137 GVCTQDGP--LYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAY 194
G C G L +++E+ P G+LRD+L +H +G A L+ FA
Sbjct: 100 GCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--------IGLA----------QLLLFAQ 141
Query: 195 QVANGMHYLQSR 206
Q+ GM YL ++
Sbjct: 142 QICEGMAYLHAQ 153
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 42.7 bits (99), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 33/148 (22%)
Query: 81 KVICAEANGILKQGIITT--------VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINI 132
KV+ + A G + +GI VA+K+L+E S +++ E +M +G +
Sbjct: 23 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPY-V 81
Query: 133 INLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISF 192
LLG+C + ++ + P+G L D +R++R LGS +DL+++
Sbjct: 82 SRLLGICLTST-VQLVTQLMPYGCLLDHVRENR------GRLGS----------QDLLNW 124
Query: 193 AYQVANGMHYLQSRKVGNDAVRFIGFDL 220
Q+A GM YL+ VR + DL
Sbjct: 125 CMQIAKGMSYLED-------VRLVHRDL 145
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 42.7 bits (99), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 33/136 (24%), Positives = 65/136 (47%), Gaps = 26/136 (19%)
Query: 81 KVICAEANGILKQGIITT--------VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINI 132
KV+ + A G + +GI VA+K+L E ++ + E +M + H ++
Sbjct: 21 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHL 79
Query: 133 INLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISF 192
+ LLGVC + ++ + PHG L +++ +H+ + G + L+++
Sbjct: 80 VRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQL----------------LLNW 122
Query: 193 AYQVANGMHYLQSRKV 208
Q+A GM YL+ R++
Sbjct: 123 CVQIAKGMMYLEERRL 138
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 41.2 bits (95), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 28/80 (35%), Positives = 40/80 (50%), Gaps = 17/80 (21%)
Query: 129 HINIINLLGV-CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEK 187
H N++ L+G+ +G +V++ + HG+L F+R S N V K
Sbjct: 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR-------------SPQRNPTV---K 124
Query: 188 DLISFAYQVANGMHYLQSRK 207
DLISF QVA GM YL +K
Sbjct: 125 DLISFGLQVARGMEYLAEQK 144
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 41.2 bits (95), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 7/78 (8%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFGKV A K +A + E S+ E+ D + E+E++ H I+ LLG
Sbjct: 31 AFGKVYKA------KNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPYIVKLLG 83
Query: 138 VCTQDGPLYVIVEFAPHG 155
DG L++++EF P G
Sbjct: 84 AYYHDGKLWIMIEFCPGG 101
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 40.8 bits (94), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 26/78 (33%), Positives = 39/78 (50%), Gaps = 7/78 (8%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AFGKV A K +A + E S+ E+ D + E+E++ H I+ LLG
Sbjct: 23 AFGKVYKA------KNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPYIVKLLG 75
Query: 138 VCTQDGPLYVIVEFAPHG 155
DG L++++EF P G
Sbjct: 76 AYYHDGKLWIMIEFCPGG 93
>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70
Length = 613
Score = 40.4 bits (93), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 33/124 (26%), Positives = 60/124 (48%), Gaps = 24/124 (19%)
Query: 89 GILKQGIIT------TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQD 142
G ++QG+ VA+K+LK+G A+ +++ E ++M + + I+ L+GVC +
Sbjct: 350 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQAE 408
Query: 143 GPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHY 202
L +++E A G L FL R E P+ ++ +QV+ GM Y
Sbjct: 409 A-LMLVMEMAGGGPLHKFLVGKR----EEIPVS------------NVAELLHQVSMGMKY 451
Query: 203 LQSR 206
L+ +
Sbjct: 452 LEEK 455
>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex
With Staurosporine
Length = 287
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 33/124 (26%), Positives = 60/124 (48%), Gaps = 24/124 (19%)
Query: 89 GILKQGIIT------TVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQD 142
G ++QG+ VA+K+LK+G A+ +++ E ++M + + I+ L+GVC +
Sbjct: 24 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQAE 82
Query: 143 GPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHY 202
L +++E A G L FL R E P+ ++ +QV+ GM Y
Sbjct: 83 A-LMLVMEMAGGGPLHKFLVGKRE----EIPVS------------NVAELLHQVSMGMKY 125
Query: 203 LQSR 206
L+ +
Sbjct: 126 LEEK 129
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 22/77 (28%), Positives = 39/77 (50%), Gaps = 17/77 (22%)
Query: 129 HINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKD 188
H +I+ LLG+C L ++ ++ P G+L D +R+HR L +
Sbjct: 74 HAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHR----------------GALGPQL 116
Query: 189 LISFAYQVANGMHYLQS 205
L+++ Q+A GM+YL+
Sbjct: 117 LLNWGVQIAKGMYYLEE 133
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 22/77 (28%), Positives = 39/77 (50%), Gaps = 17/77 (22%)
Query: 129 HINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKD 188
H +I+ LLG+C L ++ ++ P G+L D +R+HR L +
Sbjct: 92 HAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHR----------------GALGPQL 134
Query: 189 LISFAYQVANGMHYLQS 205
L+++ Q+A GM+YL+
Sbjct: 135 LLNWGVQIAKGMYYLEE 151
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 43/90 (47%), Gaps = 19/90 (21%)
Query: 119 EMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAY 178
E ++ M+ +H NII L GVC ++ L +++EFA G L L
Sbjct: 56 EAKLFAML-KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL----------------- 97
Query: 179 TNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
+G + L+++A Q+A GM+YL +
Sbjct: 98 -SGKRIPPDILVNWAVQIARGMNYLHDEAI 126
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 38.9 bits (89), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 47/140 (33%), Positives = 60/140 (42%), Gaps = 25/140 (17%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKE---GHSDAEMMDLVSEMEMMKMIGQHINI 132
K FG V EA + G VAVKMLK SD E + + E MK H ++
Sbjct: 33 KGEFGSV--REAQLKQEDGSFVKVAVKMLKADIIASSDIE--EFLREAACMKEF-DHPHV 87
Query: 133 INLLGVCTQD---GPL---YVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTE 186
L+GV + G L VI+ F HG+L FL R E+P L
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIG---ENPFN--------LPL 136
Query: 187 KDLISFAYQVANGMHYLQSR 206
+ L+ F +A GM YL SR
Sbjct: 137 QTLVRFMVDIACGMEYLSSR 156
>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
pdb|2R0I|B Chain B, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
Length = 327
Score = 38.1 bits (87), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 33/119 (27%), Positives = 57/119 (47%), Gaps = 15/119 (12%)
Query: 48 NIATSVHDKVSLINV-LTVTINSQEYVKIKCAFGKVICAEANGILKQGIITTVAVKMLKE 106
N ATS ++ + N L TI + K+K A + E VAVK++ +
Sbjct: 2 NSATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKE------------VAVKIIDK 49
Query: 107 GH-SDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKH 164
+ + + L E+ +MK++ H NI+ L V + LY+++E+A G + D+L H
Sbjct: 50 TQLNSSSLQKLFREVRIMKVL-NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH 107
>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
pdb|1ZMU|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
Length = 327
Score = 38.1 bits (87), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 33/119 (27%), Positives = 57/119 (47%), Gaps = 15/119 (12%)
Query: 48 NIATSVHDKVSLINV-LTVTINSQEYVKIKCAFGKVICAEANGILKQGIITTVAVKMLKE 106
N ATS ++ + N L TI + K+K A + E VAVK++ +
Sbjct: 2 NSATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKE------------VAVKIIDK 49
Query: 107 GH-SDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKH 164
+ + + L E+ +MK++ H NI+ L V + LY+++E+A G + D+L H
Sbjct: 50 TQLNSSSLQKLFREVRIMKVL-NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH 107
>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
pdb|1ZMW|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
Length = 327
Score = 38.1 bits (87), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 33/119 (27%), Positives = 57/119 (47%), Gaps = 15/119 (12%)
Query: 48 NIATSVHDKVSLINV-LTVTINSQEYVKIKCAFGKVICAEANGILKQGIITTVAVKMLKE 106
N ATS ++ + N L TI + K+K A + E VAVK++ +
Sbjct: 2 NSATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKE------------VAVKIIDK 49
Query: 107 GH-SDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKH 164
+ + + L E+ +MK++ H NI+ L V + LY+++E+A G + D+L H
Sbjct: 50 TQLNSSSLQKLFREVRIMKVL-NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH 107
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen
Length = 284
Score = 37.7 bits (86), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 35/135 (25%), Positives = 59/135 (43%), Gaps = 25/135 (18%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMD--LVSEMEMMKMIGQHINII 133
K FG V A KQ +A+K+L + + E ++ L E+E+ + +H NI+
Sbjct: 24 KGKFGNVYLARE----KQNKFI-MALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNIL 77
Query: 134 NLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFA 193
+ +Y+++EFAP G L L+KH E+ +F
Sbjct: 78 RMYNYFHDRKRIYLMLEFAPRGELYKELQKH-----------------GRFDEQRSATFM 120
Query: 194 YQVANGMHYLQSRKV 208
++A+ +HY RKV
Sbjct: 121 EELADALHYCHERKV 135
>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin.
pdb|2BFY|B Chain B, Complex Of Aurora-B With Incenp And Hesperidin
Length = 284
Score = 37.7 bits (86), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 35/135 (25%), Positives = 59/135 (43%), Gaps = 25/135 (18%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMD--LVSEMEMMKMIGQHINII 133
K FG V A KQ +A+K+L + + E ++ L E+E+ + +H NI+
Sbjct: 24 KGKFGNVYLARE----KQNKFI-MALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNIL 77
Query: 134 NLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFA 193
+ +Y+++EFAP G L L+KH E+ +F
Sbjct: 78 RMYNYFHDRKRIYLMLEFAPRGELYKELQKH-----------------GRFDEQRSATFM 120
Query: 194 YQVANGMHYLQSRKV 208
++A+ +HY RKV
Sbjct: 121 EELADALHYCHERKV 135
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 37.7 bits (86), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 35/135 (25%), Positives = 59/135 (43%), Gaps = 25/135 (18%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMD--LVSEMEMMKMIGQHINII 133
K FG V A KQ +A+K+L + + E ++ L E+E+ + +H NI+
Sbjct: 25 KGKFGNVYLARE----KQNKFI-MALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNIL 78
Query: 134 NLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFA 193
+ +Y+++EFAP G L L+KH E+ +F
Sbjct: 79 RMYNYFHDRKRIYLMLEFAPRGELYKELQKH-----------------GRFDEQRSATFM 121
Query: 194 YQVANGMHYLQSRKV 208
++A+ +HY RKV
Sbjct: 122 EELADALHYCHERKV 136
>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant
Length = 334
Score = 37.4 bits (85), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 18/96 (18%)
Query: 115 DLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPL 174
D+ E+ ++K I QH N+I L V + +I+E G L DFL
Sbjct: 60 DIEREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFL------------- 105
Query: 175 GSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVGN 210
LTE++ F Q+ NG++YL S ++ +
Sbjct: 106 ----AEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex
Length = 334
Score = 37.4 bits (85), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 18/96 (18%)
Query: 115 DLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPL 174
D+ E+ ++K I QH N+I L V + +I+E G L DFL
Sbjct: 60 DIEREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFL------------- 105
Query: 175 GSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVGN 210
LTE++ F Q+ NG++YL S ++ +
Sbjct: 106 ----AEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 37.4 bits (85), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 30/93 (32%), Positives = 44/93 (47%), Gaps = 8/93 (8%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
+ FGKV G L G T VAVK LKE + +E+EM+ M H N++ L
Sbjct: 48 RGGFGKVY----KGRLADG--TLVAVKRLKEERXQGGELQFQTEVEMISM-AVHRNLLRL 100
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSS 168
G C ++ + +G++ LR+ RP S
Sbjct: 101 RGFCMTPTERLLVYPYMANGSVASCLRE-RPES 132
>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mn.
pdb|1JKL|A Chain A, 1.6a X-Ray Structure Of Binary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue
pdb|1JKS|A Chain A, 1.5a X-Ray Structure Of Apo Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|A Chain A, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|B Chain B, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKK|A Chain A, 2.4a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mg.
pdb|3F5G|A Chain A, Crystal Structure Of Death Associated Protein Kinase In
Complex With Adp And Mg2+
pdb|3EH9|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Adp
pdb|3EHA|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Amppnp
Length = 294
Score = 37.4 bits (85), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 18/96 (18%)
Query: 115 DLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPL 174
D+ E+ ++K I QH N+I L V + +I+E G L DFL
Sbjct: 59 DIEREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFL------------- 104
Query: 175 GSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVGN 210
LTE++ F Q+ NG++YL S ++ +
Sbjct: 105 ----AEKESLTEEEATEFLKQILNGVYYLHSLQIAH 136
>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain With
Amppnp
pdb|3DGK|A Chain A, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain
Length = 295
Score = 37.4 bits (85), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 18/96 (18%)
Query: 115 DLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPL 174
D+ E+ ++K I QH N+I L V + +I+E G L DFL
Sbjct: 60 DIEREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFL------------- 105
Query: 175 GSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVGN 210
LTE++ F Q+ NG++YL S ++ +
Sbjct: 106 ----AEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With
Bound Inhibitor Fragment
Length = 293
Score = 37.4 bits (85), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 18/96 (18%)
Query: 115 DLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPL 174
D+ E+ ++K I QH N+I L V + +I+E G L DFL
Sbjct: 59 DIEREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFL------------- 104
Query: 175 GSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVGN 210
LTE++ F Q+ NG++YL S ++ +
Sbjct: 105 ----AEKESLTEEEATEFLKQILNGVYYLHSLQIAH 136
>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp
pdb|3GU5|A Chain A, Crystal Structure Of Dapkq23v-Amppnp-Mg2+
pdb|3GU6|A Chain A, Crystal Structure Of Dapkq23v-Adp
pdb|3GU7|A Chain A, Crystal Structure Of Dapkq23v-Adp-Mg2+
Length = 295
Score = 37.4 bits (85), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 18/96 (18%)
Query: 115 DLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPL 174
D+ E+ ++K I QH N+I L V + +I+E G L DFL
Sbjct: 60 DIEREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFL------------- 105
Query: 175 GSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVGN 210
LTE++ F Q+ NG++YL S ++ +
Sbjct: 106 ----AEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312
pdb|2XZS|B Chain B, Death Associated Protein Kinase 1 Residues 1-312
Length = 312
Score = 37.4 bits (85), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 18/96 (18%)
Query: 115 DLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPL 174
D+ E+ ++K I QH N+I L V + +I+E G L DFL
Sbjct: 60 DIEREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFL------------- 105
Query: 175 GSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVGN 210
LTE++ F Q+ NG++YL S ++ +
Sbjct: 106 ----AEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase
In Complex With Amppnp And Mg2+
Length = 295
Score = 37.4 bits (85), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 18/96 (18%)
Query: 115 DLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPL 174
D+ E+ ++K I QH N+I L V + +I+E G L DFL
Sbjct: 60 DIEREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFL------------- 105
Query: 175 GSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVGN 210
LTE++ F Q+ NG++YL S ++ +
Sbjct: 106 ----AEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
pdb|1ZMV|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
Length = 327
Score = 37.4 bits (85), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 32/119 (26%), Positives = 57/119 (47%), Gaps = 15/119 (12%)
Query: 48 NIATSVHDKVSLINV-LTVTINSQEYVKIKCAFGKVICAEANGILKQGIITTVAVKMLKE 106
N ATS ++ + N L TI + K+K A + E VAV+++ +
Sbjct: 2 NSATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKE------------VAVRIIDK 49
Query: 107 GH-SDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKH 164
+ + + L E+ +MK++ H NI+ L V + LY+++E+A G + D+L H
Sbjct: 50 TQLNSSSLQKLFREVRIMKVL-NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH 107
>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302
Length = 302
Score = 37.4 bits (85), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 18/96 (18%)
Query: 115 DLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPL 174
D+ E+ ++K I QH N+I L V + +I+E G L DFL
Sbjct: 60 DIEREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFL------------- 105
Query: 175 GSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVGN 210
LTE++ F Q+ NG++YL S ++ +
Sbjct: 106 ----AEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|B Chain B, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|C Chain C, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|D Chain D, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|E Chain E, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|F Chain F, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
Length = 327
Score = 37.0 bits (84), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 32/119 (26%), Positives = 57/119 (47%), Gaps = 15/119 (12%)
Query: 48 NIATSVHDKVSLINV-LTVTINSQEYVKIKCAFGKVICAEANGILKQGIITTVAVKMLKE 106
N ATS ++ + N L TI + K+K A + E VAV+++ +
Sbjct: 2 NSATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKE------------VAVRIIDK 49
Query: 107 GH-SDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKH 164
+ + + L E+ +MK++ H NI+ L V + LY+++E+A G + D+L H
Sbjct: 50 TQLNSSSLQKLFREVRIMKVL-NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH 107
>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277
Length = 277
Score = 37.0 bits (84), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 18/96 (18%)
Query: 115 DLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPL 174
D+ E+ ++K I QH N+I L V + +I+E G L DFL
Sbjct: 60 DIEREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFL------------- 105
Query: 175 GSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVGN 210
LTE++ F Q+ NG++YL S ++ +
Sbjct: 106 ----AEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In
Complex With A Ruthenium Octasporine Ligand (Osv)
pdb|2Y4P|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|3ZXT|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
Length = 285
Score = 37.0 bits (84), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 18/96 (18%)
Query: 115 DLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPL 174
D+ E+ ++K I QH N+I L V + +I+E G L DFL
Sbjct: 60 DIEREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFL------------- 105
Query: 175 GSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVGN 210
LTE++ F Q+ NG++YL S ++ +
Sbjct: 106 ----AEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVX|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVY|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
Length = 278
Score = 37.0 bits (84), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 18/96 (18%)
Query: 115 DLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPL 174
D+ E+ ++K I QH N+I L V + +I+E G L DFL
Sbjct: 60 DIEREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFL------------- 105
Query: 175 GSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVGN 210
LTE++ F Q+ NG++YL S ++ +
Sbjct: 106 ----AEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 37.0 bits (84), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 29/93 (31%), Positives = 45/93 (48%), Gaps = 8/93 (8%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
+ FGKV G L G + VAVK LKE + + +E+EM+ M H N++ L
Sbjct: 40 RGGFGKVY----KGRLADGXL--VAVKRLKEERTQGGELQFQTEVEMISM-AVHRNLLRL 92
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSS 168
G C ++ + +G++ LR+ RP S
Sbjct: 93 RGFCMTPTERLLVYPYMANGSVASCLRE-RPES 124
>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304
Length = 326
Score = 37.0 bits (84), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 44/96 (45%), Gaps = 18/96 (18%)
Query: 115 DLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPL 174
D+ E+ ++K I QH N+I L V + +I+E G L DFL +
Sbjct: 60 DIEREVSILKEI-QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-------- 110
Query: 175 GSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVGN 210
LTE++ F Q+ NG++YL S ++ +
Sbjct: 111 ---------LTEEEATEFLKQILNGVYYLHSLQIAH 137
>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|B Chain B, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|C Chain C, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|D Chain D, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
Length = 319
Score = 36.2 bits (82), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 21/67 (31%), Positives = 39/67 (58%), Gaps = 2/67 (2%)
Query: 99 VAVKMLKEGH-SDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
VAVK++ + + + + L E+ +MK++ H NI+ L V + LY+++E+A G +
Sbjct: 35 VAVKIIDKTQLNSSSLQKLFREVRIMKVL-NHPNIVKLFEVIETEKTLYLVMEYASGGEV 93
Query: 158 RDFLRKH 164
D+L H
Sbjct: 94 FDYLVAH 100
>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia
pdb|3GC0|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In
Complex With Amp
Length = 329
Score = 35.8 bits (81), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 30/111 (27%), Positives = 57/111 (51%), Gaps = 20/111 (18%)
Query: 98 TVAVKMLKEGHSDAEMMDL-VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGN 156
TVA+K ++ H + + + E+ ++K + QH NII L V + L++I E+A +
Sbjct: 61 TVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVIHHNHRLHLIFEYA-END 118
Query: 157 LRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRK 207
L+ ++ K N +V + + + SF YQ+ NG+++ SR+
Sbjct: 119 LKKYMDK----------------NPDV-SMRVIKSFLYQLINGVNFCHSRR 152
>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine
pdb|3GUB|A Chain A, Crystal Structure Of Dapkl93g Complexed With N6-(2-
Phenylethyl)adenosine
Length = 295
Score = 35.8 bits (81), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 27/96 (28%), Positives = 42/96 (43%), Gaps = 18/96 (18%)
Query: 115 DLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPL 174
D+ E+ ++K I QH N+I L V + +I E G L DFL
Sbjct: 60 DIEREVSILKEI-QHPNVITLHEVYENKTDVILIGELVAGGELFDFL------------- 105
Query: 175 GSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVGN 210
LTE++ F Q+ NG++YL S ++ +
Sbjct: 106 ----AEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
pdb|1Y8G|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
Length = 327
Score = 35.8 bits (81), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 32/119 (26%), Positives = 55/119 (46%), Gaps = 15/119 (12%)
Query: 48 NIATSVHDKVSLINV-LTVTINSQEYVKIKCAFGKVICAEANGILKQGIITTVAVKMLKE 106
N ATS ++ + N L TI + K+K A + E VAVK++ +
Sbjct: 2 NSATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKE------------VAVKIIDK 49
Query: 107 GH-SDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKH 164
+ + + L E+ + K++ H NI+ L V + LY++ E+A G + D+L H
Sbjct: 50 TQLNSSSLQKLFREVRIXKVL-NHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAH 107
>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
pdb|3FE3|B Chain B, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
Length = 328
Score = 35.4 bits (80), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 21/67 (31%), Positives = 38/67 (56%), Gaps = 2/67 (2%)
Query: 99 VAVKMLKEGH-SDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
VA+K++ + + + L E+ +MK++ H NI+ L V + LY+I+E+A G +
Sbjct: 43 VAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVIETEKTLYLIMEYASGGEV 101
Query: 158 RDFLRKH 164
D+L H
Sbjct: 102 FDYLVAH 108
>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|C Chain C, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|D Chain D, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|E Chain E, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|F Chain F, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|G Chain G, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|H Chain H, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
Length = 328
Score = 35.4 bits (80), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 21/67 (31%), Positives = 38/67 (56%), Gaps = 2/67 (2%)
Query: 99 VAVKMLKEGH-SDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
VAVK++ + + + L E+ +MK++ H NI+ L V + LY+++E+A G +
Sbjct: 43 VAVKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVIETEKTLYLVMEYASGGEV 101
Query: 158 RDFLRKH 164
D+L H
Sbjct: 102 FDYLVAH 108
>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
pdb|1YRP|B Chain B, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
Length = 278
Score = 35.4 bits (80), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 24/96 (25%), Positives = 43/96 (44%), Gaps = 18/96 (18%)
Query: 115 DLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPL 174
++ E+ +++ I +H NII L + + +I+E G L DFL
Sbjct: 61 EIEREVNILREI-RHPNIITLHDIFENKTDVVLILELVSGGELFDFL------------- 106
Query: 175 GSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVGN 210
LTE + F Q+ +G+HYL S+++ +
Sbjct: 107 ----AEKESLTEDEATQFLKQILDGVHYLHSKRIAH 138
>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
pdb|2QNJ|B Chain B, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
Length = 328
Score = 35.4 bits (80), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 21/67 (31%), Positives = 38/67 (56%), Gaps = 2/67 (2%)
Query: 99 VAVKMLKEGH-SDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
VA+K++ + + + L E+ +MK++ H NI+ L V + LY+I+E+A G +
Sbjct: 40 VAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVIETEKTLYLIMEYASGGEV 98
Query: 158 RDFLRKH 164
D+L H
Sbjct: 99 FDYLVAH 105
>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With A Beta-Carboline Ligand
pdb|3BQR|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With An Imidazo-Pyridazine Ligand
Length = 283
Score = 35.4 bits (80), Expect = 0.032, Method: Compositional matrix adjust.
Identities = 29/132 (21%), Positives = 51/132 (38%), Gaps = 18/132 (13%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
F V G K+ + + L ++ E+ +++ I +H NII L +
Sbjct: 18 FAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDI 76
Query: 139 CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVAN 198
+ +I+E G L DFL LTE + F Q+ +
Sbjct: 77 FENKTDVVLILELVSGGELFDFL-----------------AEKESLTEDEATQFLKQILD 119
Query: 199 GMHYLQSRKVGN 210
G+HYL S+++ +
Sbjct: 120 GVHYLHSKRIAH 131
>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
pdb|2J90|B Chain B, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
Length = 304
Score = 35.0 bits (79), Expect = 0.037, Method: Compositional matrix adjust.
Identities = 24/96 (25%), Positives = 43/96 (44%), Gaps = 18/96 (18%)
Query: 115 DLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPL 174
++ E+ +++ I +H NII L + + +I+E G L DFL
Sbjct: 75 EIEREVNILREI-RHPNIITLHDIFENKTDVVLILELVSGGELFDFL------------- 120
Query: 175 GSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVGN 210
LTE + F Q+ +G+HYL S+++ +
Sbjct: 121 ----AEKESLTEDEATQFLKQILDGVHYLHSKRIAH 152
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 35.0 bits (79), Expect = 0.040, Method: Compositional matrix adjust.
Identities = 27/111 (24%), Positives = 51/111 (45%), Gaps = 19/111 (17%)
Query: 99 VAVKMLKEGHSDAEMMDL-VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
VA+K E D + + + E++++K + +H N++NLL VC + Y++ EF H L
Sbjct: 53 VAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKKKRWYLVFEFVDHTIL 111
Query: 158 RDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
D + NG L + + + +Q+ NG+ + S +
Sbjct: 112 DDL---------------ELFPNG--LDYQVVQKYLFQIINGIGFCHSHNI 145
>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90
Ribosomal S6 Kinase 2: Se-Met Derivative
Length = 342
Score = 34.7 bits (78), Expect = 0.061, Method: Compositional matrix adjust.
Identities = 21/66 (31%), Positives = 31/66 (46%), Gaps = 5/66 (7%)
Query: 100 AVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRD 159
AVK++ D D E+E++ GQH NII L V +YV+ E G L D
Sbjct: 51 AVKII-----DKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLD 105
Query: 160 FLRKHR 165
+ + +
Sbjct: 106 KILRQK 111
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 34.3 bits (77), Expect = 0.069, Method: Compositional matrix adjust.
Identities = 24/90 (26%), Positives = 42/90 (46%), Gaps = 17/90 (18%)
Query: 116 LVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLG 175
+ E+++M+ + +H N++ +GV +D L I E+ G LR ++ +
Sbjct: 54 FLKEVKVMRCL-EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS----------MD 102
Query: 176 SAYTNGNVLTEKDLISFAYQVANGMHYLQS 205
S Y +SFA +A+GM YL S
Sbjct: 103 SQYPWSQ------RVSFAKDIASGMAYLHS 126
>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YA9|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YAA|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAA|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAB|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
pdb|2YAB|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
Length = 361
Score = 34.3 bits (77), Expect = 0.078, Method: Compositional matrix adjust.
Identities = 28/116 (24%), Positives = 51/116 (43%), Gaps = 23/116 (19%)
Query: 100 AVKMLKEGHSDAEMM-----DLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPH 154
A K +K+ S A ++ E+ +++ + H NII L V + +I+E
Sbjct: 41 AAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYENRTDVVLILELVSG 99
Query: 155 GNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVGN 210
G L DFL L+E++ SF Q+ +G++YL ++K+ +
Sbjct: 100 GELFDFL-----------------AQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138
>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|B Chain B, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|C Chain C, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|D Chain D, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2CKE|A Chain A, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|B Chain B, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|C Chain C, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|D Chain D, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
Length = 321
Score = 33.9 bits (76), Expect = 0.097, Method: Compositional matrix adjust.
Identities = 27/116 (23%), Positives = 51/116 (43%), Gaps = 23/116 (19%)
Query: 100 AVKMLKEGHSDAEMM-----DLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPH 154
A K +K+ S A ++ E+ +++ + H N+I L V + +I+E
Sbjct: 41 AAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH-NVITLHDVYENRTDVVLILELVSG 99
Query: 155 GNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVGN 210
G L DFL L+E++ SF Q+ +G++YL ++K+ +
Sbjct: 100 GELFDFL-----------------AQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138
>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
Length = 321
Score = 33.9 bits (76), Expect = 0.098, Method: Compositional matrix adjust.
Identities = 27/116 (23%), Positives = 51/116 (43%), Gaps = 23/116 (19%)
Query: 100 AVKMLKEGHSDAEMM-----DLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPH 154
A K +K+ S A ++ E+ +++ + H N+I L V + +I+E
Sbjct: 41 AAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH-NVITLHDVYENRTDVVLILELVSG 99
Query: 155 GNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVGN 210
G L DFL L+E++ SF Q+ +G++YL ++K+ +
Sbjct: 100 GELFDFL-----------------AQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 33.9 bits (76), Expect = 0.099, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 44/83 (53%), Gaps = 16/83 (19%)
Query: 89 GILKQGII--TTVAVKMLKEGHSDAEMMDLVSEM------EMMKMIG--QHINIINLLGV 138
G++ +G + TTVAVK L A M+D+ +E + +K+ QH N++ LLG
Sbjct: 36 GVVYKGYVNNTTVAVKKL------AAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGF 89
Query: 139 CTQDGPLYVIVEFAPHGNLRDFL 161
+ L ++ + P+G+L D L
Sbjct: 90 SSDGDDLCLVYVYXPNGSLLDRL 112
>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|D Chain D, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|E Chain E, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|F Chain F, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|G Chain G, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|H Chain H, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
Length = 321
Score = 33.9 bits (76), Expect = 0.099, Method: Compositional matrix adjust.
Identities = 27/116 (23%), Positives = 51/116 (43%), Gaps = 23/116 (19%)
Query: 100 AVKMLKEGHSDAEMM-----DLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPH 154
A K +K+ S A ++ E+ +++ + H N+I L V + +I+E
Sbjct: 41 AAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH-NVITLHDVYENRTDVVLILELVSG 99
Query: 155 GNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVGN 210
G L DFL L+E++ SF Q+ +G++YL ++K+ +
Sbjct: 100 GELFDFL-----------------AQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138
>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|E Chain E, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|C Chain C, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|B Chain B, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|F Chain F, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|D Chain D, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|H Chain H, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|G Chain G, Human Death-Associated Kinase Drp-1, Mutant S308d D40
Length = 321
Score = 33.5 bits (75), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 27/116 (23%), Positives = 51/116 (43%), Gaps = 23/116 (19%)
Query: 100 AVKMLKEGHSDAEMM-----DLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPH 154
A K +K+ S A ++ E+ +++ + H N+I L V + +I+E
Sbjct: 41 AAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH-NVITLHDVYENRTDVVLILELVSG 99
Query: 155 GNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVGN 210
G L DFL L+E++ SF Q+ +G++YL ++K+ +
Sbjct: 100 GELFDFL-----------------AQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138
>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90
Ribosomal S6 Kinase 2 (rsk2)
pdb|4D9U|A Chain A, Rsk2 C-Terminal Kinase Domain, (E)-Tert-Butyl
3-(4-Amino-7-(3-
Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
pdb|4D9T|A Chain A, Rsk2 C-Terminal Kinase Domain With Inhibitor (E)-Methyl
3-(4-Amino-7-
(3-Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
Length = 342
Score = 33.5 bits (75), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 18/56 (32%), Positives = 26/56 (46%)
Query: 110 DAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHR 165
D D E+E++ GQH NII L V +YV+ E G L D + + +
Sbjct: 56 DKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK 111
>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|B Chain B, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|C Chain C, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|D Chain D, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|E Chain E, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
Length = 326
Score = 33.5 bits (75), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 23/103 (22%), Positives = 42/103 (40%), Gaps = 21/103 (20%)
Query: 112 EMMDLVSEMEMMKMIGQHINIINLLGVCTQDGP------LYVIVEFAPHGNLRDFLRKHR 165
E ++ E+ M+K H NI G + P L++++EF G++ D ++
Sbjct: 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-- 120
Query: 166 PSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
T GN L E+ + ++ G+ +L KV
Sbjct: 121 -------------TKGNTLKEEWIAYICREILRGLSHLHQHKV 150
>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|B Chain B, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|C Chain C, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|D Chain D, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|E Chain E, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|F Chain F, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|G Chain G, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|H Chain H, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
Length = 288
Score = 33.5 bits (75), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 27/116 (23%), Positives = 51/116 (43%), Gaps = 23/116 (19%)
Query: 100 AVKMLKEGHSDAEMM-----DLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPH 154
A K +K+ S A ++ E+ +++ + H N+I L V + +I+E
Sbjct: 41 AAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH-NVITLHDVYENRTDVVLILELVSG 99
Query: 155 GNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVGN 210
G L DFL L+E++ SF Q+ +G++YL ++K+ +
Sbjct: 100 GELFDFL-----------------AQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 33.5 bits (75), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 45/83 (54%), Gaps = 16/83 (19%)
Query: 89 GILKQGII--TTVAVKMLKEGHSDAEMMDLVSEM------EMMKMIG--QHINIINLLGV 138
G++ +G + TTVAVK L A M+D+ +E + +K++ QH N++ LLG
Sbjct: 45 GVVYKGYVNNTTVAVKKL------AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF 98
Query: 139 CTQDGPLYVIVEFAPHGNLRDFL 161
+ L ++ + P+G+L D L
Sbjct: 99 SSDGDDLCLVYVYMPNGSLLDRL 121
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 33.5 bits (75), Expect = 0.13, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 45/83 (54%), Gaps = 16/83 (19%)
Query: 89 GILKQGII--TTVAVKMLKEGHSDAEMMDLVSEM------EMMKMIG--QHINIINLLGV 138
G++ +G + TTVAVK L A M+D+ +E + +K++ QH N++ LLG
Sbjct: 45 GVVYKGYVNNTTVAVKKL------AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF 98
Query: 139 CTQDGPLYVIVEFAPHGNLRDFL 161
+ L ++ + P+G+L D L
Sbjct: 99 SSDGDDLCLVYVYMPNGSLLDRL 121
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 33.1 bits (74), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 26/83 (31%), Positives = 45/83 (54%), Gaps = 16/83 (19%)
Query: 89 GILKQGII--TTVAVKMLKEGHSDAEMMDLVSEM------EMMKMIG--QHINIINLLGV 138
G++ +G + TTVAVK L A M+D+ +E + +K++ QH N++ LLG
Sbjct: 39 GVVYKGYVNNTTVAVKKL------AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF 92
Query: 139 CTQDGPLYVIVEFAPHGNLRDFL 161
+ L ++ + P+G+L D L
Sbjct: 93 SSDGDDLCLVYVYMPNGSLLDRL 115
>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|B Chain B, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|C Chain C, Crystal Structure Of The Human Cdkl1 Kinase Domain
Length = 311
Score = 32.3 bits (72), Expect = 0.24, Method: Compositional matrix adjust.
Identities = 20/68 (29%), Positives = 36/68 (52%), Gaps = 2/68 (2%)
Query: 99 VAVKMLKEGHSDAEMMDL-VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
VA+K E D + + + E+ M+K + +H N++NLL V + L+++ E+ H L
Sbjct: 31 VAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRRKRRLHLVFEYCDHTVL 89
Query: 158 RDFLRKHR 165
+ R R
Sbjct: 90 HELDRYQR 97
>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420
Length = 504
Score = 32.0 bits (71), Expect = 0.32, Method: Compositional matrix adjust.
Identities = 24/87 (27%), Positives = 40/87 (45%), Gaps = 8/87 (9%)
Query: 78 AFGKVI-CAEANGILKQGIITTVAVKMLKEGHSDAEM------MDLVSEMEMMKMIGQHI 130
A+G+V+ C E NG ++ I + K +SD ++ +E+ ++K + H
Sbjct: 48 AYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHP 106
Query: 131 NIINLLGVCTQDGPLYVIVEFAPHGNL 157
NII L V Y++ EF G L
Sbjct: 107 NIIKLFDVFEDKKYFYLVTEFYEGGEL 133
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 32.0 bits (71), Expect = 0.34, Method: Compositional matrix adjust.
Identities = 16/45 (35%), Positives = 28/45 (62%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+DF+
Sbjct: 50 IREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFM 92
>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 31.6 bits (70), Expect = 0.43, Method: Compositional matrix adjust.
Identities = 24/104 (23%), Positives = 52/104 (50%), Gaps = 20/104 (19%)
Query: 103 MLKEGHSDAEMMD-LVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+LK +D + D L++E +M+ + I+ ++G+C + + +++E A G L +L
Sbjct: 45 ILKNEANDPALKDELLAEANVMQQLDNPY-IVRMIGICEAESWM-LVMEMAELGPLNKYL 102
Query: 162 RKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQS 205
+++R + +K++I +QV+ GM YL+
Sbjct: 103 QQNRH-----------------VKDKNIIELVHQVSMGMKYLEE 129
>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
pdb|2WNT|B Chain B, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
Length = 330
Score = 31.6 bits (70), Expect = 0.43, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%)
Query: 110 DAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHR 165
D D E+E++ GQH NII L V +Y++ E G L D + + +
Sbjct: 61 DKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK 116
>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A Sulfonamidopyrazine Piperidine Inhibitor
pdb|4DFN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
An Adamantylpyrazine Inhibitor
Length = 274
Score = 31.6 bits (70), Expect = 0.44, Method: Compositional matrix adjust.
Identities = 24/104 (23%), Positives = 52/104 (50%), Gaps = 20/104 (19%)
Query: 103 MLKEGHSDAEMMD-LVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+LK +D + D L++E +M+ + I+ ++G+C + + +++E A G L +L
Sbjct: 41 ILKNEANDPALKDELLAEANVMQQLDNPY-IVRMIGICEAESWM-LVMEMAELGPLNKYL 98
Query: 162 RKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQS 205
+++R + +K++I +QV+ GM YL+
Sbjct: 99 QQNRH-----------------VKDKNIIELVHQVSMGMKYLEE 125
>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 31.6 bits (70), Expect = 0.45, Method: Compositional matrix adjust.
Identities = 24/104 (23%), Positives = 52/104 (50%), Gaps = 20/104 (19%)
Query: 103 MLKEGHSDAEMMD-LVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+LK +D + D L++E +M+ + I+ ++G+C + + +++E A G L +L
Sbjct: 45 ILKNEANDPALKDELLAEANVMQQLDNPY-IVRMIGICEAESWM-LVMEMAELGPLNKYL 102
Query: 162 RKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQS 205
+++R + +K++I +QV+ GM YL+
Sbjct: 103 QQNRH-----------------VKDKNIIELVHQVSMGMKYLEE 129
>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836
Length = 273
Score = 31.6 bits (70), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 24/104 (23%), Positives = 52/104 (50%), Gaps = 20/104 (19%)
Query: 103 MLKEGHSDAEMMD-LVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+LK +D + D L++E +M+ + I+ ++G+C + + +++E A G L +L
Sbjct: 39 ILKNEANDPALKDELLAEANVMQQLDNPY-IVRMIGICEAESWM-LVMEMAELGPLNKYL 96
Query: 162 RKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQS 205
+++R + +K++I +QV+ GM YL+
Sbjct: 97 QQNRH-----------------VKDKNIIELVHQVSMGMKYLEE 123
>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 635
Score = 31.6 bits (70), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 24/104 (23%), Positives = 53/104 (50%), Gaps = 20/104 (19%)
Query: 103 MLKEGHSDAEMMD-LVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+LK +D + D L++E +M+ + + I+ ++G+C + + +++E A G L +L
Sbjct: 403 ILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYL 460
Query: 162 RKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQS 205
+++R + +K++I +QV+ GM YL+
Sbjct: 461 QQNR-----------------HVKDKNIIELVHQVSMGMKYLEE 487
>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain
pdb|1XBB|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Gleevec
pdb|1XBC|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Staurosporin
pdb|3FQE|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
Ym193306
pdb|3FQH|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQH|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQS|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
R406
pdb|4FL1|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
pdb|4FYN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
3-(8-{4-
[ethyl-(2-hydroxy-ethyl)-amino]-phenylamino}-imidazo[1,
2-a]pyrazin-5- Yl)-phenol
pdb|4FYO|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
N-{(s)-1-
[7-(3,4-dimethoxy-phenylamino)-thiazolo[5,
4-d]pyrimidin-5-yl]- Pyrrolidin-3-yl}-terephthalamic
Acid
pdb|4FZ6|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
[6-((s)-2-
Methyl-pyrrolidin-1-yl)-pyridin-2-yl]-(6-phenyl-
imidazo[1,2- B]pyridazin-8-yl)-amine
Length = 291
Score = 31.6 bits (70), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 24/104 (23%), Positives = 52/104 (50%), Gaps = 20/104 (19%)
Query: 103 MLKEGHSDAEMMD-LVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+LK +D + D L++E +M+ + I+ ++G+C + + +++E A G L +L
Sbjct: 51 ILKNEANDPALKDELLAEANVMQQLDNPY-IVRMIGICEAESWM-LVMEMAELGPLNKYL 108
Query: 162 RKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQS 205
+++R + +K++I +QV+ GM YL+
Sbjct: 109 QQNRH-----------------VKDKNIIELVHQVSMGMKYLEE 135
>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
pdb|3RNY|B Chain B, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
Length = 346
Score = 31.6 bits (70), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 17/56 (30%), Positives = 26/56 (46%)
Query: 110 DAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHR 165
D D E+E++ GQH NII L V +Y++ E G L D + + +
Sbjct: 61 DKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK 116
>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 636
Score = 31.6 bits (70), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 24/104 (23%), Positives = 53/104 (50%), Gaps = 20/104 (19%)
Query: 103 MLKEGHSDAEMMD-LVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+LK +D + D L++E +M+ + + I+ ++G+C + + +++E A G L +L
Sbjct: 404 ILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEAESWM-LVMEMAELGPLNKYL 461
Query: 162 RKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQS 205
+++R + +K++I +QV+ GM YL+
Sbjct: 462 QQNR-----------------HVKDKNIIELVHQVSMGMKYLEE 488
>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat
Length = 332
Score = 31.6 bits (70), Expect = 0.49, Method: Compositional matrix adjust.
Identities = 34/130 (26%), Positives = 52/130 (40%), Gaps = 27/130 (20%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKML--KEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
AF +VI AE K I +A K L KEG + +E+ ++ I +H NI+ L
Sbjct: 30 AFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS-------MENEIAVLHKI-KHPNIVAL 81
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
+ G LY+I++ G L D + TE+D +Q
Sbjct: 82 DDIYESGGHLYLIMQLVSGGELFDRI-----------------VEKGFYTERDASRLIFQ 124
Query: 196 VANGMHYLQS 205
V + + YL
Sbjct: 125 VLDAVKYLHD 134
>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2-
Phenylcyclopropyl)urea
Length = 293
Score = 31.6 bits (70), Expect = 0.51, Method: Compositional matrix adjust.
Identities = 24/104 (23%), Positives = 52/104 (50%), Gaps = 20/104 (19%)
Query: 103 MLKEGHSDAEMMD-LVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+LK +D + D L++E +M+ + I+ ++G+C + + +++E A G L +L
Sbjct: 61 ILKNEANDPALKDELLAEANVMQQLDNPY-IVRMIGICEAESWM-LVMEMAELGPLNKYL 118
Query: 162 RKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQS 205
+++R + +K++I +QV+ GM YL+
Sbjct: 119 QQNRH-----------------VKDKNIIELVHQVSMGMKYLEE 145
>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Pyrazolylbenzimidazole Inhibitor 416
pdb|3VF9|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Thienopyrazolylindole Inhibitor 027
pdb|3TUC|A Chain A, Crystal Structure Of Syk Kinase Domain With
1-Benzyl-N-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-2-Oxo-1,
2-Dihydropyridine-3- Carboxamide
pdb|3TUD|A Chain A, Crystal Structure Of Syk Kinase Domain With
N-(4-Methyl-3-(8-Methyl-7-
Oxo-2-(Phenylamino)-7,8-Dihydropyrido[2,
3-D]pyrimidin-6-Yl)phenyl)-3- (Trifluoromethyl)benzamide
Length = 299
Score = 31.6 bits (70), Expect = 0.51, Method: Compositional matrix adjust.
Identities = 24/104 (23%), Positives = 52/104 (50%), Gaps = 20/104 (19%)
Query: 103 MLKEGHSDAEMMD-LVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+LK +D + D L++E +M+ + I+ ++G+C + + +++E A G L +L
Sbjct: 61 ILKNEANDPALKDELLAEANVMQQLDNPY-IVRMIGICEAESWM-LVMEMAELGPLNKYL 118
Query: 162 RKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQS 205
+++R + +K++I +QV+ GM YL+
Sbjct: 119 QQNRH-----------------VKDKNIIELVHQVSMGMKYLEE 145
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 31.2 bits (69), Expect = 0.52, Method: Compositional matrix adjust.
Identities = 35/162 (21%), Positives = 69/162 (42%), Gaps = 22/162 (13%)
Query: 56 KVSLINVLTVTIN-SQEYVKIKCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMM 114
+V L+++ T N +++ FGKV G+L+ G VA+K S
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVY----KGVLRDG--AKVALKRRTPESSQGIEE 81
Query: 115 DLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPL 174
+ +H ++++L+G C + + +I ++ +GNL+ L G + P
Sbjct: 82 FETEIETLS--FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL------YGSDLPT 133
Query: 175 GSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVGNDAVRFI 216
S ++ + + A G+HYL +R + + V+ I
Sbjct: 134 MS-------MSWEQRLEICIGAARGLHYLHTRAIIHRDVKSI 168
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 31.2 bits (69), Expect = 0.53, Method: Compositional matrix adjust.
Identities = 35/162 (21%), Positives = 69/162 (42%), Gaps = 22/162 (13%)
Query: 56 KVSLINVLTVTIN-SQEYVKIKCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMM 114
+V L+++ T N +++ FGKV G+L+ G VA+K S
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVY----KGVLRDG--AKVALKRRTPESSQGIEE 81
Query: 115 DLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPL 174
+ +H ++++L+G C + + +I ++ +GNL+ L G + P
Sbjct: 82 FETEIETLS--FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL------YGSDLPT 133
Query: 175 GSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVGNDAVRFI 216
S ++ + + A G+HYL +R + + V+ I
Sbjct: 134 MS-------MSWEQRLEICIGAARGLHYLHTRAIIHRDVKSI 168
>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2-
Phenylaminopyrimidines As Potent Inhibitors Of Spleen
Tyrosine Kinase (Syk)
Length = 291
Score = 31.2 bits (69), Expect = 0.57, Method: Compositional matrix adjust.
Identities = 24/104 (23%), Positives = 52/104 (50%), Gaps = 20/104 (19%)
Query: 103 MLKEGHSDAEMMD-LVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+LK +D + D L++E +M+ + I+ ++G+C + + +++E A G L +L
Sbjct: 59 ILKNEANDPALKDELLAEANVMQQLDNPY-IVRMIGICEAESWM-LVMEMAELGPLNKYL 116
Query: 162 RKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQS 205
+++R + +K++I +QV+ GM YL+
Sbjct: 117 QQNRH-----------------VKDKNIIELVHQVSMGMKYLEE 143
>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
pdb|2JC6|C Chain C, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
Length = 334
Score = 31.2 bits (69), Expect = 0.66, Method: Compositional matrix adjust.
Identities = 30/126 (23%), Positives = 51/126 (40%), Gaps = 23/126 (18%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLG 137
AF +V+ AE K + + K LK S E +E+ +++ I +H NI+ L
Sbjct: 34 AFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIE-----NEIAVLRKI-KHENIVALED 87
Query: 138 VCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
+ LY++++ G L D + TEKD + QV
Sbjct: 88 IYESPNHLYLVMQLVSGGELFDRI-----------------VEKGFYTEKDASTLIRQVL 130
Query: 198 NGMHYL 203
+ ++YL
Sbjct: 131 DAVYYL 136
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 31.2 bits (69), Expect = 0.66, Method: Compositional matrix adjust.
Identities = 33/152 (21%), Positives = 63/152 (41%), Gaps = 30/152 (19%)
Query: 63 LTVTINSQEYVKI-----KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLV 117
+T +N +++ +I AFGKV A+ + +A + + S+ E+ D +
Sbjct: 29 VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKET------SVLAAAKVIDTKSEEELEDYM 82
Query: 118 SEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRD-FLRKHRPSSGYESPLGS 176
E++++ H NI+ LL + L++++EF G + L RP
Sbjct: 83 VEIDILASC-DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP---------- 131
Query: 177 AYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
LTE + Q + ++YL K+
Sbjct: 132 -------LTESQIQVVCKQTLDALNYLHDNKI 156
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 31.2 bits (69), Expect = 0.67, Method: Compositional matrix adjust.
Identities = 33/152 (21%), Positives = 63/152 (41%), Gaps = 30/152 (19%)
Query: 63 LTVTINSQEYVKI-----KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLV 117
+T +N +++ +I AFGKV A+ + +A + + S+ E+ D +
Sbjct: 29 VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKET------SVLAAAKVIDTKSEEELEDYM 82
Query: 118 SEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRD-FLRKHRPSSGYESPLGS 176
E++++ H NI+ LL + L++++EF G + L RP
Sbjct: 83 VEIDILASC-DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP---------- 131
Query: 177 AYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
LTE + Q + ++YL K+
Sbjct: 132 -------LTESQIQVVCKQTLDALNYLHDNKI 156
>pdb|1EAM|A Chain A, Vaccinia Methyltransferase Vp39 Mutant (Ec: 2.7.7.19)
Length = 307
Score = 31.2 bits (69), Expect = 0.67, Method: Compositional matrix adjust.
Identities = 32/108 (29%), Positives = 44/108 (40%), Gaps = 3/108 (2%)
Query: 151 FAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVGN 210
+ PHGN L+ PS E L S YT N+ + S A A M+YL ++ V N
Sbjct: 189 YIPHGN--KMLQPFAPSYSAEMRLLSIYTGENMRLTRVTKSDAVNYAKKMYYL-NKIVRN 245
Query: 211 DAVRFIGFDLCILVFFHDSTLLKTTSTIASLILRNQKVSVLLDLIFVF 258
V + +FH +L+T + KV L IF F
Sbjct: 246 KVVVNFDYPNQEYDYFHMYFMLRTVYCNKTFPTTKAKVLFLQQSIFRF 293
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 30.8 bits (68), Expect = 0.69, Method: Compositional matrix adjust.
Identities = 33/152 (21%), Positives = 63/152 (41%), Gaps = 30/152 (19%)
Query: 63 LTVTINSQEYVKI-----KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLV 117
+T +N +++ +I AFGKV A+ + +A + + S+ E+ D +
Sbjct: 29 VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKET------SVLAAAKVIDTKSEEELEDYM 82
Query: 118 SEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRD-FLRKHRPSSGYESPLGS 176
E++++ H NI+ LL + L++++EF G + L RP
Sbjct: 83 VEIDILASC-DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP---------- 131
Query: 177 AYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
LTE + Q + ++YL K+
Sbjct: 132 -------LTESQIQVVCKQTLDALNYLHDNKI 156
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 30.8 bits (68), Expect = 0.80, Method: Compositional matrix adjust.
Identities = 22/93 (23%), Positives = 42/93 (45%), Gaps = 18/93 (19%)
Query: 116 LVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLG 175
L E+E+ + +H NI+ L G +Y+I+E+AP G + L+K
Sbjct: 60 LRREVEIQSHL-RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKL----------- 107
Query: 176 SAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
+ E+ ++ ++AN + Y S++V
Sbjct: 108 ------SKFDEQRTATYITELANALSYCHSKRV 134
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 30.8 bits (68), Expect = 0.86, Method: Compositional matrix adjust.
Identities = 22/93 (23%), Positives = 42/93 (45%), Gaps = 18/93 (19%)
Query: 116 LVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLG 175
L E+E+ + +H NI+ L G +Y+I+E+AP G + L+K
Sbjct: 60 LRREVEIQSHL-RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKL----------- 107
Query: 176 SAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
+ E+ ++ ++AN + Y S++V
Sbjct: 108 ------SKFDEQRTATYITELANALSYCHSKRV 134
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 30.8 bits (68), Expect = 0.88, Method: Compositional matrix adjust.
Identities = 24/96 (25%), Positives = 42/96 (43%), Gaps = 24/96 (25%)
Query: 116 LVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLG 175
L E+E+ + +H NI+ L G +Y+I+E+A PLG
Sbjct: 55 LRREVEIQSHL-RHPNILRLYGYFHDSTRVYLILEYA--------------------PLG 93
Query: 176 SAYTNGNVLT---EKDLISFAYQVANGMHYLQSRKV 208
+ Y L+ E+ ++ ++AN + Y S+KV
Sbjct: 94 TVYRELQKLSKFDEQRTATYITELANALSYCHSKKV 129
>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7
pdb|2WQN|A Chain A, Structure Of Adp-Bound Human Nek7
Length = 310
Score = 30.4 bits (67), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 17/94 (18%), Positives = 43/94 (45%), Gaps = 14/94 (14%)
Query: 115 DLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPL 174
D + E++++K + H N+I +D L +++E A G+L ++ +
Sbjct: 78 DCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFK--------- 127
Query: 175 GSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
++ E+ + + Q+ + + ++ SR+V
Sbjct: 128 ----KQKRLIPERTVWKYFVQLCSALEHMHSRRV 157
>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
pdb|4FG8|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
Length = 315
Score = 30.4 bits (67), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 33/130 (25%), Positives = 52/130 (40%), Gaps = 27/130 (20%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKML--KEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
AF +VI AE K I +A + L KEG + +E+ ++ I +H NI+ L
Sbjct: 30 AFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS-------MENEIAVLHKI-KHPNIVAL 81
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
+ G LY+I++ G L D + TE+D +Q
Sbjct: 82 DDIYESGGHLYLIMQLVSGGELFDRI-----------------VEKGFYTERDASRLIFQ 124
Query: 196 VANGMHYLQS 205
V + + YL
Sbjct: 125 VLDAVKYLHD 134
>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FG9|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FGB|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I Apo Form
Length = 320
Score = 30.4 bits (67), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 33/130 (25%), Positives = 52/130 (40%), Gaps = 27/130 (20%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKML--KEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
AF +VI AE K I +A + L KEG + +E+ ++ I +H NI+ L
Sbjct: 30 AFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS-------MENEIAVLHKI-KHPNIVAL 81
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
+ G LY+I++ G L D + TE+D +Q
Sbjct: 82 DDIYESGGHLYLIMQLVSGGELFDRI-----------------VEKGFYTERDASRLIFQ 124
Query: 196 VANGMHYLQS 205
V + + YL
Sbjct: 125 VLDAVKYLHD 134
>pdb|3ZGW|A Chain A, Crystal Structure Of Maternal Embryonic Leucine Zipper
Kinase (melk) In Complex With Amp-pnp
Length = 347
Score = 30.4 bits (67), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 15/63 (23%), Positives = 37/63 (58%), Gaps = 1/63 (1%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLR 158
VA+K++ + +++ + +E+E +K + +H +I L V +++++E+ P G L
Sbjct: 38 VAIKIMDKNTLGSDLPRIKTEIEALKNL-RHQHICQLYHVLETANKIFMVLEYCPGGELF 96
Query: 159 DFL 161
D++
Sbjct: 97 DYI 99
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 30.0 bits (66), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 43/90 (47%), Gaps = 8/90 (8%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMD--LVSEMEMMKMIGQHINII 133
K FG V A K I VA+K+L + + E ++ L E+E+ + H NI+
Sbjct: 33 KGKFGNVYLAREK---KSHFI--VALKVLFKSQIEKEGVEHQLRREIEIQAHL-HHPNIL 86
Query: 134 NLLGVCTQDGPLYVIVEFAPHGNLRDFLRK 163
L +Y+I+E+AP G L L+K
Sbjct: 87 RLYNYFYDRRRIYLILEYAPRGELYKELQK 116
>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-293 In Complex With Atp
Length = 293
Score = 30.0 bits (66), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 33/130 (25%), Positives = 52/130 (40%), Gaps = 27/130 (20%)
Query: 78 AFGKVICAEANGILKQGIITTVAVKML--KEGHSDAEMMDLVSEMEMMKMIGQHINIINL 135
AF +VI AE K I +A + L KEG + +E+ ++ I +H NI+ L
Sbjct: 30 AFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS-------MENEIAVLHKI-KHPNIVAL 81
Query: 136 LGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQ 195
+ G LY+I++ G L D + TE+D +Q
Sbjct: 82 DDIYESGGHLYLIMQLVSGGELFDRI-----------------VEKGFYTERDASRLIFQ 124
Query: 196 VANGMHYLQS 205
V + + YL
Sbjct: 125 VLDAVKYLHD 134
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 29.3 bits (64), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+ F+
Sbjct: 50 IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC
Length = 405
Score = 29.3 bits (64), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 23/94 (24%), Positives = 47/94 (50%), Gaps = 12/94 (12%)
Query: 114 MDLVSEMEMMKMIGQHINIINLLGV--CTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYE 171
M E+ +++ + +H N+I+L V D ++++ ++A H +L ++ HR S +
Sbjct: 63 MSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANK 120
Query: 172 SPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQS 205
P+ L + S YQ+ +G+HYL +
Sbjct: 121 KPVQ--------LPRGMVKSLLYQILDGIHYLHA 146
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 29.3 bits (64), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+ F+
Sbjct: 50 IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 29.3 bits (64), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+ F+
Sbjct: 50 IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 29.3 bits (64), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+ F+
Sbjct: 50 IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 29.3 bits (64), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+ F+
Sbjct: 49 IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 91
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 29.3 bits (64), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+ F+
Sbjct: 49 IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 91
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 29.3 bits (64), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+ F+
Sbjct: 50 IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+ F+
Sbjct: 49 IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 91
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+ F+
Sbjct: 50 IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+ F+
Sbjct: 49 IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 91
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+ F+
Sbjct: 49 IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 91
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+ F+
Sbjct: 50 IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+ F+
Sbjct: 51 IREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 93
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+ F+
Sbjct: 51 IREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 93
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+ F+
Sbjct: 50 IREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+ F+
Sbjct: 57 IREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 99
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+ F+
Sbjct: 50 IREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+ F+
Sbjct: 52 IREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 94
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+ F+
Sbjct: 53 IREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 95
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+ F+
Sbjct: 51 IREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 93
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+ F+
Sbjct: 52 IREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 94
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+ F+
Sbjct: 54 IREISLLKELN-HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 96
>pdb|2UV2|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To
4-(4-(
5-Cyclopropyl-1h-Pyrazol-3-Ylamino)-Quinazolin-2-
Ylamino)- Phenyl)-Acetonitrile
Length = 287
Score = 29.3 bits (64), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 29/131 (22%), Positives = 53/131 (40%), Gaps = 25/131 (19%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGV 138
FGKV A+ + +A + + S+ E+ D + E++++ H NI+ LL
Sbjct: 23 FGKVYKAQNKET------SVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDA 75
Query: 139 CTQDGPLYVIVEFAPHGNLRD-FLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVA 197
+ L++++EF G + L RP LTE + Q
Sbjct: 76 FYYENNLWILIEFCAGGAVDAVMLELERP-----------------LTESQIQVVCKQTL 118
Query: 198 NGMHYLQSRKV 208
+ ++YL K+
Sbjct: 119 DALNYLHDNKI 129
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 29.3 bits (64), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+ F+
Sbjct: 52 IREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 94
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 29.3 bits (64), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+ F+
Sbjct: 53 IREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 95
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 29.3 bits (64), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+ F+
Sbjct: 57 IREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 99
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 29.3 bits (64), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+ F+
Sbjct: 54 IREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 96
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 29.3 bits (64), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+ F+
Sbjct: 51 IREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 93
>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4APC|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4B9D|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor.
pdb|4B9D|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor
Length = 350
Score = 28.9 bits (63), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 17/92 (18%), Positives = 43/92 (46%), Gaps = 9/92 (9%)
Query: 70 QEYVKIK----CAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKM 125
++YV+++ +FGK I ++ +Q +I + + + + ++ M
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM--- 80
Query: 126 IGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
+H NI+ ++G LY+++++ G+L
Sbjct: 81 --KHPNIVQYRESFEENGSLYIVMDYCEGGDL 110
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 28.9 bits (63), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF H +L+ F+
Sbjct: 53 IREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFM 95
>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3Q4T|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3SOC|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|3SOC|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|4ASX|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
pdb|4ASX|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
Length = 322
Score = 28.9 bits (63), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 24/93 (25%), Positives = 40/93 (43%), Gaps = 23/93 (24%)
Query: 118 SEMEMMKMIG-QHINIINLLGVCTQ----DGPLYVIVEFAPHGNLRDFLRKHRPSSGYES 172
+E E+ + G +H NI+ +G + D L++I F G+L DFL+
Sbjct: 65 NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---------- 114
Query: 173 PLGSAYTNGNVLTEKDLISFAYQVANGMHYLQS 205
NV++ +L A +A G+ YL
Sbjct: 115 --------ANVVSWNELCHIAETMARGLAYLHE 139
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 28.5 bits (62), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 11/40 (27%), Positives = 23/40 (57%)
Query: 129 HINIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSS 168
H NI++++ V +D Y+++E+ L +++ H P S
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLS 109
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 28.5 bits (62), Expect = 4.0, Method: Compositional matrix adjust.
Identities = 27/110 (24%), Positives = 49/110 (44%), Gaps = 16/110 (14%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLR 158
+A+K + E S L E+ + K + +H NI+ LG +++G + + +E P G+L
Sbjct: 36 IAIKEIPERDSRYSQ-PLHEEIALHKHL-KHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 93
Query: 159 DFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
LR S G N E+ + + Q+ G+ YL ++
Sbjct: 94 ALLR---------SKWGPLKDN-----EQTIGFYTKQILEGLKYLHDNQI 129
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 28.1 bits (61), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 27/110 (24%), Positives = 49/110 (44%), Gaps = 16/110 (14%)
Query: 99 VAVKMLKEGHSDAEMMDLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLR 158
+A+K + E S L E+ + K + +H NI+ LG +++G + + +E P G+L
Sbjct: 50 IAIKEIPERDSRYSQ-PLHEEIALHKHL-KHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107
Query: 159 DFLRKHRPSSGYESPLGSAYTNGNVLTEKDLISFAYQVANGMHYLQSRKV 208
LR S G N E+ + + Q+ G+ YL ++
Sbjct: 108 ALLR---------SKWGPLKDN-----EQTIGFYTKQILEGLKYLHDNQI 143
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 28.1 bits (61), Expect = 5.5, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF +L+DF+
Sbjct: 52 IREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFM 94
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 28.1 bits (61), Expect = 5.6, Method: Compositional matrix adjust.
Identities = 15/45 (33%), Positives = 27/45 (60%), Gaps = 2/45 (4%)
Query: 117 VSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNLRDFL 161
+ E+ ++K + H NI+ LL V + LY++ EF +L+DF+
Sbjct: 53 IREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFM 95
>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent
Protein Kinase Cgd3_920 From Cryptosporidium Parvum
Length = 286
Score = 27.7 bits (60), Expect = 5.7, Method: Compositional matrix adjust.
Identities = 24/103 (23%), Positives = 44/103 (42%), Gaps = 2/103 (1%)
Query: 71 EYVKIKCAFGKVICAEANGILKQGIITTVAVKML-KEGHSDAEMMDLVSEMEMMKMIGQH 129
E I C GK E + AVK++ K + + ++ E+E++K + H
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DH 80
Query: 130 INIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYES 172
NI+ L + Y++ E G L D + K + S +++
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA 123
>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1,
Cgd3_920
pdb|3MWU|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Rm-1-95
pdb|3NCG|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Nm-Pp1
Length = 486
Score = 27.7 bits (60), Expect = 5.9, Method: Compositional matrix adjust.
Identities = 24/103 (23%), Positives = 44/103 (42%), Gaps = 2/103 (1%)
Query: 71 EYVKIKCAFGKVICAEANGILKQGIITTVAVKML-KEGHSDAEMMDLVSEMEMMKMIGQH 129
E I C GK E + AVK++ K + + ++ E+E++K + H
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DH 80
Query: 130 INIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYES 172
NI+ L + Y++ E G L D + K + S +++
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA 123
>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium
Parvum Calcium Dependent Protein Kinase In Complex With
3- Mb-Pp1
Length = 287
Score = 27.7 bits (60), Expect = 6.1, Method: Compositional matrix adjust.
Identities = 24/103 (23%), Positives = 44/103 (42%), Gaps = 2/103 (1%)
Query: 71 EYVKIKCAFGKVICAEANGILKQGIITTVAVKML-KEGHSDAEMMDLVSEMEMMKMIGQH 129
E I C GK E + AVK++ K + + ++ E+E++K + H
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DH 80
Query: 130 INIINLLGVCTQDGPLYVIVEFAPHGNLRDFLRKHRPSSGYES 172
NI+ L + Y++ E G L D + K + S +++
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA 123
>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native
pdb|3MFS|A Chain A, Cask-4m Cam Kinase Domain, Amppnp
pdb|3MFT|A Chain A, Cask-4m Cam Kinase Domain, Mn2+
pdb|3MFU|A Chain A, Cask-4m Cam Kinase Domain, Amppnp-Mn2+
Length = 351
Score = 27.7 bits (60), Expect = 6.3, Method: Compositional matrix adjust.
Identities = 15/43 (34%), Positives = 24/43 (55%), Gaps = 1/43 (2%)
Query: 115 DLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
DL E + M+ +H +I+ LL + DG LY++ EF +L
Sbjct: 72 DLKREASICHML-KHPHIVELLETYSSDGMLYMVFEFMDGADL 113
>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX
Length = 361
Score = 27.7 bits (60), Expect = 6.4, Method: Compositional matrix adjust.
Identities = 15/43 (34%), Positives = 24/43 (55%), Gaps = 1/43 (2%)
Query: 115 DLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
DL E + M+ +H +I+ LL + DG LY++ EF +L
Sbjct: 74 DLKREASICHML-KHPHIVELLETYSSDGMLYMVFEFMDGADL 115
>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
pdb|3C0G|B Chain B, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
pdb|3C0H|A Chain A, Cask Cam-Kinase Domain- Amppnp Complex, P1 Form
pdb|3C0H|B Chain B, Cask Cam-Kinase Domain- Amppnp Complex, P1 Form
pdb|3C0I|A Chain A, Cask Cam-Kinase Domain- 3'-Amp Complex, P212121 Form
Length = 351
Score = 27.7 bits (60), Expect = 6.4, Method: Compositional matrix adjust.
Identities = 15/43 (34%), Positives = 24/43 (55%), Gaps = 1/43 (2%)
Query: 115 DLVSEMEMMKMIGQHINIINLLGVCTQDGPLYVIVEFAPHGNL 157
DL E + M+ +H +I+ LL + DG LY++ EF +L
Sbjct: 72 DLKREASICHML-KHPHIVELLETYSSDGMLYMVFEFMDGADL 113
>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|D Chain D, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|F Chain F, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|H Chain H, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1IAS|A Chain A, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|B Chain B, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|C Chain C, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|D Chain D, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|E Chain E, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|3FAA|A Chain A, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|B Chain B, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|C Chain C, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|D Chain D, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|E Chain E, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3KCF|A Chain A, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|B Chain B, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|C Chain C, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|D Chain D, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|E Chain E, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|2X7O|A Chain A, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|B Chain B, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|C Chain C, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|D Chain D, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|E Chain E, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
Length = 342
Score = 27.7 bits (60), Expect = 6.9, Method: Compositional matrix adjust.
Identities = 35/154 (22%), Positives = 62/154 (40%), Gaps = 35/154 (22%)
Query: 61 NVLTVTINSQEYVKIKCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEM 120
+ TI QE + K FG+V + G VAVK+ S E E
Sbjct: 38 RTIARTIVLQESIG-KGRFGEVWRGKWRG-------EEVAVKIF----SSREERSWFREA 85
Query: 121 EMMKMIG-QHINIINLLGVCTQDG----PLYVIVEFAPHGNLRDFLRKHRPSSGYESPLG 175
E+ + + +H NI+ + +D L+++ ++ HG+L D+L ++
Sbjct: 86 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----------- 134
Query: 176 SAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVG 209
+T + +I A A+G+ +L VG
Sbjct: 135 -------TVTVEGMIKLALSTASGLAHLHMEIVG 161
>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With
Inhibitor
Length = 326
Score = 27.7 bits (60), Expect = 7.0, Method: Compositional matrix adjust.
Identities = 35/149 (23%), Positives = 61/149 (40%), Gaps = 35/149 (23%)
Query: 66 TINSQEYVKIKCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKM 125
TI QE + K FG+V + G VAVK+ S E E E+ +
Sbjct: 30 TIVLQESIG-KGRFGEVWRGKWRG-------EEVAVKIF----SSREERSWFREAEIYQT 77
Query: 126 IG-QHINIINLLGVCTQDG----PLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTN 180
+ +H NI+ + +D L+++ ++ HG+L D+L ++
Sbjct: 78 VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---------------- 121
Query: 181 GNVLTEKDLISFAYQVANGMHYLQSRKVG 209
+T + +I A A+G+ +L VG
Sbjct: 122 --TVTVEGMIKLALSTASGLAHLHMEIVG 148
>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542
Length = 309
Score = 27.7 bits (60), Expect = 7.2, Method: Compositional matrix adjust.
Identities = 35/154 (22%), Positives = 63/154 (40%), Gaps = 35/154 (22%)
Query: 61 NVLTVTINSQEYVKIKCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEM 120
+ + TI QE + K FG+V + G VAVK+ S E E
Sbjct: 5 STIARTIVLQESIG-KGRFGEVWRGKWRG-------EEVAVKIF----SSREERSWFREA 52
Query: 121 EMMKMIG-QHINIINLLGVCTQDG----PLYVIVEFAPHGNLRDFLRKHRPSSGYESPLG 175
E+ + + +H NI+ + +D L+++ ++ HG+L D+L ++
Sbjct: 53 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----------- 101
Query: 176 SAYTNGNVLTEKDLISFAYQVANGMHYLQSRKVG 209
+T + +I A A+G+ +L VG
Sbjct: 102 -------TVTVEGMIKLALSTASGLAHLHMEIVG 128
>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp
Site Inhibitor
Length = 301
Score = 27.7 bits (60), Expect = 7.3, Method: Compositional matrix adjust.
Identities = 31/139 (22%), Positives = 56/139 (40%), Gaps = 34/139 (24%)
Query: 76 KCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKMIG-QHINIIN 134
K FG+V + G VAVK+ S E E E+ + + +H NI+
Sbjct: 14 KGRFGEVWRGKWRG-------EEVAVKIF----SSREERSWFREAEIYQTVMLRHENILG 62
Query: 135 LLGVCTQDG----PLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTNGNVLTEKDLI 190
+ +D L+++ ++ HG+L D+L ++ +T + +I
Sbjct: 63 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY------------------TVTVEGMI 104
Query: 191 SFAYQVANGMHYLQSRKVG 209
A A+G+ +L VG
Sbjct: 105 KLALSTASGLAHLHMEIVG 123
>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human
Tgf- Beta Type I Receptor
pdb|3GXL|A Chain A, Alk-5 Kinase Complex With Gw857175
pdb|3HMM|A Chain A, Structure Of Alk5 + Gw855857
Length = 303
Score = 27.3 bits (59), Expect = 7.7, Method: Compositional matrix adjust.
Identities = 35/149 (23%), Positives = 61/149 (40%), Gaps = 35/149 (23%)
Query: 66 TINSQEYVKIKCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKM 125
TI QE + K FG+V + G VAVK+ S E E E+ +
Sbjct: 4 TIVLQESIG-KGRFGEVWRGKWRG-------EEVAVKIF----SSREERSWFREAEIYQT 51
Query: 126 IG-QHINIINLLGVCTQDG----PLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTN 180
+ +H NI+ + +D L+++ ++ HG+L D+L ++
Sbjct: 52 VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---------------- 95
Query: 181 GNVLTEKDLISFAYQVANGMHYLQSRKVG 209
+T + +I A A+G+ +L VG
Sbjct: 96 --TVTVEGMIKLALSTASGLAHLHMEIVG 122
>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3-
Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine
pdb|2WOU|A Chain A, Alk5 In Complex With
4-((4-((2,6-Dimethyl-3-Pyridyl)oxy)-2-
Pyridyl)amino)benzenesulfonamide
Length = 306
Score = 27.3 bits (59), Expect = 7.7, Method: Compositional matrix adjust.
Identities = 35/149 (23%), Positives = 61/149 (40%), Gaps = 35/149 (23%)
Query: 66 TINSQEYVKIKCAFGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVSEMEMMKM 125
TI QE + K FG+V + G VAVK+ S E E E+ +
Sbjct: 7 TIVLQESIG-KGRFGEVWRGKWRG-------EEVAVKIF----SSREERSWFREAEIYQT 54
Query: 126 IG-QHINIINLLGVCTQDG----PLYVIVEFAPHGNLRDFLRKHRPSSGYESPLGSAYTN 180
+ +H NI+ + +D L+++ ++ HG+L D+L ++
Sbjct: 55 VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---------------- 98
Query: 181 GNVLTEKDLISFAYQVANGMHYLQSRKVG 209
+T + +I A A+G+ +L VG
Sbjct: 99 --TVTVEGMIKLALSTASGLAHLHMEIVG 125
>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated
Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2
Chain)
Length = 276
Score = 27.3 bits (59), Expect = 8.2, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 43/90 (47%), Gaps = 12/90 (13%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVS----EMEMMKMIGQHINIIN 134
FGKV E Q VAVK+L +D+V E++ +K+ +H +II
Sbjct: 24 FGKVKIGE-----HQLTGHKVAVKILNR--QKIRSLDVVGKIKREIQNLKLF-RHPHIIK 75
Query: 135 LLGVCTQDGPLYVIVEFAPHGNLRDFLRKH 164
L V + ++++E+ G L D++ KH
Sbjct: 76 LYQVISTPTDFFMVMEYVSGGELFDYICKH 105
>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human
5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant
(T172d)
pdb|3AQV|A Chain A, Human Amp-Activated Protein Kinase Alpha 2 Subunit Kinase
Domain (T172d) Complexed With Compound C
Length = 276
Score = 27.3 bits (59), Expect = 8.5, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 43/90 (47%), Gaps = 12/90 (13%)
Query: 79 FGKVICAEANGILKQGIITTVAVKMLKEGHSDAEMMDLVS----EMEMMKMIGQHINIIN 134
FGKV E Q VAVK+L +D+V E++ +K+ +H +II
Sbjct: 24 FGKVKIGE-----HQLTGHKVAVKILNR--QKIRSLDVVGKIKREIQNLKLF-RHPHIIK 75
Query: 135 LLGVCTQDGPLYVIVEFAPHGNLRDFLRKH 164
L V + ++++E+ G L D++ KH
Sbjct: 76 LYQVISTPTDFFMVMEYVSGGELFDYICKH 105
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.323 0.136 0.401
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 7,172,443
Number of Sequences: 62578
Number of extensions: 280002
Number of successful extensions: 1537
Number of sequences better than 100.0: 456
Number of HSP's better than 100.0 without gapping: 254
Number of HSP's successfully gapped in prelim test: 202
Number of HSP's that attempted gapping in prelim test: 907
Number of HSP's gapped (non-prelim): 483
length of query: 258
length of database: 14,973,337
effective HSP length: 97
effective length of query: 161
effective length of database: 8,903,271
effective search space: 1433426631
effective search space used: 1433426631
T: 11
A: 40
X1: 16 ( 7.5 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (22.0 bits)
S2: 50 (23.9 bits)